<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8" /><meta name="viewport" content="user-scalable=yes, width=device-width, initial-scale=1, maximum-scale=2, viewport-fit=cover" /><link href="https://takeda-mo.mo.cloudinary.net" rel="dns-prefetch" /><link href="https://takeda-mo.mo.cloudinary.net" rel="preconnect" /><style>:root {
  --cta-fontWeightMobile:700;
  --cta-fontSize:1rem;
  --cta-fontSizeMobile:1rem;
  --cta-fontLineHeight:1.625rem;
  --cta-fontWeight:700;
  --cta-fontLineHeightMobile:1.625rem;
  --colorDarkGrey:#333333;
  --subHeading-fontWeight:500;
  --subHeading-fontLineHeightMobile:1.5rem;
  --subHeading-fontWeightMobile:700;
  --subHeading-fontSize:1.125rem;
  --subHeading-fontSizeMobile:1rem;
  --subHeading-fontLineHeight:1.25rem;
  --h3-fontWeight:500;
  --h3-fontLineHeightMobile:1.75rem;
  --h3-fontWeightMobile:500;
  --h3-fontSize:1.5rem;
  --h3-fontSizeMobile:1.25rem;
  --h3-fontLineHeight:2rem;
  --colorPrimaryContrast:#ffffff;
  --spacings-marginTopMobile:0rem;
  --spacings-marginBottomMobile:2.5rem;
  --spacings-paddingTopMobile:0rem;
  --spacings-marginTopFirstComponent:3.125rem;
  --spacings-marginBottom:3.125rem;
  --spacings-marginTopFirstComponentMobile:2.5rem;
  --spacings-paddingTop:0rem;
  --spacings-paddingBottomMobile:0rem;
  --spacings-marginTop:0rem;
  --spacings-paddingBottom:0rem;
  --colorLightGrey:#edf2f4;
  --colorPrimary:#BD120A;
  --colorPrimaryActiveContrast:#ffffff;
  --colorLightGreyContrast:#333333;
  --h2-fontSizeMobile:1.5rem;
  --h2-fontLineHeight:2.6875rem;
  --h2-fontWeight:300;
  --h2-fontLineHeightMobile:2rem;
  --h2-fontWeightMobile:300;
  --h2-fontSize:2.25rem;
  --h4-fontWeightMobile:500;
  --h4-fontSize:1.25rem;
  --h4-fontSizeMobile:1.125rem;
  --h4-fontLineHeight:1.75rem;
  --h4-fontWeight:500;
  --h4-fontLineHeightMobile:1.75rem;
  --bodyBlock-fontWeight:400;
  --bodyBlock-fontLineHeightMobile:1.625rem;
  --bodyBlock-fontWeightMobile:400;
  --bodyBlock-fontSize:1rem;
  --bodyBlock-fontSizeMobile:1rem;
  --bodyBlock-fontLineHeight:1.625rem;
  --colorMediumGrey:#a1a4ac;
  --textColor:#333333;
  --buttonPrimary-hoverBackgroundColor:#891515;
  --buttonPrimary-textColor:#ffffff;
  --buttonPrimary-backgroundColor:#BD120A;
  --buttonPrimary-borderRadiusBottomLeft:1.25rem;
  --colorMediumGreyContrast:#ffffff;
  --buttonSecondary-textColor:#333333;
  --colorSecondary:#891515;
  --globalImages-borderRadiusBottomLeft:1.875rem;
  --quote-fontLineHeight:2.75rem;
  --quote-fontWeight:400;
  --quote-fontLineHeightMobile:1.625rem;
  --quote-fontWeightMobile:400;
  --quote-fontSize:2rem;
  --quote-fontSizeMobile:1.25rem;
  --colorSecondaryContrast:#ffffff;
  --colorPrimaryActive:#891515;
  --h1-fontSizeMobile:1.875rem;
  --h1-fontLineHeight:2.875rem;
  --h1-fontWeight:300;
  --h1-fontWeightMobile:300;
  --h1-fontSize:2.625rem;
  --h5-fontSizeMobile:1rem;
  --h5-fontLineHeight:1.75rem;
  --h5-fontWeight:700;
  --h5-fontLineHeightMobile:1.75rem;
  --h5-fontWeightMobile:700;
  --h5-fontSize:1rem;
  --colorDarkGreyContrast:#ffffff;
  --colorHoverGrey:#DCE6E9;
}</style><link rel="preload" href="/fonts/woff2/GothamSSm-Book_Web.woff2" as="font" crossorigin type="font/woff2" /><link rel="shortcut icon" href="/favicon.ico" /><link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png" /><link rel="alternate" href="https://www.takeda.com/" hrefLang="x-default" /><link rel="alternate" href="https://www.takeda.com/jp/" hrefLang="ja" /><title>Takeda Pharmaceuticals: Global Homepage</title><meta name="robots" content="index,follow" /><meta name="description" content="Takeda is a patient-focused, R&amp;D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future." /><meta property="og:title" content="Takeda Pharmaceuticals: Global Homepage" /><meta property="og:description" content="Takeda is a patient-focused, R&amp;D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future." /><meta property="og:url" content="https://www.takeda.com/" /><meta property="og:image" content="http://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg" /><meta property="og:image:alt" content="Takeda Pharmaceuticals: Global Homepage" /><meta property="og:image:secure_url" content="https://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg" /><meta property="og:image:type" content="image" /><meta property="og:image:width" content="1200" /><meta property="og:image:height" content="627" /><link rel="canonical" href="https://www.takeda.com/" /><link rel="preload" as="image" imageSrcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 1920w" imageSizes="100vw" /><link rel="preload" as="image" imageSrcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1920w" imageSizes="100vw" /><meta name="next-head-count" content="25" /><script type="text/javascript" data-nscript="beforeInteractive">
  function OptanonWrapper() {}
</script><script type="application/ld+json" data-nscript="beforeInteractive">{"@context": "https://schema.org","@type":"Organization","name": "Takeda Pharmaceutical Company Limited","url": "https://www.takeda.com","logo": "https://www.takeda.com/4ab4e2/siteassets/system/top/howwework_logo_1600x900.jpg","address": {"@type": "PostalAddress","streetAddress": "2-ch?me-1-1 Nihonbashihonch?","addressLocality": "Chuo City","addressRegion": "Tokyo","postalCode": "103-0023","addressCountry": "Japan"},"contactPoint": {"@type": "ContactPoint","contactType": "contact","telephone": "+81 3-3278-2111","email": "Media_Relations@takeda.com"},"sameAs":["https://www.linkedin.com/company/takeda-pharmaceuticals/","https://twitter.com/takedapharma","https://www.youtube.com/takeda-pharmaceuticals"]} </script><script data-nscript="beforeInteractive">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-5XBTH5B');</script><script data-nscript="beforeInteractive">
var _mtm = window._mtm = window._mtm || [];
_mtm.push({'mtm.startTime': (new Date().getTime()), 'event': 'mtm.Start'});
var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
g.async=true; g.src='https://cdn.matomo.cloud/takeda.matomo.cloud/container_rTZNKGIx.js'; s.parentNode.insertBefore(g,s);
</script><script id="disable-nextjs-error-overlay-with-stackbit" data-nscript="beforeInteractive">
  window.addEventListener('error', event => {
    if (undefined) {
      event.stopImmediatePropagation()
    }
  })

  window.addEventListener('unhandledrejection', event => {
    if (undefined) {
      event.stopImmediatePropagation()
    }
  })
</script><link rel="preload" href="/_next/static/css/c7da602fff778a93.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/c7da602fff778a93.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" data-n-g /><link rel="preload" href="/_next/static/css/72e6ca2a215fe06f.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/72e6ca2a215fe06f.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/7beefcb0f4723f43.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/7beefcb0f4723f43.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/2229ed37282f7e6a.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/2229ed37282f7e6a.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/6be6bab7a2356d56.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/6be6bab7a2356d56.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/1f34076c1e2b2473.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/1f34076c1e2b2473.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/14dc0d602ebe7ab5.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/14dc0d602ebe7ab5.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/ab5b7ccfdd338796.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/ab5b7ccfdd338796.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/0da6407dac8c56f2.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/0da6407dac8c56f2.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/8dfaf8f115acbb55.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/8dfaf8f115acbb55.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/0f50d0cd07675f37.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/0f50d0cd07675f37.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/5dc435d74b08c14f.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/5dc435d74b08c14f.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/d2de4fb22383fbba.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/d2de4fb22383fbba.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/b13df82911619a47.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/b13df82911619a47.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/340ffad382f47a86.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/340ffad382f47a86.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/af85821d3f1cb969.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/af85821d3f1cb969.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/ce1175c3dbd33d95.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/ce1175c3dbd33d95.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/5e3ce44307f14b35.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/5e3ce44307f14b35.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/c806bb37609563de.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/c806bb37609563de.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><link rel="preload" href="/_next/static/css/647575393d828472.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" as="style" /><link rel="stylesheet" href="/_next/static/css/647575393d828472.css?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" /><noscript data-n-css></noscript><script defer nomodule src="/_next/static/chunks/polyfills-78c92fac7aa8fdd8.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script src="https://cdn.cookielaw.org/consent/3625bb82-8e0e-4be8-80d3-257e4f469168/OtAutoBlock.js" type="text/javascript" defer data-nscript="beforeInteractive"></script><script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" data-document-language="true" type="text/javascript" charSet="UTF-8" data-domain-script="3625bb82-8e0e-4be8-80d3-257e4f469168" defer data-nscript="beforeInteractive"></script><script defer src="/_next/static/chunks/8913.0158345ceacd002a.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/1735.97bc3d6896feaf19.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/982.e36f836c46c77e6b.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/8464.a3e81665ddb20319.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/7557.0343b0520300b016.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/2789.004b3538c8f50c3e.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/147.0df26e8d73ffd848.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/7377.6cded85ce1306fb3.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/1467.58542c2b70455bbd.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/9838.f359a42f7b365b7d.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/1664.889a16dbc905c6a0.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/4676.559b4c24c74ed9c2.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/6896.29433110084c3c36.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/2066.f09abd03f2260c47.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/5997.9a7fe8936ea16732.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/5530.a5944dc0bd9e2101.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/675.5e549aefe8665198.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/6237.4895b3e2fffaa72e.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/7732.26e7665dd7f5912c.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/7588.4810920d2063e898.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/5003.0951c8c88306784b.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/4656.8e45461649028c13.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/3829.7b1cdd8ec4cb42d9.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/3477.fc7686ec2bfc4cbd.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/320.09d613fcdd5bd69a.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/9413.5128e0b822be594d.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/3566.8326998104f3dc7b.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/5186.8226cb4c344c9736.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/3644.9837ffc45034884a.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/9144.1ab014d66cc5f9c4.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/6787.8943caa843771f4f.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/8242.9a87c61163717266.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/6978.b03f20ba8a1ae965.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/2049.c75a971f206e362d.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/9634.83f534a6e693385c.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/3085.3b77ab37e6116895.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/3329.ac75dcdef83c8c8a.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/5259.001a49d8f103dce3.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/8532.b59911cd1ef25f12.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/2255.37d94396214a7a40.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/7726.e5b4b4d093e19a44.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/6914.c6313039679ab70a.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/5191.5cea5ce68bf30c70.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/7560.b3a6c61152253e2a.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/1075.245646ee4f0d594e.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/8191.8c9c506ccb3ba3fb.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/6647.c59ebc54d68159c6.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/1009.1356e8a9eacf8780.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/2616.fae94881880822b0.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/297.cdcc3f5d7c3a8186.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/5918.b125105becf738c4.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/7427.e84ac1d9846d582c.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/5609.47c23934590dd288.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/1078.5845294ba3ae287a.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/5160.4e2351d7e103a511.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/4124.4765aee881889dfc.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/7133.6baf6024d2fdc8bc.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/8102.692a9c964c0aee2e.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/6362.adceed6ba024b03d.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script defer src="/_next/static/chunks/9457.ace3bca4eac3ffb2.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3"></script><script src="/_next/static/chunks/webpack-16e8ccb7d49379c3.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" defer></script><script src="/_next/static/chunks/framework-a2363dd3c3dbe572.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" defer></script><script src="/_next/static/chunks/main-40fbf48e57637260.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" defer></script><script src="/_next/static/chunks/pages/_app-6bd4ea8508dc5c76.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" defer></script><script src="/_next/static/chunks/8764-fee6e2edf0153dd7.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" defer></script><script src="/_next/static/chunks/2162-a57760b0a9e8b896.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" defer></script><script src="/_next/static/chunks/pages/%5B%5B...slug%5D%5D-7c4115f8f9e30508.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" defer></script><script src="/_next/static/nFkK7YISqlZ_ykhgcoPzV/_buildManifest.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" defer></script><script src="/_next/static/nFkK7YISqlZ_ykhgcoPzV/_ssgManifest.js?dpl=dpl_EKwXVeH3B88ESwaPa1nxns62ypo3" defer></script></head><body><div id="__next"><div class="body-wrapper" data-lang="en">
<!-- -->
<!-- -->
<!-- -->
<!-- -->
<!-- --> <!-- -->
<!-- -->
<!-- -->
<!-- -->
<style type="text/css"> #onetrust-consent-sdk svg {display: inline;} </style><div id="root" data-sb-object-id="a6124d37-8099-4bbc-9897-50e7a249e4c5"><header data-sb-field-path="undefined:header" class="w-full shadow-lg flex items-center py-[20px] h-[90px] max-sm:h-[56px] px-[40px] max-sm:px-[20px] w-[100%] transition sticky z-[100] top-0 bg-white text-dark-grey !py-0 h-[71px] relative !px-0"><div class="Container_root__AelVI flex justify-between items-center h-full"><div class="flex items-center justify-start h-full"><a data-sb-field-path=".logo" class="flex items-center relative w-[121px] max-sm:w-[56px] ml-[-2px]" role="link" aria-label="Takeda - Global" href="/"><div class="ImageBlock_root__MFRQz" style="aspect-ratio:2.8125"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Takeda logo" _type="ImageBlock" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257" decoding="async" data-nimg="fill" class="rounded-none" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" /></span></div></a><nav class="relative items-center justify-start hidden h-full mr-5 lg:flex"><ul class="relative flex pl-10 overflow-x-auto xl:pl-20 no-scrollbar pt-1"></ul></nav><div class="crawled-navigation sr-only"></div></div><div class="h-full hidden lg:flex lg:relative items-center justify-end min-w-[180px] 2xl:min-w-[280px] font-bold"><form class="z-10 flex-col flex-1"><div class="z-10 flex flex-row items-center group"><button aria-label="Search" class="flex justify-center align-middle search-close-ignored-element" type="button"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="none" viewBox="0 0 24 24" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="block w-5 group-hover:text-primary" role="img" aria-hidden="true" data-testid="icon-Search"><circle cx="11" cy="11" r="8"></circle><line x1="21" y1="21" x2="16.65" y2="16.65"></line></svg><span class="uppercase hidden ml-2 text-sm 2xl:block">Search...</span></button><input type="text" class="flex flex-col ml-[26px] 2xl:ml-[28px] mt-[-3px] absolute opacity-0 max-w-[135px] 2xl:max-w-[235px] outline-none placeholder:uppercase placeholder:text-medium-grey text-sm xl:text-base placeholder:text-sm w-[20px] 2xl:w-[80px]" value /><button aria-label="Clear Search Input" class="search-close-ignored-element absolute right-10 lg:right-0 transition-opacity opacity-0 hidden p-1" type="button"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="22" height="23" viewBox="0 0 22 23" class="w-[14px] h-[14px]" role="img" aria-hidden="true" data-testid="icon-dotcom/Close"><path d="M21.3937 3.28314C21.7036 2.97313 21.8777 2.55273 21.8777 2.11439C21.8777 1.67604 21.7036 1.25564 21.3937 0.945639C21.0842 0.639753 20.6667 0.468204 20.2315 0.468204C19.7964 0.468204 19.3788 0.639753 19.0694 0.945639L10.9907 9.02438L2.91852 0.952251C2.76493 0.798055 2.58241 0.675704 2.38142 0.592219C2.18043 0.508735 1.96493 0.465759 1.7473 0.465759C1.52966 0.465759 1.31416 0.508735 1.11317 0.592219C0.912183 0.675704 0.729657 0.798055 0.576068 0.952251C0.270181 1.2617 0.0986328 1.67927 0.0986328 2.11439C0.0986328 2.5495 0.270181 2.96707 0.576068 3.27652L8.65977 11.3553L0.587639 19.4274C0.277729 19.7374 0.103631 20.1578 0.103631 20.5961C0.103631 21.0345 0.277729 21.4549 0.587639 21.7649C0.897089 22.0708 1.31466 22.2423 1.74977 22.2423C2.18489 22.2423 2.60246 22.0708 2.91191 21.7649L10.9907 13.6862L19.0628 21.7583C19.3728 22.0682 19.7932 22.2423 20.2315 22.2423C20.6699 22.2423 21.0903 22.0682 21.4003 21.7583C21.7062 21.4488 21.8777 21.0313 21.8777 20.5961C21.8777 20.161 21.7062 19.7435 21.4003 19.434L13.3215 11.3553L21.3937 3.28314Z"></path></svg></button></div><span class="w-[0px] h-[1px] hidden lg:block absolute bottom-[14px] bg-medium-grey transition-[width] duration-200"></span></form><div class="items-center h-full transition-opacity"><button class="flex items-center h-full px-3 py-5 transition duration-150 ease-out lg:py-0 2xl:px-5 hover:bg-light-grey focus:bg-light-grey group hover:ease-in"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 20 20" class="block w-5 transition duration-150 ease-out group-hover:text-primary group-focus:text-primary hover:ease-in " role="img" aria-hidden="false" data-testid="icon-Globe"><title>Open Location Finder</title><path d="M 7.3388671875 0.3564453125 C 8.188476562500002 0.11881510416666666 9.075520833333336 0 10 0 C 10.91796875 0 11.803385416666668 0.11881510416666666 12.65625 0.3564453125 C 13.509114583333336 0.5940755208333334 14.306640625 0.9293619791666667 15.048828125 1.3623046875 C 15.791015625 1.7952473958333335 16.466471354166668 2.316080729166667 17.0751953125 2.9248046875 C 17.683919270833336 3.533528645833334 18.20475260416667 4.208984375000001 18.6376953125 4.951171875 C 19.070638020833336 5.693359375 19.405924479166668 6.490885416666668 19.6435546875 7.34375 C 19.881184895833336 8.196614583333334 20 9.08203125 20 10 C 20 10.91796875 19.881184895833336 11.803385416666668 19.6435546875 12.65625 C 19.405924479166668 13.509114583333336 19.070638020833336 14.306640625 18.6376953125 15.048828125 C 18.20475260416667 15.791015625 17.683919270833336 16.466471354166668 17.0751953125 17.0751953125 C 16.466471354166668 17.683919270833336 15.791015625 18.20475260416667 15.048828125 18.6376953125 C 14.306640625 19.070638020833336 13.509114583333336 19.405924479166668 12.65625 19.6435546875 C 11.803385416666668 19.881184895833336 10.91796875 20 10 20 C 9.08203125 20 8.196614583333334 19.881184895833336 7.34375 19.6435546875 C 6.490885416666668 19.405924479166668 5.693359375 19.070638020833336 4.951171875 18.6376953125 C 4.208984375000001 18.20475260416667 3.533528645833334 17.683919270833336 2.9248046875 17.0751953125 C 2.316080729166667 16.466471354166668 1.7952473958333335 15.791015625 1.3623046875 15.048828125 C 0.9293619791666667 14.306640625 0.5940755208333334 13.5107421875 0.3564453125 12.6611328125 C 0.11881510416666666 11.8115234375 0 10.924479166666668 0 10 C 0 9.08203125 0.11881510416666666 8.196614583333334 0.3564453125 7.34375 C 0.5940755208333334 6.490885416666668 0.9293619791666667 5.693359375 1.3623046875 4.951171875 C 1.7952473958333335 4.208984375000001 2.316080729166667 3.533528645833334 2.9248046875 2.9248046875 C 3.533528645833334 2.316080729166667 4.208984375000001 1.7952473958333335 4.951171875 1.3623046875 C 5.693359375 0.9293619791666667 6.4892578125 0.5940755208333334 7.3388671875 0.3564453125 Z M 14.6484375 6.25 L 17.900390625 6.25 C 17.652994791666668 5.72265625 17.353515625 5.226236979166668 17.001953125 4.7607421875 C 16.650390625 4.295247395833334 16.259765625 3.870442708333334 15.830078125 3.486328125 C 15.400390625 3.102213541666667 14.934895833333336 2.760416666666667 14.43359375 2.4609375 C 13.932291666666668 2.1614583333333335 13.408203125 1.9173177083333335 12.861328125 1.728515625 C 13.095703125 2.0540364583333335 13.307291666666668 2.399088541666667 13.49609375 2.763671875 C 13.684895833333336 3.128255208333334 13.8525390625 3.504231770833334 13.9990234375 3.8916015625 C 14.1455078125 4.278971354166667 14.270833333333336 4.671223958333334 14.375 5.068359375 C 14.479166666666668 5.465494791666668 14.5703125 5.859375 14.6484375 6.25 Z M 18.388671875 12.5 C 18.62955729166667 11.69921875 18.750000000000004 10.865885416666668 18.75 10 C 18.750000000000004 9.134114583333336 18.62955729166667 8.300781250000002 18.388671875 7.5 L 14.84375 7.5 C 14.895833333333336 7.916666666666668 14.934895833333336 8.331705729166668 14.9609375 8.7451171875 C 14.986979166666664 9.158528645833334 15 9.576822916666668 15 10 C 15 10.423177083333336 14.986979166666664 10.841471354166668 14.9609375 11.2548828125 C 14.934895833333336 11.668294270833336 14.895833333333336 12.083333333333336 14.84375 12.5 L 18.388671875 12.5 Z M 9.1064453125 18.486328125 C 9.383138020833336 18.662109375000004 9.680989583333336 18.750000000000004 10 18.75 C 10.319010416666668 18.750000000000004 10.616861979166668 18.662109375000004 10.8935546875 18.486328125 C 11.170247395833336 18.310546875000004 11.42578125 18.079427083333336 11.66015625 17.79296875 C 11.89453125 17.506510416666668 12.1044921875 17.1826171875 12.2900390625 16.8212890625 C 12.4755859375 16.4599609375 12.639973958333336 16.09375 12.783203125 15.72265625 C 12.926432291666668 15.3515625 13.046875 14.993489583333336 13.14453125 14.6484375 C 13.2421875 14.303385416666668 13.317057291666668 14.00390625 13.369140625 13.75 L 6.630859375 13.75 C 6.682942708333334 14.00390625 6.7578125 14.303385416666668 6.85546875 14.6484375 C 6.953125 14.993489583333336 7.073567708333334 15.3515625 7.216796875 15.72265625 C 7.360026041666668 16.09375 7.5244140625 16.4599609375 7.7099609375 16.8212890625 C 7.8955078125 17.1826171875 8.10546875 17.506510416666668 8.33984375 17.79296875 C 8.57421875 18.079427083333336 8.829752604166668 18.310546875000004 9.1064453125 18.486328125 Z M 6.416015625 12.5 L 13.583984375 12.5 C 13.636067708333336 12.083333333333336 13.6767578125 11.668294270833336 13.7060546875 11.2548828125 C 13.7353515625 10.841471354166668 13.75 10.423177083333336 13.75 10 C 13.75 9.576822916666668 13.7353515625 9.158528645833334 13.7060546875 8.7451171875 C 13.6767578125 8.331705729166668 13.636067708333336 7.916666666666668 13.583984375 7.5 L 6.416015625 7.5 C 6.363932291666668 7.916666666666668 6.3232421875 8.331705729166668 6.2939453125 8.7451171875 C 6.2646484375 9.158528645833334 6.25 9.576822916666668 6.25 10 C 6.25 10.423177083333336 6.2646484375 10.841471354166668 6.2939453125 11.2548828125 C 6.3232421875 11.668294270833336 6.363932291666668 12.083333333333336 6.416015625 12.5 Z M 1.611328125 7.5 C 1.3704427083333335 8.300781250000002 1.25 9.134114583333336 1.25 10 C 1.25 10.865885416666668 1.3704427083333335 11.69921875 1.611328125 12.5 L 5.15625 12.5 C 5.104166666666668 12.083333333333336 5.065104166666668 11.668294270833336 5.0390625 11.2548828125 C 5.013020833333334 10.841471354166668 5 10.423177083333336 5 10 C 5 9.576822916666668 5.013020833333334 9.158528645833334 5.0390625 8.7451171875 C 5.065104166666668 8.331705729166668 5.104166666666668 7.916666666666668 5.15625 7.5 L 1.611328125 7.5 Z M 10.8935546875 1.513671875 C 10.616861979166668 1.337890625 10.319010416666668 1.25 10 1.25 C 9.680989583333336 1.25 9.383138020833336 1.337890625 9.1064453125 1.513671875 C 8.829752604166668 1.689453125 8.57421875 1.920572916666667 8.33984375 2.20703125 C 8.10546875 2.493489583333334 7.8955078125 2.8173828125 7.7099609375 3.1787109375 C 7.5244140625 3.5400390625 7.360026041666668 3.90625 7.216796875 4.27734375 C 7.073567708333334 4.648437500000001 6.953125 5.006510416666668 6.85546875 5.3515625 C 6.7578125 5.696614583333334 6.682942708333334 5.99609375 6.630859375 6.25 L 13.369140625 6.25 C 13.317057291666668 5.99609375 13.2421875 5.696614583333334 13.14453125 5.3515625 C 13.046875 5.006510416666668 12.926432291666668 4.648437500000001 12.783203125 4.27734375 C 12.639973958333336 3.90625 12.4755859375 3.5400390625 12.2900390625 3.1787109375 C 12.1044921875 2.8173828125 11.89453125 2.493489583333334 11.66015625 2.20703125 C 11.42578125 1.920572916666667 11.170247395833336 1.689453125 10.8935546875 1.513671875 Z M 6.50390625 2.763671875 C 6.692708333333334 2.399088541666667 6.904296875 2.0540364583333335 7.138671875 1.728515625 C 6.591796875 1.9173177083333335 6.067708333333334 2.1614583333333335 5.56640625 2.4609375 C 5.065104166666668 2.760416666666667 4.599609375 3.102213541666667 4.169921875 3.486328125 C 3.740234375 3.870442708333334 3.349609375 4.295247395833334 2.998046875 4.7607421875 C 2.646484375 5.226236979166668 2.3470052083333335 5.72265625 2.099609375 6.25 L 5.3515625 6.25 C 5.4296875 5.859375 5.520833333333334 5.465494791666668 5.625 5.068359375 C 5.729166666666668 4.671223958333334 5.8544921875 4.278971354166667 6.0009765625 3.8916015625 C 6.1474609375 3.504231770833334 6.315104166666668 3.128255208333334 6.50390625 2.763671875 Z M 5.3515625 13.75 L 2.099609375 13.75 C 2.3470052083333335 14.27734375 2.646484375 14.773763020833336 2.998046875 15.2392578125 C 3.349609375 15.70475260416667 3.740234375 16.12955729166667 4.169921875 16.513671875 C 4.599609375 16.897786458333336 5.065104166666668 17.239583333333336 5.56640625 17.5390625 C 6.067708333333334 17.83854166666667 6.591796875 18.08268229166667 7.138671875 18.271484375 C 6.904296875 17.94596354166667 6.692708333333334 17.600911458333336 6.50390625 17.236328125 C 6.315104166666668 16.871744791666668 6.1474609375 16.495768229166668 6.0009765625 16.1083984375 C 5.8544921875 15.721028645833336 5.729166666666668 15.32877604166667 5.625 14.931640625 C 5.520833333333334 14.534505208333336 5.4296875 14.140625 5.3515625 13.75 Z M 13.49609375 17.236328125 C 13.307291666666668 17.600911458333336 13.095703125 17.94596354166667 12.861328125 18.271484375 C 13.408203125 18.08268229166667 13.932291666666668 17.83854166666667 14.43359375 17.5390625 C 14.934895833333336 17.239583333333336 15.400390625 16.897786458333336 15.830078125 16.513671875 C 16.259765625 16.12955729166667 16.650390625 15.70475260416667 17.001953125 15.2392578125 C 17.353515625 14.773763020833336 17.652994791666668 14.27734375 17.900390625 13.75 L 14.6484375 13.75 C 14.5703125 14.140625 14.479166666666668 14.534505208333336 14.375 14.931640625 C 14.270833333333336 15.32877604166667 14.1455078125 15.721028645833336 13.9990234375 16.1083984375 C 13.8525390625 16.495768229166668 13.684895833333336 16.871744791666668 13.49609375 17.236328125 Z"></path></svg><span class="ml-2 text-sm"> GLOBAL | </span></button><div><div class="fixed inset-0 z-[100]" style="background:rgba(0, 0, 0, 0);visibility:hidden"><div class="relative max-w-[1920px] mx-auto"><aside class="absolute right-0 z-50 w-[500px] max-sm:w-screen h-screen bg-white text-dark-grey" style="opacity:0;box-shadow:-5px -1px 14px 0px rgba(0, 0, 0, 0);transform:translateX(100%) translateZ(0)"><div class="w-full h-full overflow-y-auto"><div class="mr-[calc(100%-500px)] max-sm:mr-[calc(100%-100vw)] py-[21px] px-[35px] pr-[29px] tracking-normal font-normal"><div class="flex justify-end"><button aria-label="Close menu" type="button" class="text-primary h-7" tabindex="-1">Close</button></div><div class="flex justify-between flex-wrap items-center mt-[30px] text-dark-grey"><h3 class="m-0 mr-[12px] text-lg" data-sb-field-path=".title">Takeda - Global</h3><ul class="flex flex-wrap gap-5" data-sb-field-path="undefined:globalLanguages" role="list"><li role="listitem"><button class="text-[15px] hover:font-bold h-7" data-sb-field-path=".0">English</button><a tabindex="-1" href="/" class="crawled-link sr-only" aria-hidden="true">English</a></li><li role="listitem"><button class="text-[15px] hover:font-bold h-7" data-sb-field-path=".1">Japanese</button><a tabindex="-1" href="/jp" class="crawled-link sr-only" aria-hidden="true">Japanese</a></li></ul></div></div><div class="mr-[calc(100%-500px)] max-sm:mr-[calc(100%-100vw)] py-[21px] max-md:pb-[96px] px-[35px] pr-[29px] tracking-normal font-normal"><div class="w-full mb-[20px] relative"><input data-sb-field-path="undefined:header.searchLocationPlaceholder#@placeholder" placeholder="Search for a country" class="w-full p-[11px] font-light pr-12 border-[1px] border-medium-grey focus:outline-medium-grey text-medium-grey placeholder:text-lg placeholder:font-light" style="flex-grow:1" /><div class="absolute right-0 top-0 bottom-0 py-[12px] px-[15px] text-medium-grey"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="none" viewBox="0 0 24 24" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="block w-6" role="img" aria-hidden="false" data-testid="icon-Search"><title>Search</title><circle cx="11" cy="11" r="8"></circle><line x1="21" y1="21" x2="16.65" y2="16.65"></line></svg></div></div><ul data-sb-field-path="undefined:locations" role="list"><li data-sb-field-path=".0" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Argentina</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/es-ar" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".1" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Australia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-au" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".2" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Austria</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">German</span></button><a tabindex="-1" href="/de-at" class="crawled-link sr-only" aria-hidden="true">German</a></li><li data-sb-field-path=".3" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Belgium</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-be" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".4" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Bosnia Herzegovina</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Bosnian</span></button><a tabindex="-1" href="/bs-ba" class="crawled-link sr-only" aria-hidden="true">Bosnian</a></li><li data-sb-field-path=".5" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Brazil</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Portuguese</span></button><a tabindex="-1" href="/pt-br" class="crawled-link sr-only" aria-hidden="true">Portuguese</a></li><li data-sb-field-path=".6" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Bulgaria</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Bulgarian</span></button><a tabindex="-1" href="/bg-bg" class="crawled-link sr-only" aria-hidden="true">Bulgarian</a></li><li data-sb-field-path=".7" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><div class="flex flex-wrap items-center justify-between py-[8px] bg-transparent transition-all !text-[16px] max-md:!text-[15px] group"><button tabindex="-1" aria-label="Change Canada local site to [object Object] language" class="text-left text-lg group-hover:font-bold group-focus-within:font-bold">Canada</button><div class="flex items-center justify-end group-hover:font-light"><button tabindex="0" aria-label="Change Canada local site to English language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap group-hover:font-bold h-7">English</button><a tabindex="-1" href="/en-ca" class="crawled-link sr-only" aria-hidden="true">English</a><button tabindex="0" aria-label="Change Canada local site to French language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap !mr-0 h-7">French</button><a tabindex="-1" href="/fr-ca" class="crawled-link sr-only" aria-hidden="true">French</a></div></div></li><li data-sb-field-path=".8" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Chile</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/worldwide/chile/" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".9" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Mainland China</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Chinese</span></button><a tabindex="-1" href="https://takeda.info/takeda-china" class="crawled-link sr-only" aria-hidden="true">Chinese</a></li><li data-sb-field-path=".10" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Colombia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/es-co" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".11" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Croatia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Croatian</span></button><a tabindex="-1" href="/hr-hr" class="crawled-link sr-only" aria-hidden="true">Croatian</a></li><li data-sb-field-path=".12" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Czech Republic</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Czech</span></button><a tabindex="-1" href="/cs-cz" class="crawled-link sr-only" aria-hidden="true">Czech</a></li><li data-sb-field-path=".13" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Denmark</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Danish</span></button><a tabindex="-1" href="/da-dk" class="crawled-link sr-only" aria-hidden="true">Danish</a></li><li data-sb-field-path=".14" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Ecuador</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/es-ec" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".15" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Estonia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Estonian</span></button><a tabindex="-1" href="/et-ee" class="crawled-link sr-only" aria-hidden="true">Estonian</a></li><li data-sb-field-path=".16" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Finland</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Finnish</span></button><a tabindex="-1" href="/fi-fi" class="crawled-link sr-only" aria-hidden="true">Finnish</a></li><li data-sb-field-path=".17" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">France</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">French</span></button><a tabindex="-1" href="/fr-fr" class="crawled-link sr-only" aria-hidden="true">French</a></li><li data-sb-field-path=".18" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Germany</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">German</span></button><a tabindex="-1" href="/de-de" class="crawled-link sr-only" aria-hidden="true">German</a></li><li data-sb-field-path=".19" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Greece</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Greek</span></button><a tabindex="-1" href="/el-gr" class="crawled-link sr-only" aria-hidden="true">Greek</a></li><li data-sb-field-path=".20" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><div class="flex flex-wrap items-center justify-between py-[8px] bg-transparent transition-all !text-[16px] max-md:!text-[15px] group"><button tabindex="-1" aria-label="Change Hong Kong SAR local site to [object Object] language" class="text-left text-lg group-hover:font-bold group-focus-within:font-bold">Hong Kong SAR</button><div class="flex items-center justify-end group-hover:font-light"><button tabindex="0" aria-label="Change Hong Kong SAR local site to English language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap group-hover:font-bold h-7">English</button><a tabindex="-1" href="/en-hk" class="crawled-link sr-only" aria-hidden="true">English</a><button tabindex="0" aria-label="Change Hong Kong SAR local site to Chinese language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap !mr-0 h-7">Chinese</button><a tabindex="-1" href="/zh-hk" class="crawled-link sr-only" aria-hidden="true">Chinese</a></div></div></li><li data-sb-field-path=".21" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Hungary</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Hungarian</span></button><a tabindex="-1" href="/hu-hu" class="crawled-link sr-only" aria-hidden="true">Hungarian</a></li><li data-sb-field-path=".22" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">India</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-in" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".23" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Indonesia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Indonesian</span></button><a tabindex="-1" href="/id-id" class="crawled-link sr-only" aria-hidden="true">Indonesian</a></li><li data-sb-field-path=".24" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Ireland</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-ie" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".25" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Israel</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Hebrew</span></button><a tabindex="-1" href="/he-il" class="crawled-link sr-only" aria-hidden="true">Hebrew</a></li><li data-sb-field-path=".26" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Italy</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Italian</span></button><a tabindex="-1" href="/it-it" class="crawled-link sr-only" aria-hidden="true">Italian</a></li><li data-sb-field-path=".27" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Japan</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Japanese</span></button><a tabindex="-1" href="/ja-jp" class="crawled-link sr-only" aria-hidden="true">Japanese</a></li><li data-sb-field-path=".28" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><div class="flex flex-wrap items-center justify-between py-[8px] bg-transparent transition-all !text-[16px] max-md:!text-[15px] group"><button tabindex="-1" aria-label="Change Kazakhstan local site to [object Object] language" class="text-left text-lg group-hover:font-bold group-focus-within:font-bold">Kazakhstan</button><div class="flex items-center justify-end group-hover:font-light"><button tabindex="0" aria-label="Change Kazakhstan local site to Kazakh language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap group-hover:font-bold h-7">Kazakh</button><a tabindex="-1" href="/kk-kz" class="crawled-link sr-only" aria-hidden="true">Kazakh</a><button tabindex="0" aria-label="Change Kazakhstan local site to Russian language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap !mr-0 h-7">Russian</button><a tabindex="-1" href="/ru-kz" class="crawled-link sr-only" aria-hidden="true">Russian</a></div></div></li><li data-sb-field-path=".29" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Korea</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Korean</span></button><a tabindex="-1" href="/ko-kr" class="crawled-link sr-only" aria-hidden="true">Korean</a></li><li data-sb-field-path=".30" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Latvia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Latvian</span></button><a tabindex="-1" href="/lv-lv" class="crawled-link sr-only" aria-hidden="true">Latvian</a></li><li data-sb-field-path=".31" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Lithuania</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Lithuanian</span></button><a tabindex="-1" href="/lt-lt" class="crawled-link sr-only" aria-hidden="true">Lithuanian</a></li><li data-sb-field-path=".32" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Malaysia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/worldwide/asia-pacific-pte-ltd/" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".33" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Mexico</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/es-mx" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".34" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Netherlands</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Dutch</span></button><a tabindex="-1" href="/nl-nl" class="crawled-link sr-only" aria-hidden="true">Dutch</a></li><li data-sb-field-path=".35" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">New Zealand</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-au/" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".36" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Norway</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Norweigan</span></button><a tabindex="-1" href="/nn-no" class="crawled-link sr-only" aria-hidden="true">Norweigan</a></li><li data-sb-field-path=".37" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Peru</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/es-pe" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".38" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Philippines</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/worldwide/asia-pacific-pte-ltd/" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".39" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Poland</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Polish</span></button><a tabindex="-1" href="/pl-pl" class="crawled-link sr-only" aria-hidden="true">Polish</a></li><li data-sb-field-path=".40" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Portugal</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Portuguese</span></button><a tabindex="-1" href="/pt-pt" class="crawled-link sr-only" aria-hidden="true">Portuguese</a></li><li data-sb-field-path=".41" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Romania</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Romanian</span></button><a tabindex="-1" href="/ro-ro" class="crawled-link sr-only" aria-hidden="true">Romanian</a></li><li data-sb-field-path=".42" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Russia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Russian</span></button><a tabindex="-1" href="/ru-ru" class="crawled-link sr-only" aria-hidden="true">Russian</a></li><li data-sb-field-path=".43" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Saudi Arabia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Arabic</span></button><a tabindex="-1" href="/worldwide/saudi-arabia/" class="crawled-link sr-only" aria-hidden="true">Arabic</a></li><li data-sb-field-path=".44" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Serbia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Serbian</span></button><a tabindex="-1" href="/sr-rs" class="crawled-link sr-only" aria-hidden="true">Serbian</a></li><li data-sb-field-path=".45" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Singapore</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/worldwide/asia-pacific-pte-ltd/" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".46" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Slovakia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Slovak</span></button><a tabindex="-1" href="/sk-sk" class="crawled-link sr-only" aria-hidden="true">Slovak</a></li><li data-sb-field-path=".47" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Slovenia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Slovenian</span></button><a tabindex="-1" href="/sl-si" class="crawled-link sr-only" aria-hidden="true">Slovenian</a></li><li data-sb-field-path=".48" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Spain</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/es-es" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".49" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Sweden</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Swedish</span></button><a tabindex="-1" href="/sv-se" class="crawled-link sr-only" aria-hidden="true">Swedish</a></li><li data-sb-field-path=".50" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><div class="flex flex-wrap items-center justify-between py-[8px] bg-transparent transition-all !text-[16px] max-md:!text-[15px] group"><button tabindex="-1" aria-label="Change Switzerland local site to [object Object] language" class="text-left text-lg group-hover:font-bold group-focus-within:font-bold">Switzerland</button><div class="flex items-center justify-end group-hover:font-light"><button tabindex="0" aria-label="Change Switzerland local site to German language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap group-hover:font-bold h-7">German</button><a tabindex="-1" href="/de-ch" class="crawled-link sr-only" aria-hidden="true">German</a><button tabindex="0" aria-label="Change Switzerland local site to French language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap !mr-0 h-7">French</button><a tabindex="-1" href="/fr-ch" class="crawled-link sr-only" aria-hidden="true">French</a></div></div></li><li data-sb-field-path=".51" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Taiwan</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Chinese</span></button><a tabindex="-1" href="/zh-tw" class="crawled-link sr-only" aria-hidden="true">Chinese</a></li><li data-sb-field-path=".52" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Thailand</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Thai</span></button><a tabindex="-1" href="/th-th" class="crawled-link sr-only" aria-hidden="true">Thai</a></li><li data-sb-field-path=".53" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Turkey</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Turkish</span></button><a tabindex="-1" href="/tr-tr" class="crawled-link sr-only" aria-hidden="true">Turkish</a></li><li data-sb-field-path=".54" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Ukraine</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Ukrainian</span></button><a tabindex="-1" href="/uk-ua" class="crawled-link sr-only" aria-hidden="true">Ukrainian</a></li><li data-sb-field-path=".55" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">United Kingdom</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-gb" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".56" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">United States</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-us" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".57" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Vietnam</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-vi" class="crawled-link sr-only" aria-hidden="true">English</a></li></ul></div></div></aside></div></div></div></div></div><div class="flex lg:hidden leading-[0]"><input type="text" class="absolute h-0 w-0 opacity-0" /><button aria-label="open search menu"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="none" viewBox="0 0 24 24" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="block w-6 lg:hidden" role="img" aria-hidden="false" data-testid="icon-Search"><title>Search</title><circle cx="11" cy="11" r="8"></circle><line x1="21" y1="21" x2="16.65" y2="16.65"></line></svg></button><div><div class="fixed inset-0 z-[100]" style="background:rgba(0, 0, 0, 0);visibility:hidden"><div class="relative max-w-[1920px] mx-auto"><aside class="absolute right-0 z-50 w-[500px] max-sm:w-screen h-screen bg-white text-dark-grey" style="opacity:0;box-shadow:-5px -1px 14px 0px rgba(0, 0, 0, 0);transform:translateX(100%) translateZ(0)"><div class="w-full h-full overflow-y-auto"><div class="bg-white w-full h-[100vh] overflow-y-auto absolute top-0 left-0 text-text-color font-bold"><div class="w-full flex justify-end items-center px-7 mt-[3rem]"><button aria-label="close search menu"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 20 20" class="block w-5" role="img" aria-hidden="false" data-testid="icon-Close"><title>Close</title><path d="M 20 1.416015625 L 11.416015625 10 L 20 18.583984375 L 18.583984375 20 L 10 11.416015625 L 1.416015625 20 L 0 18.583984375 L 8.583984375 10 L 0 1.416015625 L 1.416015625 0 L 10 8.583984375 L 18.583984375 0 L 20 1.416015625 Z"></path></svg></button></div><div class="flex relative flex-col justify-center px-5 pt-10 pb-5 border-b border-medium-grey"><form class="w-full"><div class="z-10 flex flex-row items-center group"><button aria-label="Search" class="flex justify-center align-middle search-close-ignored-element" type="button"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="none" viewBox="0 0 24 24" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="block w-5 group-hover:text-primary" role="img" aria-hidden="true" data-testid="icon-Search"><circle cx="11" cy="11" r="8"></circle><line x1="21" y1="21" x2="16.65" y2="16.65"></line></svg><span class="uppercase hidden ml-2 text-sm 2xl:block opacity-0">Search...</span></button><input type="text" class="ml-2 flex flex-col outline-none placeholder:uppercase placeholder:text-medium-grey text-sm placeholder:xl:text-sm w-full pr-10" value /><button aria-label="Clear Search Input" class="search-close-ignored-element absolute right-10 lg:right-0 transition-opacity opacity-0 hidden p-1 !block" type="button"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="22" height="23" viewBox="0 0 22 23" class="w-[14px] h-[14px]" role="img" aria-hidden="true" data-testid="icon-dotcom/Close"><path d="M21.3937 3.28314C21.7036 2.97313 21.8777 2.55273 21.8777 2.11439C21.8777 1.67604 21.7036 1.25564 21.3937 0.945639C21.0842 0.639753 20.6667 0.468204 20.2315 0.468204C19.7964 0.468204 19.3788 0.639753 19.0694 0.945639L10.9907 9.02438L2.91852 0.952251C2.76493 0.798055 2.58241 0.675704 2.38142 0.592219C2.18043 0.508735 1.96493 0.465759 1.7473 0.465759C1.52966 0.465759 1.31416 0.508735 1.11317 0.592219C0.912183 0.675704 0.729657 0.798055 0.576068 0.952251C0.270181 1.2617 0.0986328 1.67927 0.0986328 2.11439C0.0986328 2.5495 0.270181 2.96707 0.576068 3.27652L8.65977 11.3553L0.587639 19.4274C0.277729 19.7374 0.103631 20.1578 0.103631 20.5961C0.103631 21.0345 0.277729 21.4549 0.587639 21.7649C0.897089 22.0708 1.31466 22.2423 1.74977 22.2423C2.18489 22.2423 2.60246 22.0708 2.91191 21.7649L10.9907 13.6862L19.0628 21.7583C19.3728 22.0682 19.7932 22.2423 20.2315 22.2423C20.6699 22.2423 21.0903 22.0682 21.4003 21.7583C21.7062 21.4488 21.8777 21.0313 21.8777 20.5961C21.8777 20.161 21.7062 19.7435 21.4003 19.434L13.3215 11.3553L21.3937 3.28314Z"></path></svg></button></div><span class="w-[0px] h-[1px] hidden lg:block absolute bottom-[14px] bg-medium-grey transition-[width] duration-200 !w-full"></span></form></div></div></div></aside></div></div></div><button aria-label="Open mobile menu" type="button" class="HamButton_root__ZbZY9 ml-3"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="28" height="24" class="HamButton_icon__Ej4Kt" role="img" aria-hidden="true" viewBox="0 0 28 24" data-testid="icon-Hamburger"><rect width="100%" height="1"></rect><rect y="10.5" width="100%" height="1"></rect><rect y="21" width="100%" height="1"></rect></svg></button><div><div class="fixed inset-0 z-[100]" style="background:rgba(0, 0, 0, 0);visibility:hidden"><div class="relative max-w-[1920px] mx-auto"><aside class="absolute right-0 z-50 w-[500px] max-sm:w-screen h-screen bg-white text-dark-grey" style="opacity:0;box-shadow:-5px -1px 14px 0px rgba(0, 0, 0, 0);transform:translateX(100%) translateZ(0)"><div class="w-full h-full overflow-y-auto"><div class="bg-white w-full h-[100vh] overflow-y-auto absolute top-0 left-0 text-text-color font-bold"><div class="w-full flex justify-between items-center px-7 mt-[2rem]"><button class="flex items-center h-full px-3 py-5 transition duration-150 ease-out lg:py-0 2xl:px-5 hover:bg-light-grey focus:bg-light-grey group hover:ease-in"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 20 20" class="block w-5 transition duration-150 ease-out group-hover:text-primary group-focus:text-primary hover:ease-in " role="img" aria-hidden="false" data-testid="icon-Globe"><title>Open Location Finder</title><path d="M 7.3388671875 0.3564453125 C 8.188476562500002 0.11881510416666666 9.075520833333336 0 10 0 C 10.91796875 0 11.803385416666668 0.11881510416666666 12.65625 0.3564453125 C 13.509114583333336 0.5940755208333334 14.306640625 0.9293619791666667 15.048828125 1.3623046875 C 15.791015625 1.7952473958333335 16.466471354166668 2.316080729166667 17.0751953125 2.9248046875 C 17.683919270833336 3.533528645833334 18.20475260416667 4.208984375000001 18.6376953125 4.951171875 C 19.070638020833336 5.693359375 19.405924479166668 6.490885416666668 19.6435546875 7.34375 C 19.881184895833336 8.196614583333334 20 9.08203125 20 10 C 20 10.91796875 19.881184895833336 11.803385416666668 19.6435546875 12.65625 C 19.405924479166668 13.509114583333336 19.070638020833336 14.306640625 18.6376953125 15.048828125 C 18.20475260416667 15.791015625 17.683919270833336 16.466471354166668 17.0751953125 17.0751953125 C 16.466471354166668 17.683919270833336 15.791015625 18.20475260416667 15.048828125 18.6376953125 C 14.306640625 19.070638020833336 13.509114583333336 19.405924479166668 12.65625 19.6435546875 C 11.803385416666668 19.881184895833336 10.91796875 20 10 20 C 9.08203125 20 8.196614583333334 19.881184895833336 7.34375 19.6435546875 C 6.490885416666668 19.405924479166668 5.693359375 19.070638020833336 4.951171875 18.6376953125 C 4.208984375000001 18.20475260416667 3.533528645833334 17.683919270833336 2.9248046875 17.0751953125 C 2.316080729166667 16.466471354166668 1.7952473958333335 15.791015625 1.3623046875 15.048828125 C 0.9293619791666667 14.306640625 0.5940755208333334 13.5107421875 0.3564453125 12.6611328125 C 0.11881510416666666 11.8115234375 0 10.924479166666668 0 10 C 0 9.08203125 0.11881510416666666 8.196614583333334 0.3564453125 7.34375 C 0.5940755208333334 6.490885416666668 0.9293619791666667 5.693359375 1.3623046875 4.951171875 C 1.7952473958333335 4.208984375000001 2.316080729166667 3.533528645833334 2.9248046875 2.9248046875 C 3.533528645833334 2.316080729166667 4.208984375000001 1.7952473958333335 4.951171875 1.3623046875 C 5.693359375 0.9293619791666667 6.4892578125 0.5940755208333334 7.3388671875 0.3564453125 Z M 14.6484375 6.25 L 17.900390625 6.25 C 17.652994791666668 5.72265625 17.353515625 5.226236979166668 17.001953125 4.7607421875 C 16.650390625 4.295247395833334 16.259765625 3.870442708333334 15.830078125 3.486328125 C 15.400390625 3.102213541666667 14.934895833333336 2.760416666666667 14.43359375 2.4609375 C 13.932291666666668 2.1614583333333335 13.408203125 1.9173177083333335 12.861328125 1.728515625 C 13.095703125 2.0540364583333335 13.307291666666668 2.399088541666667 13.49609375 2.763671875 C 13.684895833333336 3.128255208333334 13.8525390625 3.504231770833334 13.9990234375 3.8916015625 C 14.1455078125 4.278971354166667 14.270833333333336 4.671223958333334 14.375 5.068359375 C 14.479166666666668 5.465494791666668 14.5703125 5.859375 14.6484375 6.25 Z M 18.388671875 12.5 C 18.62955729166667 11.69921875 18.750000000000004 10.865885416666668 18.75 10 C 18.750000000000004 9.134114583333336 18.62955729166667 8.300781250000002 18.388671875 7.5 L 14.84375 7.5 C 14.895833333333336 7.916666666666668 14.934895833333336 8.331705729166668 14.9609375 8.7451171875 C 14.986979166666664 9.158528645833334 15 9.576822916666668 15 10 C 15 10.423177083333336 14.986979166666664 10.841471354166668 14.9609375 11.2548828125 C 14.934895833333336 11.668294270833336 14.895833333333336 12.083333333333336 14.84375 12.5 L 18.388671875 12.5 Z M 9.1064453125 18.486328125 C 9.383138020833336 18.662109375000004 9.680989583333336 18.750000000000004 10 18.75 C 10.319010416666668 18.750000000000004 10.616861979166668 18.662109375000004 10.8935546875 18.486328125 C 11.170247395833336 18.310546875000004 11.42578125 18.079427083333336 11.66015625 17.79296875 C 11.89453125 17.506510416666668 12.1044921875 17.1826171875 12.2900390625 16.8212890625 C 12.4755859375 16.4599609375 12.639973958333336 16.09375 12.783203125 15.72265625 C 12.926432291666668 15.3515625 13.046875 14.993489583333336 13.14453125 14.6484375 C 13.2421875 14.303385416666668 13.317057291666668 14.00390625 13.369140625 13.75 L 6.630859375 13.75 C 6.682942708333334 14.00390625 6.7578125 14.303385416666668 6.85546875 14.6484375 C 6.953125 14.993489583333336 7.073567708333334 15.3515625 7.216796875 15.72265625 C 7.360026041666668 16.09375 7.5244140625 16.4599609375 7.7099609375 16.8212890625 C 7.8955078125 17.1826171875 8.10546875 17.506510416666668 8.33984375 17.79296875 C 8.57421875 18.079427083333336 8.829752604166668 18.310546875000004 9.1064453125 18.486328125 Z M 6.416015625 12.5 L 13.583984375 12.5 C 13.636067708333336 12.083333333333336 13.6767578125 11.668294270833336 13.7060546875 11.2548828125 C 13.7353515625 10.841471354166668 13.75 10.423177083333336 13.75 10 C 13.75 9.576822916666668 13.7353515625 9.158528645833334 13.7060546875 8.7451171875 C 13.6767578125 8.331705729166668 13.636067708333336 7.916666666666668 13.583984375 7.5 L 6.416015625 7.5 C 6.363932291666668 7.916666666666668 6.3232421875 8.331705729166668 6.2939453125 8.7451171875 C 6.2646484375 9.158528645833334 6.25 9.576822916666668 6.25 10 C 6.25 10.423177083333336 6.2646484375 10.841471354166668 6.2939453125 11.2548828125 C 6.3232421875 11.668294270833336 6.363932291666668 12.083333333333336 6.416015625 12.5 Z M 1.611328125 7.5 C 1.3704427083333335 8.300781250000002 1.25 9.134114583333336 1.25 10 C 1.25 10.865885416666668 1.3704427083333335 11.69921875 1.611328125 12.5 L 5.15625 12.5 C 5.104166666666668 12.083333333333336 5.065104166666668 11.668294270833336 5.0390625 11.2548828125 C 5.013020833333334 10.841471354166668 5 10.423177083333336 5 10 C 5 9.576822916666668 5.013020833333334 9.158528645833334 5.0390625 8.7451171875 C 5.065104166666668 8.331705729166668 5.104166666666668 7.916666666666668 5.15625 7.5 L 1.611328125 7.5 Z M 10.8935546875 1.513671875 C 10.616861979166668 1.337890625 10.319010416666668 1.25 10 1.25 C 9.680989583333336 1.25 9.383138020833336 1.337890625 9.1064453125 1.513671875 C 8.829752604166668 1.689453125 8.57421875 1.920572916666667 8.33984375 2.20703125 C 8.10546875 2.493489583333334 7.8955078125 2.8173828125 7.7099609375 3.1787109375 C 7.5244140625 3.5400390625 7.360026041666668 3.90625 7.216796875 4.27734375 C 7.073567708333334 4.648437500000001 6.953125 5.006510416666668 6.85546875 5.3515625 C 6.7578125 5.696614583333334 6.682942708333334 5.99609375 6.630859375 6.25 L 13.369140625 6.25 C 13.317057291666668 5.99609375 13.2421875 5.696614583333334 13.14453125 5.3515625 C 13.046875 5.006510416666668 12.926432291666668 4.648437500000001 12.783203125 4.27734375 C 12.639973958333336 3.90625 12.4755859375 3.5400390625 12.2900390625 3.1787109375 C 12.1044921875 2.8173828125 11.89453125 2.493489583333334 11.66015625 2.20703125 C 11.42578125 1.920572916666667 11.170247395833336 1.689453125 10.8935546875 1.513671875 Z M 6.50390625 2.763671875 C 6.692708333333334 2.399088541666667 6.904296875 2.0540364583333335 7.138671875 1.728515625 C 6.591796875 1.9173177083333335 6.067708333333334 2.1614583333333335 5.56640625 2.4609375 C 5.065104166666668 2.760416666666667 4.599609375 3.102213541666667 4.169921875 3.486328125 C 3.740234375 3.870442708333334 3.349609375 4.295247395833334 2.998046875 4.7607421875 C 2.646484375 5.226236979166668 2.3470052083333335 5.72265625 2.099609375 6.25 L 5.3515625 6.25 C 5.4296875 5.859375 5.520833333333334 5.465494791666668 5.625 5.068359375 C 5.729166666666668 4.671223958333334 5.8544921875 4.278971354166667 6.0009765625 3.8916015625 C 6.1474609375 3.504231770833334 6.315104166666668 3.128255208333334 6.50390625 2.763671875 Z M 5.3515625 13.75 L 2.099609375 13.75 C 2.3470052083333335 14.27734375 2.646484375 14.773763020833336 2.998046875 15.2392578125 C 3.349609375 15.70475260416667 3.740234375 16.12955729166667 4.169921875 16.513671875 C 4.599609375 16.897786458333336 5.065104166666668 17.239583333333336 5.56640625 17.5390625 C 6.067708333333334 17.83854166666667 6.591796875 18.08268229166667 7.138671875 18.271484375 C 6.904296875 17.94596354166667 6.692708333333334 17.600911458333336 6.50390625 17.236328125 C 6.315104166666668 16.871744791666668 6.1474609375 16.495768229166668 6.0009765625 16.1083984375 C 5.8544921875 15.721028645833336 5.729166666666668 15.32877604166667 5.625 14.931640625 C 5.520833333333334 14.534505208333336 5.4296875 14.140625 5.3515625 13.75 Z M 13.49609375 17.236328125 C 13.307291666666668 17.600911458333336 13.095703125 17.94596354166667 12.861328125 18.271484375 C 13.408203125 18.08268229166667 13.932291666666668 17.83854166666667 14.43359375 17.5390625 C 14.934895833333336 17.239583333333336 15.400390625 16.897786458333336 15.830078125 16.513671875 C 16.259765625 16.12955729166667 16.650390625 15.70475260416667 17.001953125 15.2392578125 C 17.353515625 14.773763020833336 17.652994791666668 14.27734375 17.900390625 13.75 L 14.6484375 13.75 C 14.5703125 14.140625 14.479166666666668 14.534505208333336 14.375 14.931640625 C 14.270833333333336 15.32877604166667 14.1455078125 15.721028645833336 13.9990234375 16.1083984375 C 13.8525390625 16.495768229166668 13.684895833333336 16.871744791666668 13.49609375 17.236328125 Z"></path></svg><span class="ml-2 text-sm"> GLOBAL | </span></button><div><div class="fixed inset-0 z-[100]" style="background:rgba(0, 0, 0, 0);visibility:hidden"><div class="relative max-w-[1920px] mx-auto"><aside class="absolute right-0 z-50 w-[500px] max-sm:w-screen h-screen bg-white text-dark-grey" style="opacity:0;box-shadow:-5px -1px 14px 0px rgba(0, 0, 0, 0);transform:translateX(100%) translateZ(0)"><div class="w-full h-full overflow-y-auto"><div class="mr-[calc(100%-500px)] max-sm:mr-[calc(100%-100vw)] py-[21px] px-[35px] pr-[29px] tracking-normal font-normal"><div class="flex justify-end"><button aria-label="Close menu" type="button" class="text-primary h-7" tabindex="-1">Close</button></div><div class="flex justify-between flex-wrap items-center mt-[30px] text-dark-grey"><h3 class="m-0 mr-[12px] text-lg" data-sb-field-path=".title">Takeda - Global</h3><ul class="flex flex-wrap gap-5" data-sb-field-path="undefined:globalLanguages" role="list"><li role="listitem"><button class="text-[15px] hover:font-bold h-7" data-sb-field-path=".0">English</button><a tabindex="-1" href="/" class="crawled-link sr-only" aria-hidden="true">English</a></li><li role="listitem"><button class="text-[15px] hover:font-bold h-7" data-sb-field-path=".1">Japanese</button><a tabindex="-1" href="/jp" class="crawled-link sr-only" aria-hidden="true">Japanese</a></li></ul></div></div><div class="mr-[calc(100%-500px)] max-sm:mr-[calc(100%-100vw)] py-[21px] max-md:pb-[96px] px-[35px] pr-[29px] tracking-normal font-normal"><div class="w-full mb-[20px] relative"><input data-sb-field-path="undefined:header.searchLocationPlaceholder#@placeholder" placeholder="Search for a country" class="w-full p-[11px] font-light pr-12 border-[1px] border-medium-grey focus:outline-medium-grey text-medium-grey placeholder:text-lg placeholder:font-light" style="flex-grow:1" /><div class="absolute right-0 top-0 bottom-0 py-[12px] px-[15px] text-medium-grey"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="none" viewBox="0 0 24 24" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="block w-6" role="img" aria-hidden="false" data-testid="icon-Search"><title>Search</title><circle cx="11" cy="11" r="8"></circle><line x1="21" y1="21" x2="16.65" y2="16.65"></line></svg></div></div><ul data-sb-field-path="undefined:locations" role="list"><li data-sb-field-path=".0" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Argentina</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/es-ar" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".1" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Australia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-au" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".2" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Austria</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">German</span></button><a tabindex="-1" href="/de-at" class="crawled-link sr-only" aria-hidden="true">German</a></li><li data-sb-field-path=".3" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Belgium</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-be" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".4" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Bosnia Herzegovina</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Bosnian</span></button><a tabindex="-1" href="/bs-ba" class="crawled-link sr-only" aria-hidden="true">Bosnian</a></li><li data-sb-field-path=".5" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Brazil</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Portuguese</span></button><a tabindex="-1" href="/pt-br" class="crawled-link sr-only" aria-hidden="true">Portuguese</a></li><li data-sb-field-path=".6" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Bulgaria</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Bulgarian</span></button><a tabindex="-1" href="/bg-bg" class="crawled-link sr-only" aria-hidden="true">Bulgarian</a></li><li data-sb-field-path=".7" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><div class="flex flex-wrap items-center justify-between py-[8px] bg-transparent transition-all !text-[16px] max-md:!text-[15px] group"><button tabindex="-1" aria-label="Change Canada local site to [object Object] language" class="text-left text-lg group-hover:font-bold group-focus-within:font-bold">Canada</button><div class="flex items-center justify-end group-hover:font-light"><button tabindex="0" aria-label="Change Canada local site to English language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap group-hover:font-bold h-7">English</button><a tabindex="-1" href="/en-ca" class="crawled-link sr-only" aria-hidden="true">English</a><button tabindex="0" aria-label="Change Canada local site to French language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap !mr-0 h-7">French</button><a tabindex="-1" href="/fr-ca" class="crawled-link sr-only" aria-hidden="true">French</a></div></div></li><li data-sb-field-path=".8" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Chile</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/worldwide/chile/" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".9" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Mainland China</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Chinese</span></button><a tabindex="-1" href="https://takeda.info/takeda-china" class="crawled-link sr-only" aria-hidden="true">Chinese</a></li><li data-sb-field-path=".10" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Colombia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/es-co" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".11" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Croatia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Croatian</span></button><a tabindex="-1" href="/hr-hr" class="crawled-link sr-only" aria-hidden="true">Croatian</a></li><li data-sb-field-path=".12" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Czech Republic</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Czech</span></button><a tabindex="-1" href="/cs-cz" class="crawled-link sr-only" aria-hidden="true">Czech</a></li><li data-sb-field-path=".13" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Denmark</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Danish</span></button><a tabindex="-1" href="/da-dk" class="crawled-link sr-only" aria-hidden="true">Danish</a></li><li data-sb-field-path=".14" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Ecuador</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/es-ec" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".15" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Estonia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Estonian</span></button><a tabindex="-1" href="/et-ee" class="crawled-link sr-only" aria-hidden="true">Estonian</a></li><li data-sb-field-path=".16" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Finland</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Finnish</span></button><a tabindex="-1" href="/fi-fi" class="crawled-link sr-only" aria-hidden="true">Finnish</a></li><li data-sb-field-path=".17" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">France</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">French</span></button><a tabindex="-1" href="/fr-fr" class="crawled-link sr-only" aria-hidden="true">French</a></li><li data-sb-field-path=".18" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Germany</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">German</span></button><a tabindex="-1" href="/de-de" class="crawled-link sr-only" aria-hidden="true">German</a></li><li data-sb-field-path=".19" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Greece</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Greek</span></button><a tabindex="-1" href="/el-gr" class="crawled-link sr-only" aria-hidden="true">Greek</a></li><li data-sb-field-path=".20" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><div class="flex flex-wrap items-center justify-between py-[8px] bg-transparent transition-all !text-[16px] max-md:!text-[15px] group"><button tabindex="-1" aria-label="Change Hong Kong SAR local site to [object Object] language" class="text-left text-lg group-hover:font-bold group-focus-within:font-bold">Hong Kong SAR</button><div class="flex items-center justify-end group-hover:font-light"><button tabindex="0" aria-label="Change Hong Kong SAR local site to English language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap group-hover:font-bold h-7">English</button><a tabindex="-1" href="/en-hk" class="crawled-link sr-only" aria-hidden="true">English</a><button tabindex="0" aria-label="Change Hong Kong SAR local site to Chinese language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap !mr-0 h-7">Chinese</button><a tabindex="-1" href="/zh-hk" class="crawled-link sr-only" aria-hidden="true">Chinese</a></div></div></li><li data-sb-field-path=".21" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Hungary</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Hungarian</span></button><a tabindex="-1" href="/hu-hu" class="crawled-link sr-only" aria-hidden="true">Hungarian</a></li><li data-sb-field-path=".22" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">India</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-in" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".23" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Indonesia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Indonesian</span></button><a tabindex="-1" href="/id-id" class="crawled-link sr-only" aria-hidden="true">Indonesian</a></li><li data-sb-field-path=".24" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Ireland</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-ie" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".25" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Israel</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Hebrew</span></button><a tabindex="-1" href="/he-il" class="crawled-link sr-only" aria-hidden="true">Hebrew</a></li><li data-sb-field-path=".26" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Italy</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Italian</span></button><a tabindex="-1" href="/it-it" class="crawled-link sr-only" aria-hidden="true">Italian</a></li><li data-sb-field-path=".27" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Japan</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Japanese</span></button><a tabindex="-1" href="/ja-jp" class="crawled-link sr-only" aria-hidden="true">Japanese</a></li><li data-sb-field-path=".28" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><div class="flex flex-wrap items-center justify-between py-[8px] bg-transparent transition-all !text-[16px] max-md:!text-[15px] group"><button tabindex="-1" aria-label="Change Kazakhstan local site to [object Object] language" class="text-left text-lg group-hover:font-bold group-focus-within:font-bold">Kazakhstan</button><div class="flex items-center justify-end group-hover:font-light"><button tabindex="0" aria-label="Change Kazakhstan local site to Kazakh language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap group-hover:font-bold h-7">Kazakh</button><a tabindex="-1" href="/kk-kz" class="crawled-link sr-only" aria-hidden="true">Kazakh</a><button tabindex="0" aria-label="Change Kazakhstan local site to Russian language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap !mr-0 h-7">Russian</button><a tabindex="-1" href="/ru-kz" class="crawled-link sr-only" aria-hidden="true">Russian</a></div></div></li><li data-sb-field-path=".29" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Korea</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Korean</span></button><a tabindex="-1" href="/ko-kr" class="crawled-link sr-only" aria-hidden="true">Korean</a></li><li data-sb-field-path=".30" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Latvia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Latvian</span></button><a tabindex="-1" href="/lv-lv" class="crawled-link sr-only" aria-hidden="true">Latvian</a></li><li data-sb-field-path=".31" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Lithuania</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Lithuanian</span></button><a tabindex="-1" href="/lt-lt" class="crawled-link sr-only" aria-hidden="true">Lithuanian</a></li><li data-sb-field-path=".32" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Malaysia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/worldwide/asia-pacific-pte-ltd/" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".33" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Mexico</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/es-mx" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".34" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Netherlands</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Dutch</span></button><a tabindex="-1" href="/nl-nl" class="crawled-link sr-only" aria-hidden="true">Dutch</a></li><li data-sb-field-path=".35" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">New Zealand</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-au/" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".36" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Norway</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Norweigan</span></button><a tabindex="-1" href="/nn-no" class="crawled-link sr-only" aria-hidden="true">Norweigan</a></li><li data-sb-field-path=".37" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Peru</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/es-pe" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".38" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Philippines</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/worldwide/asia-pacific-pte-ltd/" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".39" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Poland</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Polish</span></button><a tabindex="-1" href="/pl-pl" class="crawled-link sr-only" aria-hidden="true">Polish</a></li><li data-sb-field-path=".40" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Portugal</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Portuguese</span></button><a tabindex="-1" href="/pt-pt" class="crawled-link sr-only" aria-hidden="true">Portuguese</a></li><li data-sb-field-path=".41" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Romania</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Romanian</span></button><a tabindex="-1" href="/ro-ro" class="crawled-link sr-only" aria-hidden="true">Romanian</a></li><li data-sb-field-path=".42" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Russia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Russian</span></button><a tabindex="-1" href="/ru-ru" class="crawled-link sr-only" aria-hidden="true">Russian</a></li><li data-sb-field-path=".43" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Saudi Arabia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Arabic</span></button><a tabindex="-1" href="/worldwide/saudi-arabia/" class="crawled-link sr-only" aria-hidden="true">Arabic</a></li><li data-sb-field-path=".44" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Serbia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Serbian</span></button><a tabindex="-1" href="/sr-rs" class="crawled-link sr-only" aria-hidden="true">Serbian</a></li><li data-sb-field-path=".45" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Singapore</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/worldwide/asia-pacific-pte-ltd/" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".46" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Slovakia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Slovak</span></button><a tabindex="-1" href="/sk-sk" class="crawled-link sr-only" aria-hidden="true">Slovak</a></li><li data-sb-field-path=".47" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Slovenia</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Slovenian</span></button><a tabindex="-1" href="/sl-si" class="crawled-link sr-only" aria-hidden="true">Slovenian</a></li><li data-sb-field-path=".48" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Spain</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Spanish</span></button><a tabindex="-1" href="/es-es" class="crawled-link sr-only" aria-hidden="true">Spanish</a></li><li data-sb-field-path=".49" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Sweden</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Swedish</span></button><a tabindex="-1" href="/sv-se" class="crawled-link sr-only" aria-hidden="true">Swedish</a></li><li data-sb-field-path=".50" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><div class="flex flex-wrap items-center justify-between py-[8px] bg-transparent transition-all !text-[16px] max-md:!text-[15px] group"><button tabindex="-1" aria-label="Change Switzerland local site to [object Object] language" class="text-left text-lg group-hover:font-bold group-focus-within:font-bold">Switzerland</button><div class="flex items-center justify-end group-hover:font-light"><button tabindex="0" aria-label="Change Switzerland local site to German language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap group-hover:font-bold h-7">German</button><a tabindex="-1" href="/de-ch" class="crawled-link sr-only" aria-hidden="true">German</a><button tabindex="0" aria-label="Change Switzerland local site to French language" class="mr-2 py-[4px] max-md:py-[3px] text-[15px] font-light hover:font-bold whitespace-nowrap !mr-0 h-7">French</button><a tabindex="-1" href="/fr-ch" class="crawled-link sr-only" aria-hidden="true">French</a></div></div></li><li data-sb-field-path=".51" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Taiwan</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Chinese</span></button><a tabindex="-1" href="/zh-tw" class="crawled-link sr-only" aria-hidden="true">Chinese</a></li><li data-sb-field-path=".52" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Thailand</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Thai</span></button><a tabindex="-1" href="/th-th" class="crawled-link sr-only" aria-hidden="true">Thai</a></li><li data-sb-field-path=".53" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Turkey</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Turkish</span></button><a tabindex="-1" href="/tr-tr" class="crawled-link sr-only" aria-hidden="true">Turkish</a></li><li data-sb-field-path=".54" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Ukraine</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">Ukrainian</span></button><a tabindex="-1" href="/uk-ua" class="crawled-link sr-only" aria-hidden="true">Ukrainian</a></li><li data-sb-field-path=".55" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">United Kingdom</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-gb" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".56" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">United States</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-us" class="crawled-link sr-only" aria-hidden="true">English</a></li><li data-sb-field-path=".57" class="border-b-[1px] last:border-none border-medium-grey" role="listitem"><button tabindex="0" class="flex items-center justify-between w-full py-[12px] bg-transparent transition-all !text-[15px] max-md:!text-[15px] group"><span class="mr-[8px] text-left text-lg text-dark-grey group-hover:font-bold group-focus-within:font-bold" data-sb-field-path=".locationName">Vietnam</span><span class="text-[15px] font-light group-hover:font-bold whitespace-nowrap" data-sb-field-path=".languages">English</span></button><a tabindex="-1" href="/en-vi" class="crawled-link sr-only" aria-hidden="true">English</a></li></ul></div></div></aside></div></div></div><button aria-label="close mobile menu"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 20 20" class="block w-5" role="img" aria-hidden="false" data-testid="icon-Close"><title>Close</title><path d="M 20 1.416015625 L 11.416015625 10 L 20 18.583984375 L 18.583984375 20 L 10 11.416015625 L 1.416015625 20 L 0 18.583984375 L 8.583984375 10 L 0 1.416015625 L 1.416015625 0 L 10 8.583984375 L 18.583984375 0 L 20 1.416015625 Z"></path></svg></button></div><ul class="flex flex-col gap-6 mt-[5rem] ml-[50px] z-10 relative" role="list"></ul></div></div></aside></div></div></div></div></div></header><main><h1 class="sr-only">Takeda Pharmaceuticals: Global Homepage</h1><div data-sb-field-path="sections"><section data-section-position="0" data-sb-field-path="sections.0" data-section-name="# Hear from our new Global CSR partners

" data-exclude-from-nav="false" class="global-pt global-pb mt-0 global-mb relative h-[500px] max-sm:h-auto bg-white"><div class="absolute inset-0 max-sm:relative max-sm:h-[200px]"><div class="ImageBlock_root__MFRQz"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img data-sb-field-path=".media.0.url" alt="Takeda: Hear from our new Global CSR partners" __metadata="[object Object]" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala" decoding="async" data-nimg="fill" class="rounded-none" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover;background-size:cover;background-position:0% 0%;filter:blur(20px);background-image:url(&quot;data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAHCAMAAAAGcixRAAAAhFBMVEVPRDRyfnymeV5ZTTtDOzBLT0lgaWV6fnpXVVYIDRJkWk9FKiUeFBEmLTF3hI9alNtvVkOsjGrTSYDaw6dgV0VfXVcwJySVcVYxJRh2g4QCHzxrd5CkhGIVO18MIDWTjphRQS8/Vn8yNzOnb1OmaZ1VaZTEYmGyYo6rj3RXHCryJIO6m3mvkAV3AAAATElEQVQI1w3GRQKAIAAEwFVpUOzujv//T+Y06GcppUEAiiQOh7bUyJnrGo5+TRTHp8i2TKIqOG7oc7edLzxkxKSXjXjhGjxvekSMNj+noASaRqhVIAAAAABJRU5ErkJggg==&quot;)" /><noscript><img data-sb-field-path=".media.0.url" alt="Takeda: Hear from our new Global CSR partners" __metadata="[object Object]" loading="eager" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" class="rounded-none" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala"/></noscript></span></div></div><div class="absolute bottom-0 left-0 w-11/12 px-14 pt-10 pb-8 bg-black/80 max-sm:relative max-sm:w-full max-sm:p-6 max-lg:px-8 max-lg:py-8"><hr class="absolute w-36 max-md:w-28 top-0 left-0 h-[6px] bg-primary border-none" /><div class="space-y-4"><div class="MarkdownRedesign_root__x_GKG"><h2 class="MarkdownTitle_root__aLK5c !m-0 !font-light normal-case tracking-normal md:line-clamp-3 text-white" id="Hear from our new Global CSR partners" data-sb-field-path=".title">Hear from our new Global CSR partners</h2></div><a data-sb-field-path=".button" __metadata="[object Object]" type="Action" class="ActionRedesign_link__BERDu ActionRedesign_primary__gaHSB ActionRedesign_medium__BeEct" role="link" aria-label="Learn more" href="/our-impact/our-stories/hear-from-our-new-global-csr-partners/"><span class="ActionRedesign_label__pFlEJ">Learn More</span></a></div></div></section><section data-section-position="1" data-sb-field-path="sections.1" data-section-name data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb flex flex-col justify-center border-none bg-white"><div class="Container_root__AelVI"><div class="flex w-full max-w-screen-xl"><div class><p class="TextBody_subtitle__RwtIz text-dark-grey" data-sb-field-path=".subtitle">We exist to create better health for people and a brighter future for the world. While the science and technology we advance are constantly evolving, our ambition remains. We move science forward, so we can transform more lives.</p><div class="MarkdownRedesign_root__x_GKG"><div class="TextBody_markdownText__gH5fT text-dark-grey" data-sb-field-path=".text"></div></div></div></div></div></section><section data-section-position="2" data-sb-field-path="sections.2" data-section-name="&lt;h2 style=&quot;text-align: center;&quot;&gt;Recent News&lt;/h2&gt;

" data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb bg-white"><div class="Container_root__AelVI"><div class="SectionTitleContainer_root__CntCn text-dark-grey" data-testid="sectionTitleContainer"><div class="Markdown_root__STsP7"><h2 style="text-align:center" class="SectionWrapperWithTitle_title__KwWWJ text-center" data-sb-field-path=".title">Recent News</h2></div></div><div class="grid gap-x-8 gap-y-4 xl:grid-cols-4 lg:grid-cols-3 sm:grid-cols-2 xs:grid-cols-1 justify-center"><div><a class="group flex max-w-[330px] min-h-[250px] lg:min-h-[300px] p-[30px] hover:bg-primary bg-light-grey transition-colors duration-200 ease-linear" role="link" href="/newsroom/newsreleases/2023/Takeda-Dengue-Vaccine-Recommended-by-World-Health-Organization-Advisory-Group-for-Introduction-in-High-Dengue-Burden-and-Transmission-Areas-in-Children-Ages-Six-to-16-Years/"><article class="flex flex-col justify-between"><div class="MarkdownRedesign_root__x_GKG"><h3 class="!my-6 !text-[16px] !font-semibold group-hover:text-white text-primary !leading-tight line-clamp-4 hover:text-primary cursor-pointer">Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years</h3></div><div class="flex items-center mt-[8px] shrink-0 group-hover:text-white"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 34 39" class="mr-[16px] w-[16px] h-[16px]" role="img" aria-hidden="false" data-testid="icon-dotcom/Calendar"><title>Calendar</title><path d="M30.2578 5.5C31.2227 5.5 32.0391 5.87109 32.7812 6.53906C33.4492 7.28125 33.8203 8.09766 33.8203 9.0625V35.1875C33.8203 36.2266 33.4492 37.043 32.7812 37.7109C32.0391 38.4531 31.2227 38.75 30.2578 38.75H4.13281C3.09375 38.75 2.27734 38.4531 1.60938 37.7109C0.867188 37.043 0.570312 36.2266 0.570312 35.1875V9.0625C0.570312 8.09766 0.867188 7.28125 1.60938 6.53906C2.27734 5.87109 3.09375 5.5 4.13281 5.5H7.69531V1.64062C7.69531 1.41797 7.76953 1.19531 7.91797 1.04688C8.06641 0.898438 8.28906 0.75 8.58594 0.75H9.17969C9.40234 0.75 9.625 0.898438 9.77344 1.04688C9.92188 1.19531 10.0703 1.41797 10.0703 1.64062V5.5H24.3203V1.64062C24.3203 1.41797 24.3945 1.19531 24.543 1.04688C24.6914 0.898438 24.9141 0.75 25.2109 0.75H25.8047C26.0273 0.75 26.25 0.898438 26.3984 1.04688C26.5469 1.19531 26.6953 1.41797 26.6953 1.64062V5.5H30.2578ZM4.13281 7.875C3.76172 7.875 3.46484 8.02344 3.24219 8.24609C3.01953 8.46875 2.94531 8.76562 2.94531 9.0625V12.625H31.4453V9.0625C31.4453 8.76562 31.2969 8.46875 31.0742 8.24609C30.8516 8.02344 30.5547 7.875 30.2578 7.875H4.13281ZM30.2578 36.375C30.5547 36.375 30.8516 36.3008 31.0742 36.0781C31.2969 35.8555 31.4453 35.5586 31.4453 35.1875V15H2.94531V35.1875C2.94531 35.5586 3.01953 35.8555 3.24219 36.0781C3.46484 36.3008 3.76172 36.375 4.13281 36.375H30.2578ZM11.5547 24.5C11.7773 24.5 12 24.4258 12.1484 24.2773C12.2969 24.1289 12.4453 23.9062 12.4453 23.6094V20.6406C12.4453 20.418 12.2969 20.1953 12.1484 20.0469C12 19.8984 11.7773 19.75 11.5547 19.75H8.58594C8.28906 19.75 8.06641 19.8984 7.91797 20.0469C7.76953 20.1953 7.69531 20.418 7.69531 20.6406V23.6094C7.69531 23.9062 7.76953 24.1289 7.91797 24.2773C8.06641 24.4258 8.28906 24.5 8.58594 24.5H11.5547ZM18.6797 24.5C18.9023 24.5 19.125 24.4258 19.2734 24.2773C19.4219 24.1289 19.5703 23.9062 19.5703 23.6094V20.6406C19.5703 20.418 19.4219 20.1953 19.2734 20.0469C19.125 19.8984 18.9023 19.75 18.6797 19.75H15.7109C15.4141 19.75 15.1914 19.8984 15.043 20.0469C14.8945 20.1953 14.8203 20.418 14.8203 20.6406V23.6094C14.8203 23.9062 14.8945 24.1289 15.043 24.2773C15.1914 24.4258 15.4141 24.5 15.7109 24.5H18.6797ZM25.8047 24.5C26.0273 24.5 26.25 24.4258 26.3984 24.2773C26.5469 24.1289 26.6953 23.9062 26.6953 23.6094V20.6406C26.6953 20.418 26.5469 20.1953 26.3984 20.0469C26.25 19.8984 26.0273 19.75 25.8047 19.75H22.8359C22.5391 19.75 22.3164 19.8984 22.168 20.0469C22.0195 20.1953 21.9453 20.418 21.9453 20.6406V23.6094C21.9453 23.9062 22.0195 24.1289 22.168 24.2773C22.3164 24.4258 22.5391 24.5 22.8359 24.5H25.8047ZM18.6797 31.625C18.9023 31.625 19.125 31.5508 19.2734 31.4023C19.4219 31.2539 19.5703 31.0312 19.5703 30.7344V27.7656C19.5703 27.543 19.4219 27.3203 19.2734 27.1719C19.125 27.0234 18.9023 26.875 18.6797 26.875H15.7109C15.4141 26.875 15.1914 27.0234 15.043 27.1719C14.8945 27.3203 14.8203 27.543 14.8203 27.7656V30.7344C14.8203 31.0312 14.8945 31.2539 15.043 31.4023C15.1914 31.5508 15.4141 31.625 15.7109 31.625H18.6797ZM11.5547 31.625C11.7773 31.625 12 31.5508 12.1484 31.4023C12.2969 31.2539 12.4453 31.0312 12.4453 30.7344V27.7656C12.4453 27.543 12.2969 27.3203 12.1484 27.1719C12 27.0234 11.7773 26.875 11.5547 26.875H8.58594C8.28906 26.875 8.06641 27.0234 7.91797 27.1719C7.76953 27.3203 7.69531 27.543 7.69531 27.7656V30.7344C7.69531 31.0312 7.76953 31.2539 7.91797 31.4023C8.06641 31.5508 8.28906 31.625 8.58594 31.625H11.5547ZM25.8047 31.625C26.0273 31.625 26.25 31.5508 26.3984 31.4023C26.5469 31.2539 26.6953 31.0312 26.6953 30.7344V27.7656C26.6953 27.543 26.5469 27.3203 26.3984 27.1719C26.25 27.0234 26.0273 26.875 25.8047 26.875H22.8359C22.5391 26.875 22.3164 27.0234 22.168 27.1719C22.0195 27.3203 21.9453 27.543 21.9453 27.7656V30.7344C21.9453 31.0312 22.0195 31.2539 22.168 31.4023C22.3164 31.5508 22.5391 31.625 22.8359 31.625H25.8047Z" fill="currentColor"></path></svg><span class="text-[14px] ">October 3, 2023</span></div></article></a></div><div><a class="group flex max-w-[330px] min-h-[250px] lg:min-h-[300px] p-[30px] hover:bg-primary bg-light-grey transition-colors duration-200 ease-linear" role="link" href="/newsroom/newsreleases/2023/Takeda-Provides-Update-on-EXKIVITY-mobocertinib/"><article class="flex flex-col justify-between"><div class="MarkdownRedesign_root__x_GKG"><h3 class="!my-6 !text-[16px] !font-semibold group-hover:text-white text-primary !leading-tight line-clamp-4 hover:text-primary cursor-pointer">Takeda Provides Update on EXKIVITY® (mobocertinib)</h3></div><div class="flex items-center mt-[8px] shrink-0 group-hover:text-white"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 34 39" class="mr-[16px] w-[16px] h-[16px]" role="img" aria-hidden="false" data-testid="icon-dotcom/Calendar"><title>Calendar</title><path d="M30.2578 5.5C31.2227 5.5 32.0391 5.87109 32.7812 6.53906C33.4492 7.28125 33.8203 8.09766 33.8203 9.0625V35.1875C33.8203 36.2266 33.4492 37.043 32.7812 37.7109C32.0391 38.4531 31.2227 38.75 30.2578 38.75H4.13281C3.09375 38.75 2.27734 38.4531 1.60938 37.7109C0.867188 37.043 0.570312 36.2266 0.570312 35.1875V9.0625C0.570312 8.09766 0.867188 7.28125 1.60938 6.53906C2.27734 5.87109 3.09375 5.5 4.13281 5.5H7.69531V1.64062C7.69531 1.41797 7.76953 1.19531 7.91797 1.04688C8.06641 0.898438 8.28906 0.75 8.58594 0.75H9.17969C9.40234 0.75 9.625 0.898438 9.77344 1.04688C9.92188 1.19531 10.0703 1.41797 10.0703 1.64062V5.5H24.3203V1.64062C24.3203 1.41797 24.3945 1.19531 24.543 1.04688C24.6914 0.898438 24.9141 0.75 25.2109 0.75H25.8047C26.0273 0.75 26.25 0.898438 26.3984 1.04688C26.5469 1.19531 26.6953 1.41797 26.6953 1.64062V5.5H30.2578ZM4.13281 7.875C3.76172 7.875 3.46484 8.02344 3.24219 8.24609C3.01953 8.46875 2.94531 8.76562 2.94531 9.0625V12.625H31.4453V9.0625C31.4453 8.76562 31.2969 8.46875 31.0742 8.24609C30.8516 8.02344 30.5547 7.875 30.2578 7.875H4.13281ZM30.2578 36.375C30.5547 36.375 30.8516 36.3008 31.0742 36.0781C31.2969 35.8555 31.4453 35.5586 31.4453 35.1875V15H2.94531V35.1875C2.94531 35.5586 3.01953 35.8555 3.24219 36.0781C3.46484 36.3008 3.76172 36.375 4.13281 36.375H30.2578ZM11.5547 24.5C11.7773 24.5 12 24.4258 12.1484 24.2773C12.2969 24.1289 12.4453 23.9062 12.4453 23.6094V20.6406C12.4453 20.418 12.2969 20.1953 12.1484 20.0469C12 19.8984 11.7773 19.75 11.5547 19.75H8.58594C8.28906 19.75 8.06641 19.8984 7.91797 20.0469C7.76953 20.1953 7.69531 20.418 7.69531 20.6406V23.6094C7.69531 23.9062 7.76953 24.1289 7.91797 24.2773C8.06641 24.4258 8.28906 24.5 8.58594 24.5H11.5547ZM18.6797 24.5C18.9023 24.5 19.125 24.4258 19.2734 24.2773C19.4219 24.1289 19.5703 23.9062 19.5703 23.6094V20.6406C19.5703 20.418 19.4219 20.1953 19.2734 20.0469C19.125 19.8984 18.9023 19.75 18.6797 19.75H15.7109C15.4141 19.75 15.1914 19.8984 15.043 20.0469C14.8945 20.1953 14.8203 20.418 14.8203 20.6406V23.6094C14.8203 23.9062 14.8945 24.1289 15.043 24.2773C15.1914 24.4258 15.4141 24.5 15.7109 24.5H18.6797ZM25.8047 24.5C26.0273 24.5 26.25 24.4258 26.3984 24.2773C26.5469 24.1289 26.6953 23.9062 26.6953 23.6094V20.6406C26.6953 20.418 26.5469 20.1953 26.3984 20.0469C26.25 19.8984 26.0273 19.75 25.8047 19.75H22.8359C22.5391 19.75 22.3164 19.8984 22.168 20.0469C22.0195 20.1953 21.9453 20.418 21.9453 20.6406V23.6094C21.9453 23.9062 22.0195 24.1289 22.168 24.2773C22.3164 24.4258 22.5391 24.5 22.8359 24.5H25.8047ZM18.6797 31.625C18.9023 31.625 19.125 31.5508 19.2734 31.4023C19.4219 31.2539 19.5703 31.0312 19.5703 30.7344V27.7656C19.5703 27.543 19.4219 27.3203 19.2734 27.1719C19.125 27.0234 18.9023 26.875 18.6797 26.875H15.7109C15.4141 26.875 15.1914 27.0234 15.043 27.1719C14.8945 27.3203 14.8203 27.543 14.8203 27.7656V30.7344C14.8203 31.0312 14.8945 31.2539 15.043 31.4023C15.1914 31.5508 15.4141 31.625 15.7109 31.625H18.6797ZM11.5547 31.625C11.7773 31.625 12 31.5508 12.1484 31.4023C12.2969 31.2539 12.4453 31.0312 12.4453 30.7344V27.7656C12.4453 27.543 12.2969 27.3203 12.1484 27.1719C12 27.0234 11.7773 26.875 11.5547 26.875H8.58594C8.28906 26.875 8.06641 27.0234 7.91797 27.1719C7.76953 27.3203 7.69531 27.543 7.69531 27.7656V30.7344C7.69531 31.0312 7.76953 31.2539 7.91797 31.4023C8.06641 31.5508 8.28906 31.625 8.58594 31.625H11.5547ZM25.8047 31.625C26.0273 31.625 26.25 31.5508 26.3984 31.4023C26.5469 31.2539 26.6953 31.0312 26.6953 30.7344V27.7656C26.6953 27.543 26.5469 27.3203 26.3984 27.1719C26.25 27.0234 26.0273 26.875 25.8047 26.875H22.8359C22.5391 26.875 22.3164 27.0234 22.168 27.1719C22.0195 27.3203 21.9453 27.543 21.9453 27.7656V30.7344C21.9453 31.0312 22.0195 31.2539 22.168 31.4023C22.3164 31.5508 22.5391 31.625 22.8359 31.625H25.8047Z" fill="currentColor"></path></svg><span class="text-[14px] ">October 2, 2023</span></div></article></a></div><div><a class="group flex max-w-[330px] min-h-[250px] lg:min-h-[300px] p-[30px] hover:bg-primary bg-light-grey transition-colors duration-200 ease-linear" role="link" href="/newsroom/newsreleases/2023/Amendment-of-Compensation-Recoupment-Policy/"><article class="flex flex-col justify-between"><div class="MarkdownRedesign_root__x_GKG"><h3 class="!my-6 !text-[16px] !font-semibold group-hover:text-white text-primary !leading-tight line-clamp-4 hover:text-primary cursor-pointer">Takeda Announces Amendment of Compensation Recoupment Policy</h3></div><div class="flex items-center mt-[8px] shrink-0 group-hover:text-white"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 34 39" class="mr-[16px] w-[16px] h-[16px]" role="img" aria-hidden="false" data-testid="icon-dotcom/Calendar"><title>Calendar</title><path d="M30.2578 5.5C31.2227 5.5 32.0391 5.87109 32.7812 6.53906C33.4492 7.28125 33.8203 8.09766 33.8203 9.0625V35.1875C33.8203 36.2266 33.4492 37.043 32.7812 37.7109C32.0391 38.4531 31.2227 38.75 30.2578 38.75H4.13281C3.09375 38.75 2.27734 38.4531 1.60938 37.7109C0.867188 37.043 0.570312 36.2266 0.570312 35.1875V9.0625C0.570312 8.09766 0.867188 7.28125 1.60938 6.53906C2.27734 5.87109 3.09375 5.5 4.13281 5.5H7.69531V1.64062C7.69531 1.41797 7.76953 1.19531 7.91797 1.04688C8.06641 0.898438 8.28906 0.75 8.58594 0.75H9.17969C9.40234 0.75 9.625 0.898438 9.77344 1.04688C9.92188 1.19531 10.0703 1.41797 10.0703 1.64062V5.5H24.3203V1.64062C24.3203 1.41797 24.3945 1.19531 24.543 1.04688C24.6914 0.898438 24.9141 0.75 25.2109 0.75H25.8047C26.0273 0.75 26.25 0.898438 26.3984 1.04688C26.5469 1.19531 26.6953 1.41797 26.6953 1.64062V5.5H30.2578ZM4.13281 7.875C3.76172 7.875 3.46484 8.02344 3.24219 8.24609C3.01953 8.46875 2.94531 8.76562 2.94531 9.0625V12.625H31.4453V9.0625C31.4453 8.76562 31.2969 8.46875 31.0742 8.24609C30.8516 8.02344 30.5547 7.875 30.2578 7.875H4.13281ZM30.2578 36.375C30.5547 36.375 30.8516 36.3008 31.0742 36.0781C31.2969 35.8555 31.4453 35.5586 31.4453 35.1875V15H2.94531V35.1875C2.94531 35.5586 3.01953 35.8555 3.24219 36.0781C3.46484 36.3008 3.76172 36.375 4.13281 36.375H30.2578ZM11.5547 24.5C11.7773 24.5 12 24.4258 12.1484 24.2773C12.2969 24.1289 12.4453 23.9062 12.4453 23.6094V20.6406C12.4453 20.418 12.2969 20.1953 12.1484 20.0469C12 19.8984 11.7773 19.75 11.5547 19.75H8.58594C8.28906 19.75 8.06641 19.8984 7.91797 20.0469C7.76953 20.1953 7.69531 20.418 7.69531 20.6406V23.6094C7.69531 23.9062 7.76953 24.1289 7.91797 24.2773C8.06641 24.4258 8.28906 24.5 8.58594 24.5H11.5547ZM18.6797 24.5C18.9023 24.5 19.125 24.4258 19.2734 24.2773C19.4219 24.1289 19.5703 23.9062 19.5703 23.6094V20.6406C19.5703 20.418 19.4219 20.1953 19.2734 20.0469C19.125 19.8984 18.9023 19.75 18.6797 19.75H15.7109C15.4141 19.75 15.1914 19.8984 15.043 20.0469C14.8945 20.1953 14.8203 20.418 14.8203 20.6406V23.6094C14.8203 23.9062 14.8945 24.1289 15.043 24.2773C15.1914 24.4258 15.4141 24.5 15.7109 24.5H18.6797ZM25.8047 24.5C26.0273 24.5 26.25 24.4258 26.3984 24.2773C26.5469 24.1289 26.6953 23.9062 26.6953 23.6094V20.6406C26.6953 20.418 26.5469 20.1953 26.3984 20.0469C26.25 19.8984 26.0273 19.75 25.8047 19.75H22.8359C22.5391 19.75 22.3164 19.8984 22.168 20.0469C22.0195 20.1953 21.9453 20.418 21.9453 20.6406V23.6094C21.9453 23.9062 22.0195 24.1289 22.168 24.2773C22.3164 24.4258 22.5391 24.5 22.8359 24.5H25.8047ZM18.6797 31.625C18.9023 31.625 19.125 31.5508 19.2734 31.4023C19.4219 31.2539 19.5703 31.0312 19.5703 30.7344V27.7656C19.5703 27.543 19.4219 27.3203 19.2734 27.1719C19.125 27.0234 18.9023 26.875 18.6797 26.875H15.7109C15.4141 26.875 15.1914 27.0234 15.043 27.1719C14.8945 27.3203 14.8203 27.543 14.8203 27.7656V30.7344C14.8203 31.0312 14.8945 31.2539 15.043 31.4023C15.1914 31.5508 15.4141 31.625 15.7109 31.625H18.6797ZM11.5547 31.625C11.7773 31.625 12 31.5508 12.1484 31.4023C12.2969 31.2539 12.4453 31.0312 12.4453 30.7344V27.7656C12.4453 27.543 12.2969 27.3203 12.1484 27.1719C12 27.0234 11.7773 26.875 11.5547 26.875H8.58594C8.28906 26.875 8.06641 27.0234 7.91797 27.1719C7.76953 27.3203 7.69531 27.543 7.69531 27.7656V30.7344C7.69531 31.0312 7.76953 31.2539 7.91797 31.4023C8.06641 31.5508 8.28906 31.625 8.58594 31.625H11.5547ZM25.8047 31.625C26.0273 31.625 26.25 31.5508 26.3984 31.4023C26.5469 31.2539 26.6953 31.0312 26.6953 30.7344V27.7656C26.6953 27.543 26.5469 27.3203 26.3984 27.1719C26.25 27.0234 26.0273 26.875 25.8047 26.875H22.8359C22.5391 26.875 22.3164 27.0234 22.168 27.1719C22.0195 27.3203 21.9453 27.543 21.9453 27.7656V30.7344C21.9453 31.0312 22.0195 31.2539 22.168 31.4023C22.3164 31.5508 22.5391 31.625 22.8359 31.625H25.8047Z" fill="currentColor"></path></svg><span class="text-[14px] ">October 2, 2023</span></div></article></a></div><div><a class="group flex max-w-[330px] min-h-[250px] lg:min-h-[300px] p-[30px] hover:bg-primary bg-light-grey transition-colors duration-200 ease-linear" role="link" href="/newsroom/newsreleases/2023/US-FDA-Approves-Subcutaneous-Administration-of-Takeda-ENTYVIO-vedolizumab-for-Maintenance-Therapy-in-Moderately-to-Severely-Active-Ulcerative-Colitis/"><article class="flex flex-col justify-between"><div class="MarkdownRedesign_root__x_GKG"><h3 class="!my-6 !text-[16px] !font-semibold group-hover:text-white text-primary !leading-tight line-clamp-4 hover:text-primary cursor-pointer">U.S. FDA Approves Subcutaneous Administration of Takeda&#x27;s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis</h3></div><div class="flex items-center mt-[8px] shrink-0 group-hover:text-white"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 34 39" class="mr-[16px] w-[16px] h-[16px]" role="img" aria-hidden="false" data-testid="icon-dotcom/Calendar"><title>Calendar</title><path d="M30.2578 5.5C31.2227 5.5 32.0391 5.87109 32.7812 6.53906C33.4492 7.28125 33.8203 8.09766 33.8203 9.0625V35.1875C33.8203 36.2266 33.4492 37.043 32.7812 37.7109C32.0391 38.4531 31.2227 38.75 30.2578 38.75H4.13281C3.09375 38.75 2.27734 38.4531 1.60938 37.7109C0.867188 37.043 0.570312 36.2266 0.570312 35.1875V9.0625C0.570312 8.09766 0.867188 7.28125 1.60938 6.53906C2.27734 5.87109 3.09375 5.5 4.13281 5.5H7.69531V1.64062C7.69531 1.41797 7.76953 1.19531 7.91797 1.04688C8.06641 0.898438 8.28906 0.75 8.58594 0.75H9.17969C9.40234 0.75 9.625 0.898438 9.77344 1.04688C9.92188 1.19531 10.0703 1.41797 10.0703 1.64062V5.5H24.3203V1.64062C24.3203 1.41797 24.3945 1.19531 24.543 1.04688C24.6914 0.898438 24.9141 0.75 25.2109 0.75H25.8047C26.0273 0.75 26.25 0.898438 26.3984 1.04688C26.5469 1.19531 26.6953 1.41797 26.6953 1.64062V5.5H30.2578ZM4.13281 7.875C3.76172 7.875 3.46484 8.02344 3.24219 8.24609C3.01953 8.46875 2.94531 8.76562 2.94531 9.0625V12.625H31.4453V9.0625C31.4453 8.76562 31.2969 8.46875 31.0742 8.24609C30.8516 8.02344 30.5547 7.875 30.2578 7.875H4.13281ZM30.2578 36.375C30.5547 36.375 30.8516 36.3008 31.0742 36.0781C31.2969 35.8555 31.4453 35.5586 31.4453 35.1875V15H2.94531V35.1875C2.94531 35.5586 3.01953 35.8555 3.24219 36.0781C3.46484 36.3008 3.76172 36.375 4.13281 36.375H30.2578ZM11.5547 24.5C11.7773 24.5 12 24.4258 12.1484 24.2773C12.2969 24.1289 12.4453 23.9062 12.4453 23.6094V20.6406C12.4453 20.418 12.2969 20.1953 12.1484 20.0469C12 19.8984 11.7773 19.75 11.5547 19.75H8.58594C8.28906 19.75 8.06641 19.8984 7.91797 20.0469C7.76953 20.1953 7.69531 20.418 7.69531 20.6406V23.6094C7.69531 23.9062 7.76953 24.1289 7.91797 24.2773C8.06641 24.4258 8.28906 24.5 8.58594 24.5H11.5547ZM18.6797 24.5C18.9023 24.5 19.125 24.4258 19.2734 24.2773C19.4219 24.1289 19.5703 23.9062 19.5703 23.6094V20.6406C19.5703 20.418 19.4219 20.1953 19.2734 20.0469C19.125 19.8984 18.9023 19.75 18.6797 19.75H15.7109C15.4141 19.75 15.1914 19.8984 15.043 20.0469C14.8945 20.1953 14.8203 20.418 14.8203 20.6406V23.6094C14.8203 23.9062 14.8945 24.1289 15.043 24.2773C15.1914 24.4258 15.4141 24.5 15.7109 24.5H18.6797ZM25.8047 24.5C26.0273 24.5 26.25 24.4258 26.3984 24.2773C26.5469 24.1289 26.6953 23.9062 26.6953 23.6094V20.6406C26.6953 20.418 26.5469 20.1953 26.3984 20.0469C26.25 19.8984 26.0273 19.75 25.8047 19.75H22.8359C22.5391 19.75 22.3164 19.8984 22.168 20.0469C22.0195 20.1953 21.9453 20.418 21.9453 20.6406V23.6094C21.9453 23.9062 22.0195 24.1289 22.168 24.2773C22.3164 24.4258 22.5391 24.5 22.8359 24.5H25.8047ZM18.6797 31.625C18.9023 31.625 19.125 31.5508 19.2734 31.4023C19.4219 31.2539 19.5703 31.0312 19.5703 30.7344V27.7656C19.5703 27.543 19.4219 27.3203 19.2734 27.1719C19.125 27.0234 18.9023 26.875 18.6797 26.875H15.7109C15.4141 26.875 15.1914 27.0234 15.043 27.1719C14.8945 27.3203 14.8203 27.543 14.8203 27.7656V30.7344C14.8203 31.0312 14.8945 31.2539 15.043 31.4023C15.1914 31.5508 15.4141 31.625 15.7109 31.625H18.6797ZM11.5547 31.625C11.7773 31.625 12 31.5508 12.1484 31.4023C12.2969 31.2539 12.4453 31.0312 12.4453 30.7344V27.7656C12.4453 27.543 12.2969 27.3203 12.1484 27.1719C12 27.0234 11.7773 26.875 11.5547 26.875H8.58594C8.28906 26.875 8.06641 27.0234 7.91797 27.1719C7.76953 27.3203 7.69531 27.543 7.69531 27.7656V30.7344C7.69531 31.0312 7.76953 31.2539 7.91797 31.4023C8.06641 31.5508 8.28906 31.625 8.58594 31.625H11.5547ZM25.8047 31.625C26.0273 31.625 26.25 31.5508 26.3984 31.4023C26.5469 31.2539 26.6953 31.0312 26.6953 30.7344V27.7656C26.6953 27.543 26.5469 27.3203 26.3984 27.1719C26.25 27.0234 26.0273 26.875 25.8047 26.875H22.8359C22.5391 26.875 22.3164 27.0234 22.168 27.1719C22.0195 27.3203 21.9453 27.543 21.9453 27.7656V30.7344C21.9453 31.0312 22.0195 31.2539 22.168 31.4023C22.3164 31.5508 22.5391 31.625 22.8359 31.625H25.8047Z" fill="currentColor"></path></svg><span class="text-[14px] ">September 27, 2023</span></div></article></a></div></div><div class="flex justify-center align-middle mt-[40px]"><a href="/newsroom/press-releases" class="Link_link__xyyGG">View All</a></div></div></section><section data-section-position="3" data-sb-field-path="sections.3" data-section-name="## Better Health, Brighter Future

" data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb bg-white"><div class="Container_root__AelVI"><div class="SectionTitleContainer_root__CntCn text-dark-grey" data-testid="sectionTitleContainer"><div class="Markdown_root__STsP7"><h2 id="Better Health, Brighter Future" class="SectionWrapperWithTitle_title__KwWWJ text-center" data-sb-field-path=".title">Better Health, Brighter Future</h2></div></div><div data-sb-field-path=".cards" class><div class="Grid_grid__4jvOB" style="grid-template-columns:repeat(auto-fill, minmax(max(250px, 30%), 1fr))"><div class="Grid_gridItemWrapper__kdM6e last:!border-b-0"><div data-sb-field-path=".0" class="group h-full flex flex-col bg-light-grey"><a class="block" role="link" href="/careers/"><div data-sb-field-path=".image"><div class="ImageBlock_root__MFRQz !h-[230px]" style="aspect-ratio:2.240506329113924"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="two women in a laboratory" __metadata="[object Object]" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="ImageBlock_imageGlobalBorderRadius__M67Y6 w-full" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover;background-size:cover;background-position:0% 0%;filter:blur(20px);background-image:url(&quot;data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAECAMAAACA5l7/AAAARVBMVEXY2NnV1NShp6RsZWKxqqTKxsq0srHFwsHi4eLNzM3t7e2omI+Sm5zg2NiValbOyMJdTUZ8QyLItqyufWi9rqVCnZm4moP9O2iWAAAAL0lEQVQI1wXBhwEAIAgDsCoo4N7/n2oClnHg3swFRJtNVuMI0X49klaPoMEEDhY/IJkBTu1/RuYAAAAASUVORK5CYII=&quot;)" /><noscript><img alt="two women in a laboratory" __metadata="[object Object]" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" class="ImageBlock_imageGlobalBorderRadius__M67Y6 w-full" sizes="(max-width: 572px) 100vw, (max-width: 885px) 50vw, (max-width: 2000px) 33vw, 25vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_128/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/careers/careers-banner 128w, https://assets-dam.takeda.com/image/upload/c_lfill,w_256/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/careers/careers-banner 256w, https://assets-dam.takeda.com/image/upload/c_lfill,w_384/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/careers/careers-banner 384w, https://assets-dam.takeda.com/image/upload/c_lfill,w_480/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/careers/careers-banner 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/careers/careers-banner 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/careers/careers-banner 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/careers/careers-banner 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/careers/careers-banner 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/legacy-dotcom/siteassets/system/careers/careers-banner"/></noscript></span></div></div></a><div class="flex justify-between flex-col h-full px-6 pt-[2.125rem] pb-[2.935rem]"><div><a class role="link" href="/careers/"><div class="MarkdownRedesign_root__x_GKG"><h3 id="Join Us-.0-0" class="line-clamp-3 !mb-[1.25rem] font-medium text-text-color group-hover:text-primary-active" data-sb-field-path=".title">Join Us</h3></div></a><div class="MarkdownRedesign_root__x_GKG"><span class="line-clamp-3 text-text-color" data-sb-field-path=".description">Work with globally diverse colleagues who are committed to bringing Better Health to people and a Brighter Future to the world.</span></div></div><a data-sb-field-path=".callToAction" class="block mt-[1.25rem] w-fit after:mt-0.5 after:content-[&#x27;&#x27;] after:block after:w-full after:h-[3px] after:bg-primary after:group-hover:bg-primary-active" role="link" href="/careers/"><div class="MarkdownRedesign_root__x_GKG"><strong class="text-cta">FIND OUT MORE</strong></div></a></div></div></div><div class="Grid_gridItemWrapper__kdM6e last:!border-b-0"><div data-sb-field-path=".1" class="group h-full flex flex-col bg-light-grey"><a class="block" role="link" href="/investors/overview/"><div data-sb-field-path=".image"><div class="ImageBlock_root__MFRQz !h-[230px]" style="aspect-ratio:1.5"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="People shaking hands in office" __metadata="[object Object]" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="ImageBlock_imageGlobalBorderRadius__M67Y6 w-full" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover;background-size:cover;background-position:0% 0%;filter:blur(20px);background-image:url(&quot;data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAHCAMAAAAGcixRAAAAdVBMVEW9wsCyopYkQFmNnp+kqK3AyMJiaXDS1tO5t7CKgX/FysWlrq+AjpBRY3FFWGSVnqCKkpVqb3SWh4R+c3KFhomOlpZ1amquuLMXMEfOqpp1jZ03Vm6ZnaGZnZx0eHvQzslBSlaKiounnJTMz9B/YVq5qaS4uLnN2xGSAAAASUlEQVQI1wXBBQKAIAAEsJNGUsDu/P8T3dD2nANSlg+dqurUyPcpGFUFfcqUgcnSuGUtBMfsm2vV4rAAIU7dex2DweACY8wsnv6XMwPm7/VdSgAAAABJRU5ErkJggg==&quot;)" /><noscript><img alt="People shaking hands in office" __metadata="[object Object]" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" class="ImageBlock_imageGlobalBorderRadius__M67Y6 w-full" sizes="(max-width: 572px) 100vw, (max-width: 885px) 50vw, (max-width: 2000px) 33vw, 25vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_128/q_auto:eco/f_auto/v1/Global/Investor/Investors 128w, https://assets-dam.takeda.com/image/upload/c_lfill,w_256/q_auto:eco/f_auto/v1/Global/Investor/Investors 256w, https://assets-dam.takeda.com/image/upload/c_lfill,w_384/q_auto:eco/f_auto/v1/Global/Investor/Investors 384w, https://assets-dam.takeda.com/image/upload/c_lfill,w_480/q_auto:eco/f_auto/v1/Global/Investor/Investors 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/Global/Investor/Investors 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/Global/Investor/Investors 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/Global/Investor/Investors 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Global/Investor/Investors 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Global/Investor/Investors"/></noscript></span></div></div></a><div class="flex justify-between flex-col h-full px-6 pt-[2.125rem] pb-[2.935rem]"><div><a class role="link" href="/investors/overview/"><div class="MarkdownRedesign_root__x_GKG"><h3 id="Investors-.1-1" class="line-clamp-3 !mb-[1.25rem] font-medium text-text-color group-hover:text-primary-active" data-sb-field-path=".title">Investors</h3></div></a><div class="MarkdownRedesign_root__x_GKG"><span class="line-clamp-3 text-text-color" data-sb-field-path=".description">Discover our balanced, diverse portfolio and strategy for sustainable, patient-centered and resilient growth.</span></div></div><a data-sb-field-path=".callToAction" class="block mt-[1.25rem] w-fit after:mt-0.5 after:content-[&#x27;&#x27;] after:block after:w-full after:h-[3px] after:bg-primary after:group-hover:bg-primary-active" role="link" href="/investors/overview/"><div class="MarkdownRedesign_root__x_GKG"><strong class="text-cta">FIND OUT MORE</strong></div></a></div></div></div><div class="Grid_gridItemWrapper__kdM6e last:!border-b-0"><div data-sb-field-path=".2" class="group h-full flex flex-col bg-light-grey"><a class="block" role="link" href="/science/research-and-development/"><div data-sb-field-path=".image"><div class="ImageBlock_root__MFRQz !h-[230px]" style="aspect-ratio:2.320185614849188"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="man in labcoat" __metadata="[object Object]" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" class="ImageBlock_imageGlobalBorderRadius__M67Y6 w-full" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover;background-size:cover;background-position:0% 0%;filter:blur(20px);background-image:url(&quot;data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAEBAMAAABFFrP+AAAAJ1BMVEXS2uDY3uPP1925v8PAx9Gwra7JycjBwsW6mou/q6SnhHSjgXOvp6A/xFyBAAAAIElEQVQI12NQYBCyCWZgEhTMbmdgEhDIXM6gxCDgagIAKOgDtd/2M8kAAAAASUVORK5CYII=&quot;)" /><noscript><img alt="man in labcoat" __metadata="[object Object]" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" class="ImageBlock_imageGlobalBorderRadius__M67Y6 w-full" sizes="(max-width: 572px) 100vw, (max-width: 885px) 50vw, (max-width: 2000px) 33vw, 25vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_128/q_auto:eco/f_auto/v1/Global/Research%20and%20Development/R_D_home_cf7hxl 128w, https://assets-dam.takeda.com/image/upload/c_lfill,w_256/q_auto:eco/f_auto/v1/Global/Research%20and%20Development/R_D_home_cf7hxl 256w, https://assets-dam.takeda.com/image/upload/c_lfill,w_384/q_auto:eco/f_auto/v1/Global/Research%20and%20Development/R_D_home_cf7hxl 384w, https://assets-dam.takeda.com/image/upload/c_lfill,w_480/q_auto:eco/f_auto/v1/Global/Research%20and%20Development/R_D_home_cf7hxl 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/Global/Research%20and%20Development/R_D_home_cf7hxl 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/Global/Research%20and%20Development/R_D_home_cf7hxl 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/Global/Research%20and%20Development/R_D_home_cf7hxl 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Global/Research%20and%20Development/R_D_home_cf7hxl 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/Global/Research%20and%20Development/R_D_home_cf7hxl"/></noscript></span></div></div></a><div class="flex justify-between flex-col h-full px-6 pt-[2.125rem] pb-[2.935rem]"><div><a class role="link" href="/science/research-and-development/"><div class="MarkdownRedesign_root__x_GKG"><h3 id="R\&amp;D-.2-2" class="line-clamp-3 !mb-[1.25rem] font-medium text-text-color group-hover:text-primary-active" data-sb-field-path=".title">R&amp;D</h3></div></a><div class="MarkdownRedesign_root__x_GKG"><span class="line-clamp-3 text-text-color" data-sb-field-path=".description">Fueled by our inherent curiosity, we translate science into highly innovative, life-transforming medicines.</span></div></div><a data-sb-field-path=".callToAction" class="block mt-[1.25rem] w-fit after:mt-0.5 after:content-[&#x27;&#x27;] after:block after:w-full after:h-[3px] after:bg-primary after:group-hover:bg-primary-active" role="link" href="/science/research-and-development/"><div class="MarkdownRedesign_root__x_GKG"><strong class="text-cta">FIND OUT MORE</strong></div></a></div></div></div></div></div></div></section><section data-section-position="4" data-sb-field-path="sections.4" data-section-name="## Our Areas of Focus
" data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb bg-white"><div class="Container_root__AelVI"><div class="SectionTitleContainer_root__CntCn text-dark-grey" data-testid="sectionTitleContainer"><div class="Markdown_root__STsP7"><h2 id="Our Areas of Focus" class="SectionWrapperWithTitle_title__KwWWJ text-center !mb-16" data-sb-field-path=".title">Our Areas of Focus</h2></div></div><div data-sb-field-path=".items" class><div class="Grid_grid__4jvOB !gap-x-0 !gap-y-0 max-sm:!gap-y-0 !grid-cols-1 sm:!grid-cols-2 lg:!grid-cols-3 QuickLinksSectionRedesign_adaptiveBorders__KhecI" style="grid-template-columns:repeat(auto-fill, minmax(max(250px, 30%), 1fr))"><div class="Grid_gridItemWrapper__kdM6e"><a data-sb-field-path=".0" class="group flex flex-col items-center h-full px-6 cursor-pointer py-7" role="link" href="/science/areas-of-focus/gastroenterology/"><div class="box-content flex-shrink-0 w-[62px] h-[62px] mb-[35px]"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="62" height="62" viewBox="0 0 62 62" class="w-full h-full object-cover text-primary" role="img" aria-hidden="true" __metadata="[object Object]" type="Icon" data-sb-field-path=".media.0" data-testid="icon-dotcom/DigestiveTractCircle"><path d="M61.0078 31.3242C61.0078 20.0614 54.8334 9.7479 44.892 4.42407C44.8692 4.40888 44.8465 4.41647 44.8237 4.40129C44.7401 4.36331 44.6566 4.34812 44.5731 4.32534C44.4743 4.29496 44.3756 4.26458 44.2693 4.26458C44.2465 4.26458 44.2313 4.24939 44.2085 4.24939C44.1478 4.24939 44.0946 4.27977 44.0338 4.28737C43.9275 4.30256 43.8212 4.31015 43.7225 4.34812C43.6389 4.3785 43.5706 4.42407 43.4946 4.46964C43.4111 4.51521 43.3275 4.56077 43.2592 4.62912C43.1832 4.69748 43.1301 4.77342 43.0693 4.85696C43.0313 4.91013 42.9782 4.9481 42.9402 5.00886C42.9326 5.03164 42.9326 5.05442 42.925 5.06961C42.887 5.15315 42.8643 5.25188 42.8415 5.34302C42.8187 5.43415 42.7883 5.52529 42.7883 5.61643C42.7883 5.63921 42.7731 5.66199 42.7731 5.68478V14.7907C42.7731 15.9755 41.8086 16.94 40.6238 16.94H20.574C17.802 16.94 15.5464 19.1956 15.5464 21.9676C15.5464 24.7397 17.802 26.9953 20.574 26.9953H40.6314C41.8162 26.9953 42.7807 27.9598 42.7807 29.1446C42.7807 30.3293 41.8162 31.2938 40.6314 31.2938H20.574C17.802 31.2938 15.5464 33.5494 15.5464 36.3215C15.5464 39.0935 17.802 41.3491 20.574 41.3491H40.6314C41.8162 41.3491 42.7807 42.3136 42.7807 43.4984C42.7807 44.6832 41.8162 45.6477 40.6314 45.6477H34.1001C31.328 45.6477 29.0724 47.9033 29.0724 50.6753V56.0751C29.0724 56.8725 29.718 57.5181 30.5154 57.5181C31.3128 57.5181 31.9584 56.8725 31.9584 56.0751V50.6753C31.9584 49.4906 32.9229 48.526 34.1077 48.526H40.639C43.4111 48.526 45.6667 46.2704 45.6667 43.4984C45.6667 40.7264 43.4111 38.4708 40.639 38.4708H20.574C19.3893 38.4708 18.4248 37.5062 18.4248 36.3215C18.4248 35.1367 19.3893 34.1722 20.574 34.1722H40.6314C43.4035 34.1722 45.6591 31.9166 45.6591 29.1446C45.6591 26.3725 43.4035 24.1169 40.6314 24.1169H20.574C19.3893 24.1169 18.4248 23.1524 18.4248 21.9676C18.4248 20.7829 19.3893 19.8184 20.574 19.8184H40.6314C43.4035 19.8184 45.6591 17.5628 45.6591 14.7907V8.23657C53.4056 13.3174 58.1295 21.9525 58.1295 31.3242C58.1295 46.5514 45.735 58.9459 30.5078 58.9459C15.2806 58.9459 2.88617 46.559 2.88617 31.3242C2.88617 16.0894 15.2806 3.70258 30.5078 3.70258C33.5684 3.70258 36.5759 4.19623 39.4467 5.18353C40.1986 5.44175 41.0188 5.03923 41.277 4.28737C41.5352 3.5355 41.1327 2.71528 40.3808 2.45706C37.2139 1.37103 33.8874 0.824219 30.5078 0.824219C13.6933 0.824219 0.0078125 14.5097 0.0078125 31.3242C0.0078125 48.1387 13.6933 61.8242 30.5078 61.8242C47.3223 61.8242 61.0078 48.1387 61.0078 31.3242Z"></path></svg></div><div class="mb-3"><div class="MarkdownRedesign_root__x_GKG"><h3 id="Gastrointestinal and Inflammation-sections.4-0" class="text-center text-xl font-medium text-dark-grey group-hover:text-primary-active transition-colors !mb-0" data-sb-field-path=".linkLabel">Gastrointestinal and Inflammation</h3></div></div><p class="mb-16 text-body-block text-center text-dark-grey" data-sb-field-path=".description">Understanding and addressing life-limiting gastrointestinal and inflammatory diseases</p><div class="flex items-center justify-end w-full mt-auto"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="24" height="24" viewBox="0 0 24 24" class="w-[32px] h-[32px] text-primary group-hover:text-primary-active" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Go to  Gastrointestinal and Inflammation page</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></div></a></div><div class="Grid_gridItemWrapper__kdM6e"><a data-sb-field-path=".1" class="group flex flex-col items-center h-full px-6 cursor-pointer py-7" role="link" href="/science/areas-of-focus/rare-diseases/"><div class="box-content flex-shrink-0 w-[62px] h-[62px] mb-[35px]"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="63" height="64" viewBox="0 0 63 64" class="w-full h-full object-cover text-primary" role="img" aria-hidden="true" __metadata="[object Object]" type="Icon" data-sb-field-path=".media.0" data-testid="icon-dotcom/DNA"><path d="M40.9588 21.9156C41.8221 25.0387 42.596 28.0787 42.477 30.9901L32.0357 20.3804C34.9009 20.2594 37.8852 21.0308 40.9588 21.9156ZM28.6719 21.0232L41.8444 34.4082C41.4276 35.6181 40.795 36.8054 39.8573 37.9624L25.1667 23.0347C26.3053 22.0819 27.4737 21.4391 28.6645 21.0157M23.1722 25.0614L37.848 39.9739C36.6945 40.9343 35.5261 41.5771 34.3502 41.993L21.1777 28.608C21.6094 27.3452 22.2643 26.173 23.1647 25.0538M19.8009 43.3844C20.6493 46.4319 21.3935 49.3358 21.3563 52.1489C21.3489 52.7766 21.2893 53.374 21.2 53.9562L9.39689 41.9552C9.96993 41.8644 10.5579 41.8039 11.1756 41.7964C13.944 41.7585 16.8018 42.5223 19.8009 43.3768M62.0943 17.5295C61.5436 16.9699 60.6505 16.9699 60.0998 17.5295C58.9686 18.679 57.8151 19.4957 56.6467 20.0628L42.7746 5.96705C43.3626 4.72686 44.1812 3.56986 45.2677 2.46579C45.8185 1.90619 45.8185 0.998736 45.2677 0.43914C44.717 -0.120457 43.824 -0.128019 43.2733 0.43914C41.6732 2.05743 40.5346 3.81941 39.8052 5.73262C39.7978 5.75531 39.7904 5.77799 39.7755 5.80824C39.195 7.35848 38.8824 9.01458 38.8601 10.8068C38.8229 13.4384 39.3885 16.0927 40.0732 18.7017C36.3447 17.7035 32.4227 16.9699 28.5975 18.0286C28.5677 18.0362 28.5305 18.0362 28.5007 18.0513C26.3276 18.6714 24.1843 19.8813 22.1377 21.9609V21.976H22.1229C20.2102 23.9346 18.9451 26.0747 18.2827 28.4643C18.2679 28.5097 18.2604 28.5551 18.2455 28.6005C17.9255 29.7877 17.7469 31.0355 17.732 32.3513C17.7023 34.9678 18.253 37.5994 18.9228 40.1856C16.3552 39.4899 13.7431 38.9228 11.1458 38.953C9.38945 38.9757 7.76708 39.2933 6.24145 39.868C6.18191 39.8907 6.12238 39.9058 6.06284 39.9361C4.20232 40.6772 2.49064 41.8266 0.92036 43.4222C0.369646 43.9818 0.369646 44.8893 0.92036 45.4489C1.47107 46.0085 2.36412 46.0085 2.91484 45.4489C4.00138 44.3448 5.14002 43.5205 6.35308 42.9231L20.2772 57.0718C19.6893 58.3045 18.8781 59.4615 17.7916 60.5655C17.2408 61.1251 17.2408 62.0326 17.7916 62.5922C18.3423 63.1518 19.2353 63.1518 19.786 62.5922C21.3638 60.989 22.495 59.2497 23.2168 57.3668C23.2466 57.3063 23.2615 57.2458 23.2838 57.1853C23.8569 55.635 24.162 53.9865 24.1843 52.2018C24.229 48.7459 23.2541 45.2598 22.3164 41.8795C21.3935 38.5598 20.5154 35.4215 20.5526 32.3815C20.5526 32.2681 20.5675 32.1622 20.5749 32.0564L30.9864 42.6358C29.3119 42.7038 27.6449 42.4467 26.0151 42.0913C25.256 41.9249 24.5043 42.4165 24.3406 43.1953C24.2364 43.6869 24.3927 44.1784 24.7201 44.5112C24.9062 44.7002 25.1443 44.8363 25.4197 44.8968C28.0542 45.4715 31.1501 45.8497 34.3055 44.9951C34.38 44.9724 34.4544 44.9649 34.5214 44.9346C36.6572 44.3221 38.8229 43.1424 40.8843 41.0477L40.8992 41.0326C42.9458 38.9454 44.1365 36.7751 44.7468 34.567C44.7617 34.5367 44.7617 34.4989 44.7691 34.4687C46.0492 29.7348 44.6947 24.8421 43.4444 20.3578L43.4295 20.3199C42.5067 17.0002 41.6286 13.8619 41.6732 10.8295C41.6807 10.217 41.7402 9.64224 41.8221 9.06752L53.5805 21.0157C51.4075 21.356 49.2269 21.061 47.1134 20.5922C46.3543 20.4258 45.6026 20.9174 45.4389 21.6887C45.3347 22.1802 45.491 22.6718 45.8185 23.0045C46.0045 23.1936 46.2427 23.3297 46.518 23.3902C49.6362 24.0708 53.0894 24.4564 56.5499 23.2011C56.7434 23.1784 56.9146 23.1104 57.0858 23.0045C58.7677 22.3088 60.4421 21.2123 62.0794 19.5486C62.6301 18.989 62.6301 18.0816 62.0794 17.522" fill="currentColor"></path></svg></div><div class="mb-3"><div class="MarkdownRedesign_root__x_GKG"><h3 id="Rare Diseases-sections.4-1" class="text-center text-xl font-medium text-dark-grey group-hover:text-primary-active transition-colors !mb-0" data-sb-field-path=".linkLabel">Rare Diseases</h3></div></div><p class="mb-16 text-body-block text-center text-dark-grey" data-sb-field-path=".description">Working to transform treatments in immunology, hematology, metabolic and lysosomal storage disorders</p><div class="flex items-center justify-end w-full mt-auto"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="24" height="24" viewBox="0 0 24 24" class="w-[32px] h-[32px] text-primary group-hover:text-primary-active" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Go to  Rare Diseases page</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></div></a></div><div class="Grid_gridItemWrapper__kdM6e"><a data-sb-field-path=".2" class="group flex flex-col items-center h-full px-6 cursor-pointer py-7" role="link" href="/science/areas-of-focus/pdt/"><div class="box-content flex-shrink-0 w-[62px] h-[62px] mb-[35px]"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="41" height="57" viewBox="0 0 41 57" class="w-full h-full object-cover text-primary" role="img" aria-hidden="true" __metadata="[object Object]" type="Icon" data-sb-field-path=".media.0" data-testid="icon-dotcom/Drop"><path d="M20.5112 3.26564C19.2605 3.26564 18.1192 3.91065 17.4548 4.99864C8.56673 19.8107 3.47 31.2734 3.47 36.4413C3.47 45.7824 11.1151 53.375 20.5034 53.375C29.8917 53.375 37.5368 45.7747 37.5368 36.4413C37.5368 34.1954 36.5519 29.5171 31.8538 19.9972C28.6254 13.4538 24.9748 7.33003 23.5599 5.00641C22.8954 3.9262 21.7541 3.27341 20.5034 3.27341M20.5034 56.3281C9.48133 56.3203 0.507324 47.3989 0.507324 36.4413C0.507324 28.6623 9.53605 12.4513 14.9142 3.48323C16.1259 1.50155 18.213 0.320312 20.5112 0.320312C22.8095 0.320312 24.8966 1.50155 26.1004 3.46769C29.4774 9.0164 40.5073 27.7919 40.5073 36.4336C40.5073 47.3989 31.5333 56.3203 20.5112 56.3203" fill="currentColor"></path><path d="M13.5619 47.0491C13.2492 47.0491 12.9365 46.9558 12.6708 46.746C9.38758 44.2747 7.50366 40.5134 7.50366 36.4335C7.50366 33.6281 8.72313 29.5792 11.1308 24.4113C11.4747 23.673 12.3581 23.3544 13.1007 23.6963C13.8433 24.0383 14.1638 24.9164 13.8199 25.6547C11.6233 30.3641 10.4663 34.0943 10.4663 36.4335C10.4663 39.5809 11.9203 42.4873 14.4609 44.3991C15.1097 44.8887 15.2426 45.8135 14.7501 46.4663C14.4609 46.847 14.0153 47.0491 13.5697 47.0491" fill="currentColor"></path></svg></div><div class="mb-3"><div class="MarkdownRedesign_root__x_GKG"><h3 id="Plasma-Derived Therapies-sections.4-2" class="text-center text-xl font-medium text-dark-grey group-hover:text-primary-active transition-colors !mb-0" data-sb-field-path=".linkLabel">Plasma-Derived Therapies</h3></div></div><p class="mb-16 text-body-block text-center text-dark-grey" data-sb-field-path=".description">Improving the lives of patients with rare and complex chronic diseases through innovation in plasma</p><div class="flex items-center justify-end w-full mt-auto"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="24" height="24" viewBox="0 0 24 24" class="w-[32px] h-[32px] text-primary group-hover:text-primary-active" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Go to  Plasma-Derived Therapies page</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></div></a></div><div class="Grid_gridItemWrapper__kdM6e"><a data-sb-field-path=".3" class="group flex flex-col items-center h-full px-6 cursor-pointer py-7" role="link" href="/science/areas-of-focus/oncology/"><div class="box-content flex-shrink-0 w-[62px] h-[62px] mb-[35px]"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="56" height="59" viewBox="0 0 56 59" class="w-full h-full object-cover text-primary" role="img" aria-hidden="true" __metadata="[object Object]" type="Icon" data-sb-field-path=".media.0" data-testid="icon-dotcom/Molecule"><path d="M39.6369 28.0869C39.6369 32.8217 35.8068 36.6683 31.1085 36.6683C26.4102 36.6683 22.5801 32.8144 22.5801 28.0869C22.5801 23.3594 26.4102 19.5054 31.1085 19.5054C35.8068 19.5054 39.6369 23.3594 39.6369 28.0869ZM35.7995 45.5654C38.5863 45.5654 40.8479 47.8484 40.8479 50.6453C40.8479 53.4421 38.579 55.7251 35.7995 55.7251C33.0199 55.7251 30.751 53.4421 30.751 50.6453C30.751 47.8484 33.0199 45.5654 35.7995 45.5654ZM44.357 11.1075C42.2195 11.1075 40.4759 9.35302 40.4759 7.20216C40.4759 5.05129 42.2195 3.29683 44.357 3.29683C46.4946 3.29683 48.2382 5.05129 48.2382 7.20216C48.2382 9.35302 46.4946 11.1075 44.357 11.1075ZM18.8959 12.3628C18.8959 14.2934 17.3346 15.8644 15.4159 15.8644C13.4972 15.8644 11.936 14.2934 11.936 12.3628C11.936 10.4321 13.4972 8.86119 15.4159 8.86119C17.3346 8.86119 18.8959 10.4321 18.8959 12.3628ZM11.8557 39.0614C11.8557 41.5793 9.82031 43.6348 7.31067 43.6348C4.80103 43.6348 2.76559 41.5867 2.76559 39.0614C2.76559 36.5362 4.80832 34.4881 7.31067 34.4881C9.81301 34.4881 11.8557 36.5362 11.8557 39.0614ZM47.6327 31.148C47.6327 29.5991 48.8875 28.3364 50.4269 28.3364C51.9662 28.3364 53.2283 29.5991 53.2283 31.148C53.2283 32.6969 51.9735 33.9669 50.4269 33.9669C48.8802 33.9669 47.6327 32.7042 47.6327 31.148ZM45.145 28.9017L42.3727 28.4612C42.3727 28.3364 42.3946 28.2116 42.3946 28.0869C42.3946 24.5706 40.7969 21.4214 38.2945 19.3292L41.9422 13.5813C41.9714 13.5373 41.9787 13.4786 42.0006 13.4345C42.7374 13.7135 43.5254 13.8897 44.357 13.8897C48.0267 13.8897 51.0032 10.8946 51.0032 7.20216C51.0032 3.50971 48.0267 0.514648 44.357 0.514648C40.6874 0.514648 37.7109 3.50971 37.7109 7.20216C37.7109 9.07407 38.4842 10.7698 39.7171 11.981C39.6879 12.0177 39.6442 12.0471 39.615 12.0912L35.9673 17.839C34.4936 17.127 32.8448 16.7159 31.1085 16.7159C28.4821 16.7159 26.0746 17.6262 24.1486 19.1457L20.8219 15.813C20.7854 15.7689 20.727 15.7542 20.6833 15.7249C21.2961 14.7559 21.6681 13.6034 21.6681 12.3701C21.6681 8.89789 18.874 6.08635 15.4232 6.08635C11.9725 6.08635 9.1783 8.89789 9.1783 12.3701C9.1783 15.8423 11.9725 18.6539 15.4232 18.6539C16.6635 18.6539 17.8088 18.2795 18.7791 17.6555C18.8156 17.6996 18.8302 17.7509 18.8667 17.795L22.1934 21.1277C20.7051 23.051 19.8078 25.4662 19.8078 28.0942C19.8078 29.2908 19.9975 30.4433 20.3404 31.5297L13.3878 34.7377C13.344 34.7597 13.3148 34.7964 13.2784 34.8184C11.9506 32.9391 9.78383 31.7132 7.31796 31.7132C3.27627 31.7132 0.00790405 35.0093 0.00790405 39.0688C0.00790405 43.1282 3.28357 46.4243 7.31796 46.4243C11.3524 46.4243 14.628 43.1282 14.628 39.0688C14.628 38.4595 14.5478 37.8649 14.4092 37.2996C14.4529 37.2849 14.4967 37.2923 14.5405 37.2702L21.5076 34.055C23.4993 37.2923 27.0522 39.4652 31.1085 39.4652C31.4295 39.4652 31.7432 39.4505 32.0496 39.4285L32.8448 43.2457C32.8521 43.2897 32.8813 43.3191 32.8959 43.3631C30.0215 44.523 27.986 47.3492 27.986 50.6599C27.986 55.0057 31.4878 58.5293 35.8068 58.5293C40.1257 58.5293 43.6275 55.0057 43.6275 50.6599C43.6275 46.3142 40.1257 42.7906 35.8068 42.7906C35.7265 42.7906 35.639 42.7979 35.5587 42.8052C35.5587 42.7612 35.566 42.7172 35.5587 42.6731L34.7635 38.8559C38.2361 37.6593 40.9501 34.7964 41.9641 31.2287L44.7291 31.6692C44.7948 31.6839 44.8604 31.6839 44.9261 31.6839C45.1887 34.5248 47.5452 36.7637 50.4342 36.7637C53.5056 36.7637 56.0006 34.2605 56.0006 31.1627C56.0006 28.0648 53.5128 25.5616 50.4342 25.5616C48.1361 25.5616 46.159 26.971 45.3128 28.9751C45.2544 28.9604 45.2106 28.9237 45.1522 28.9164"></path></svg></div><div class="mb-3"><div class="MarkdownRedesign_root__x_GKG"><h3 id="Oncology-sections.4-3" class="text-center text-xl font-medium text-dark-grey group-hover:text-primary-active transition-colors !mb-0" data-sb-field-path=".linkLabel">Oncology</h3></div></div><p class="mb-16 text-body-block text-center text-dark-grey" data-sb-field-path=".description">Aspiring to cure cancer, with inspiration from patients and innovation from everywhere</p><div class="flex items-center justify-end w-full mt-auto"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="24" height="24" viewBox="0 0 24 24" class="w-[32px] h-[32px] text-primary group-hover:text-primary-active" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Go to  Oncology page</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></div></a></div><div class="Grid_gridItemWrapper__kdM6e"><a data-sb-field-path=".4" class="group flex flex-col items-center h-full px-6 cursor-pointer py-7" role="link" href="/science/areas-of-focus/neuroscience/"><div class="box-content flex-shrink-0 w-[62px] h-[62px] mb-[35px]"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="63" height="57" viewBox="0 0 63 57" class="w-full h-full object-cover text-primary" role="img" aria-hidden="true" __metadata="[object Object]" type="Icon" data-sb-field-path=".media.0" data-testid="icon-dotcom/Brain"><path d="M48.0868 22.0508C49.1952 21.0606 49.8541 19.6991 49.9393 18.2215C50.1098 15.1659 47.7613 12.5357 44.6997 12.3577C43.8858 12.3113 43.196 12.9302 43.1495 13.7425C43.103 14.5547 43.723 15.2432 44.5369 15.2896C45.9786 15.367 47.0947 16.6125 47.0094 18.0513C46.9707 18.7476 46.6607 19.3897 46.1336 19.8615C45.6065 20.3257 44.9399 20.5655 44.2346 20.5191C44.1958 20.5191 44.1571 20.5346 44.1106 20.5346C44.0563 20.5346 44.0021 20.5036 43.9401 20.5114C43.1262 20.5578 42.5139 21.254 42.5526 22.0585C42.6612 23.8765 41.3125 25.4236 39.4988 25.5861C38.3051 25.6867 37.1425 25.1529 36.4526 24.1782C36.4371 24.1549 36.4139 24.1472 36.3984 24.1317C36.3364 24.0466 36.2511 23.9848 36.1736 23.9229C36.1038 23.8687 36.0418 23.8068 35.9643 23.7604C35.8868 23.714 35.8015 23.6985 35.7163 23.6676C35.6155 23.6366 35.5225 23.598 35.4217 23.5825C35.3985 23.5825 35.383 23.567 35.352 23.567C35.2822 23.567 35.2202 23.5902 35.1582 23.5902C35.0497 23.5902 34.9489 23.598 34.8482 23.6289C34.7552 23.6599 34.6699 23.6985 34.5846 23.7449C34.5226 23.7759 34.4529 23.7836 34.3986 23.83C34.3754 23.8455 34.3676 23.8687 34.3521 23.8842C34.2746 23.9461 34.2126 24.0234 34.1506 24.1008C34.0886 24.1704 34.0266 24.2323 33.9801 24.3174C33.9336 24.3948 33.9181 24.4721 33.8871 24.5572C33.8561 24.6578 33.8173 24.7506 33.8018 24.8589C33.8018 24.8821 33.7863 24.8976 33.7863 24.9285C33.7785 25.0368 33.763 25.1374 33.7475 25.2457C33.4142 27.3499 31.43 28.7965 29.3217 28.4716C28.1668 28.2936 27.167 27.6052 26.5701 26.5995C26.1593 25.8955 25.2602 25.6634 24.5626 26.0734C23.8573 26.4834 23.6248 27.3808 24.0356 28.077C25.0742 29.8486 26.8337 31.0554 28.8722 31.3725C29.2287 31.4267 29.5775 31.4576 29.9263 31.4576C32.5306 31.4576 34.8714 29.9491 36.0031 27.6748C36.9642 28.2395 38.0648 28.5567 39.2042 28.5567C39.3902 28.5567 39.5763 28.5567 39.7623 28.5335C42.6612 28.2704 44.9012 26.1199 45.3895 23.3891C46.3816 23.2112 47.3117 22.7548 48.0868 22.0663M60.0466 23.3814C60.0466 24.0234 59.9148 24.6423 59.6823 25.2225C59.0312 24.3174 58.1863 23.5438 57.1787 22.9868C56.4656 22.5923 55.5743 22.8553 55.179 23.5593C54.7837 24.271 55.0472 25.1606 55.7525 25.5551C57.264 26.3906 58.2018 27.9765 58.2018 29.6938C58.2018 32.3008 56.0781 34.4205 53.466 34.4205C52.3034 34.4205 51.2182 33.9872 50.3579 33.2369C50.7144 32.2776 50.9237 31.2488 50.9237 30.1657C50.9237 29.7712 50.9004 29.3689 50.8462 28.9821C50.7377 28.1776 49.9936 27.6206 49.1952 27.7289C48.3891 27.8372 47.8233 28.5799 47.9396 29.3767C47.9783 29.6397 47.9938 29.9027 47.9938 30.1657C47.9938 33.3839 45.374 35.9986 42.1496 35.9986C39.7933 35.9986 37.6773 34.5984 36.7627 32.4401C36.4449 31.6897 35.5845 31.3416 34.8327 31.6587C34.0886 31.9759 33.732 32.8346 34.0498 33.5772C34.3521 34.2812 34.7474 34.9233 35.197 35.5112C34.3444 37.7546 32.2051 39.2786 29.748 39.2786C28.3296 39.2786 27.0042 38.7603 25.9501 37.8552C26.8259 37.1048 27.539 36.161 28.0118 35.0548C28.3296 34.3122 27.9808 33.4457 27.229 33.1363C26.4849 32.8191 25.6168 33.1672 25.299 33.9176C24.5704 35.6427 22.8807 36.7644 21.0049 36.7644C18.4316 36.7644 16.3389 34.6757 16.3389 32.1074C16.3389 30.3204 17.3852 28.665 19.0052 27.8991C19.0439 27.8836 19.0672 27.845 19.106 27.8218C19.137 27.814 19.168 27.8218 19.199 27.8063C19.9508 27.4968 20.3151 26.6459 20.0051 25.8955C19.819 25.4468 19.726 24.975 19.726 24.4799C19.726 22.4144 21.408 20.7434 23.4698 20.7434C24.5161 20.7434 25.485 21.1612 26.1981 21.9193C26.2446 21.9657 26.3066 21.9889 26.3609 22.0353C26.4384 22.1049 26.5159 22.1668 26.6089 22.2132C26.7019 22.2597 26.7949 22.2829 26.8957 22.3061C26.9577 22.3215 27.0197 22.3602 27.0895 22.368C27.1282 22.368 27.1747 22.368 27.2135 22.3757H27.229C27.229 22.3757 27.2522 22.3757 27.2677 22.3757C27.4072 22.3757 27.539 22.337 27.663 22.2983C27.7018 22.2906 27.7405 22.2906 27.7793 22.2751C27.9576 22.2132 28.1126 22.1127 28.2521 21.9812C28.2521 21.9812 28.2676 21.9812 28.2754 21.9657C28.3141 21.9348 28.3296 21.8883 28.3606 21.8497C28.4459 21.7491 28.5234 21.6563 28.5854 21.5325C28.6241 21.4551 28.6397 21.3778 28.6629 21.2927C28.6862 21.2153 28.7249 21.1534 28.7327 21.0683C29.0272 18.6547 31.089 16.8368 33.5305 16.8368C35.2435 16.8368 36.7937 17.711 37.6773 19.1808C38.0958 19.877 38.9949 20.1014 39.6925 19.6836C40.3901 19.2659 40.6149 18.3685 40.1963 17.6723C38.8012 15.3438 36.2434 13.9049 33.5305 13.9049C33.1042 13.9049 32.6857 13.9513 32.2749 14.021C32.3834 12.644 32.0346 11.2283 31.1742 10.0292C30.7014 9.37169 29.7868 9.21697 29.1202 9.68886C28.4614 10.1608 28.3064 11.0736 28.7792 11.7389C29.7015 13.023 29.5078 14.7945 28.3451 15.8621C28.3064 15.9008 28.2909 15.9472 28.2521 15.9859C27.4925 16.6898 26.8802 17.5562 26.4539 18.5232C25.5315 18.0668 24.5239 17.7961 23.4775 17.7961C19.788 17.7961 16.7884 20.7898 16.7884 24.4721C16.7884 24.8899 16.8349 25.3076 16.9124 25.7099C16.1683 26.1895 15.525 26.7929 14.9979 27.4814C13.7965 26.5608 13.1687 25.0523 13.409 23.5206C13.626 22.1436 14.5096 20.9755 15.773 20.3876C15.9746 20.2947 16.1296 20.1632 16.2614 20.0008C16.7187 19.5753 16.8892 18.9023 16.6024 18.3066C16.4086 17.9044 16.3234 17.4634 16.3544 17.0147C16.3931 16.3185 16.7109 15.6764 17.238 15.2123C17.765 14.7481 18.4394 14.516 19.1447 14.5547C19.3462 14.5625 19.54 14.6011 19.726 14.6553C20.5089 14.8796 21.3227 14.4387 21.5475 13.6574C21.7723 12.876 21.3305 12.0638 20.5476 11.8394C20.1523 11.7234 19.7338 11.6538 19.323 11.6228C17.8348 11.53 16.4086 12.0251 15.2925 13.0076C14.1763 13.99 13.5175 15.3515 13.4245 16.8368C13.3935 17.3319 13.4322 17.827 13.533 18.3066C11.9286 19.4051 10.8124 21.107 10.5101 23.0642C10.0683 25.8568 11.3395 28.6031 13.688 30.1193C13.595 30.452 13.5253 30.8001 13.4788 31.1482C12.8974 31.5118 12.2386 31.7052 11.541 31.7052C9.50251 31.7052 7.8438 30.0497 7.8438 28.0152C7.8438 27.2725 8.06083 26.5608 8.47163 25.9497C8.92894 25.2767 8.75066 24.3638 8.07633 23.9151C7.40199 23.4587 6.48738 23.6366 6.03782 24.3097C5.93706 24.4566 5.8673 24.6114 5.77429 24.7661C4.67365 24.1936 3.92181 23.0487 3.92181 21.7568C3.92181 20.55 4.57289 19.4593 5.55726 18.8559C5.73554 19.173 5.92931 19.4825 6.15409 19.7764C6.44087 20.1555 6.88268 20.3489 7.32448 20.3489C7.63452 20.3489 7.95231 20.2483 8.21585 20.0472C8.85918 19.5521 8.98319 18.6315 8.48713 17.9895C7.8593 17.1772 7.52601 16.1947 7.52601 15.1581C7.52601 12.6053 9.59552 10.5321 12.1456 10.5089C12.3161 11.0891 12.8199 11.53 13.4633 11.5687C13.4943 11.5687 13.5175 11.5687 13.5485 11.5687C14.3236 11.5687 14.9669 10.9653 15.0134 10.184C15.091 8.80697 15.7033 7.54603 16.7264 6.62546C17.7573 5.70489 19.0827 5.24847 20.4624 5.32583C22.0358 5.41092 23.4543 6.19225 24.3766 7.4764C24.8494 8.13395 25.7718 8.28867 26.4306 7.81678C27.0895 7.34489 27.2445 6.43206 26.7717 5.76677C26.7174 5.68941 26.6477 5.61979 26.5856 5.54243C27.787 4.2196 29.469 3.46148 31.275 3.46148C33.2515 3.46148 35.0962 4.38205 36.2899 5.91376C35.3985 6.90395 34.7319 8.11074 34.3909 9.47226C34.1971 10.2613 34.6777 11.0504 35.4605 11.2515C36.2511 11.4449 37.0494 10.9653 37.2432 10.184C37.8478 7.76263 40.0181 6.06847 42.5294 6.06847C45.0407 6.06847 47.304 7.8632 47.8388 10.3387V10.3541C47.9241 11.1587 48.6526 11.7389 49.4588 11.6538C49.668 11.6306 49.8851 11.6151 50.0943 11.6151C52.6677 11.6151 54.8379 13.2938 55.613 15.6068C55.4658 15.5991 55.3262 15.5836 55.179 15.5836C54.3651 15.5836 53.7063 16.2411 53.7063 17.0534C53.7063 17.8657 54.3651 18.5232 55.179 18.5232C57.8608 18.5232 60.0466 20.7047 60.0466 23.3814ZM62.9842 23.3814C62.9842 20.403 61.2945 17.8038 58.8219 16.4964C58.3569 12.2108 54.7837 8.85339 50.4044 8.69867C49.234 5.41866 46.0948 3.12884 42.5216 3.12884C41.111 3.12884 39.7778 3.48469 38.5996 4.10356C36.8557 1.86789 34.1583 0.521851 31.275 0.521851C28.6241 0.521851 26.1593 1.63582 24.3999 3.57752C23.276 2.88903 21.9893 2.47129 20.6329 2.39393C18.4704 2.27016 16.3931 2.99733 14.7732 4.4362C13.7733 5.32583 13.0292 6.42432 12.5796 7.63886C12.4556 7.60791 12.3316 7.5615 12.1998 7.5615C8.00657 7.5615 4.59614 10.9653 4.59614 15.1504C4.59614 15.4444 4.6349 15.7383 4.6659 16.0245C2.48013 17.0457 0.991943 19.2504 0.991943 21.7414C0.991943 24.2323 2.61965 26.6227 4.94494 27.5742C4.93719 27.7135 4.91393 27.8527 4.91393 27.9997C4.91393 31.651 7.89031 34.6216 11.5488 34.6216C12.3006 34.6216 13.037 34.4901 13.7423 34.2425C14.6802 37.3678 17.5868 39.6576 21.0204 39.6576C21.8033 39.6576 22.5629 39.5339 23.2837 39.3173C24.9502 41.1429 27.2677 42.1873 29.7635 42.1873C33.0655 42.1873 35.9798 40.3539 37.4758 37.5535C38.8477 38.4122 40.4521 38.9073 42.1496 38.9073C44.8392 38.9073 47.2497 37.6927 48.8619 35.782C50.1021 36.7103 51.598 37.2518 53.1715 37.3137C51.9546 41.0114 48.4511 43.6339 44.4284 43.6339C42.3821 43.6339 40.4444 42.9763 38.8244 41.7309C38.1811 41.2358 37.2587 41.3595 36.7627 42.0016C36.2666 42.6437 36.3906 43.5643 37.034 44.0594C38.4369 45.1346 40.0258 45.8773 41.7155 46.2563C41.5218 48.3837 41.0412 51.0913 40.5916 52.8396C40.4289 53.4817 39.8631 53.559 39.6925 53.5745C39.4755 53.59 38.9484 53.5513 38.7237 52.9479C37.6308 50.0469 36.0186 47.1228 33.9181 44.2373C33.4453 43.5797 32.5229 43.4328 31.8641 43.9124C31.2052 44.392 31.0657 45.3048 31.5385 45.9624C33.484 48.6313 34.9722 51.3233 35.9643 53.9767C36.5534 55.5317 37.9641 56.5064 39.615 56.5064C39.6925 56.5064 39.77 56.5064 39.8476 56.5064C41.5993 56.4135 43.0022 55.2609 43.4285 53.5667C43.9013 51.7179 44.4129 48.8556 44.6221 46.5658C50.3501 46.4652 55.2332 42.342 56.3184 36.7799C59.1397 35.6427 61.1317 32.8965 61.1317 29.6784C61.1317 29.2684 61.093 28.8738 61.0309 28.4793C62.2789 27.0559 62.9764 25.2612 62.9764 23.3659" fill="currentColor"></path></svg></div><div class="mb-3"><div class="MarkdownRedesign_root__x_GKG"><h3 id="Neuroscience-sections.4-4" class="text-center text-xl font-medium text-dark-grey group-hover:text-primary-active transition-colors !mb-0" data-sb-field-path=".linkLabel">Neuroscience</h3></div></div><p class="mb-16 text-body-block text-center text-dark-grey" data-sb-field-path=".description">Driving medical innovation for patients with neurological diseases</p><div class="flex items-center justify-end w-full mt-auto"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="24" height="24" viewBox="0 0 24 24" class="w-[32px] h-[32px] text-primary group-hover:text-primary-active" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Go to  Neuroscience page</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></div></a></div><div class="Grid_gridItemWrapper__kdM6e"><a data-sb-field-path=".5" class="group flex flex-col items-center h-full px-6 cursor-pointer py-7" role="link" href="/science/areas-of-focus/vaccines/"><div class="box-content flex-shrink-0 w-[62px] h-[62px] mb-[35px]"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="58" height="59" viewBox="0 0 58 59" class="w-full h-full object-cover text-primary" role="img" aria-hidden="true" __metadata="[object Object]" type="Icon" data-sb-field-path=".media.0" data-testid="icon-dotcom/Syringe"><path d="M33.1365 15.6689L42.9118 25.6158L21.854 47.0343C19.2058 49.729 14.8972 49.729 12.249 47.0343L12.0787 46.8611C10.7929 45.5527 10.0861 43.8198 10.0861 41.9743C10.0861 40.1288 10.7929 38.3959 12.0787 37.0875L14.4544 34.6701L19.9892 40.302C20.3042 40.6226 20.713 40.7873 21.1302 40.7873C21.5474 40.7873 21.9562 40.6226 22.2712 40.302C22.9013 39.6609 22.9013 38.6211 22.2712 37.98L16.7364 32.3481L20.2702 28.7523L25.805 34.3842C26.12 34.7048 26.5288 34.8608 26.946 34.8608C27.3632 34.8608 27.772 34.7048 28.087 34.3842C28.7171 33.743 28.7171 32.7033 28.087 32.0621L22.5522 26.4302L26.086 22.8345L31.6208 28.4664C31.9358 28.787 32.3531 28.9516 32.7618 28.9516C33.1705 28.9516 33.5878 28.787 33.9028 28.4664C34.533 27.8252 34.533 26.7855 33.9028 26.1443L28.368 20.5124L33.1194 15.6776L33.1365 15.6689ZM49.8771 28.0505L30.7437 8.5814C30.1136 7.94023 29.0918 7.94023 28.4617 8.5814C27.8316 9.22257 27.8316 10.2623 28.4617 10.9035L30.8544 13.3382L9.79662 34.7654C7.90627 36.689 6.85891 39.2536 6.85891 41.9743C6.85891 44.1837 7.55715 46.2805 8.8259 48.0221L1.46886 55.5169C0.838748 56.158 0.838748 57.1978 1.46886 57.8389C1.78392 58.1595 2.19265 58.3155 2.60989 58.3155C3.02713 58.3155 3.43585 58.1595 3.75091 57.8389L11.1165 50.3442C12.8791 51.6698 14.9653 52.337 17.06 52.337C19.6315 52.337 22.1946 51.3406 24.1445 49.3564L45.2024 27.9378L47.5951 30.3726C47.9102 30.6931 48.3189 30.8491 48.7361 30.8491C49.1534 30.8491 49.5621 30.6931 49.8771 30.3726C50.5073 29.7314 50.5073 28.6917 49.8771 28.0505ZM57.5237 15.2184L43.3546 0.80937C42.7245 0.168198 41.7027 0.168198 41.0725 0.80937C40.4424 1.45054 40.4424 2.49028 41.0725 3.13145L44.2572 6.37196L38.6713 12.0559C38.0412 12.697 38.0412 13.7368 38.6713 14.3779C38.9863 14.6985 39.4036 14.8545 39.8123 14.8545C40.221 14.8545 40.6383 14.6985 40.9533 14.3779L46.5392 8.69404L49.7664 11.9692L44.1805 17.6531C43.5504 18.2943 43.5504 19.334 44.1805 19.9752C44.4956 20.2958 44.9043 20.4604 45.3216 20.4604C45.7388 20.4604 46.1475 20.2958 46.4626 19.9752L52.0485 14.2913L55.2331 17.5318C55.5482 17.8524 55.9654 18.0084 56.3742 18.0084C56.7829 18.0084 57.2001 17.8524 57.5152 17.5318C58.1453 16.8906 58.1453 15.8509 57.5152 15.2097"></path></svg></div><div class="mb-3"><div class="MarkdownRedesign_root__x_GKG"><h3 id="Vaccines-sections.4-5" class="text-center text-xl font-medium text-dark-grey group-hover:text-primary-active transition-colors !mb-0" data-sb-field-path=".linkLabel">Vaccines</h3></div></div><p class="mb-16 text-body-block text-center text-dark-grey" data-sb-field-path=".description">Addressing unmet global health needs through vaccine development against infectious diseases</p><div class="flex items-center justify-end w-full mt-auto"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="24" height="24" viewBox="0 0 24 24" class="w-[32px] h-[32px] text-primary group-hover:text-primary-active" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Go to  Vaccines page</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></div></a></div></div></div></div></section><section data-section-position="5" data-sb-field-path="sections.5" data-section-name="## Sign up for investors newsletter

" data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb !mb-20 relative min-h-[300px] bg-dark-grey"><div class="flex flex-col items-center justify-center py-14"><div class="Markdown_root__STsP7"><h2 id="Sign up for investors newsletter" class="!m-0 !font-light normal-case tracking-normal text-center text-white" data-sb-field-path=".title">Sign up for investors newsletter</h2></div><p class="text-base text-center mt-3 text-white" data-sb-field-path=".subtitle">Stay up to date on financial results, corporate milestones and learn how we&#x27;re delivering on our commitment to patients, our people and the planet</p><a data-sb-field-path=".button" __metadata="[object Object]" type="Action" class="ActionRedesign_link__BERDu ActionRedesign_primary__gaHSB ActionRedesign_large__2VDIJ mt-6" role="link" aria-label="Sign up" href="/investors/newsletter/"><span class="ActionRedesign_label__pFlEJ">Sign up</span></a></div></section></div></main><footer data-sb-field-path="undefined:footer" class="Footer_footerRedesign__vrMel"><div class="Container_root__AelVI"><div class="Footer_wrapperRedesign__fdUnz"><div class="flex flex-wrap items-center gap-6 justify-between"><a class="Footer_logoRedesign__YQpnQ" role="link" href="/"><div class="ImageBlock_root__MFRQz" style="aspect-ratio:2.8125"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img data-sb-field-path=".logo.url" alt="Takeda logo" _type="ImageBlock" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257" decoding="async" data-nimg="fill" class="rounded-none" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:cover" /></span></div></a><ul class="flex items-center" data-sb-field-path="undefined:footer.socialLinks" role="list"><li class="flex mr-[24px] max-xs:mr-[16px] last:mr-0" data-sb-field-path=".0" role="listitem"><a _key="1f14579e-7c12-4849-be12-a7d196bfb058" elementId _type="Social" class="group link Social_root__5tl0Y SocialRedesign_root__fgflZ" target="_blank" role="link" aria-label="LinkedIn icon" rel="noreferrer" href="https://www.linkedin.com/company/takeda-pharmaceuticals/"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 22 21" class="Social_icon__8MXQu SocialRedesign_icon__21vHV" role="img" aria-hidden="false" _type="Icon" data-testid="icon-LinkedIn"><title>LinkedIn</title><path d="M 0.24739583333333331 6.173705722070846 L 4.544270833333333 6.173705722070846 L 4.544270833333333 19 L 0.24739583333333331 19 L 0.24739583333333331 6.173705722070846 Z M 4.153645833333333 0.627724795640327 C 4.587673611111112 1.0462079927338777 4.809027777777779 1.5747048138056288 4.817708333333333 2.2132152588555862 C 4.826388888888889 2.8430971843778368 4.607204861111112 3.3694368755676645 4.16015625 3.7922343324250676 C 3.713107638888889 4.2150317892824685 3.125 4.4264305177111725 2.3958333333333335 4.4264305177111725 L 2.3697916666666665 4.4264305177111725 C 1.6579861111111114 4.4264305177111725 1.0850694444444446 4.2150317892824685 0.6510416666666667 3.7922343324250676 C 0.21701388888888884 3.3694368755676645 0 2.8430971843778368 0 2.2132152588555862 C 0 1.5747048138056288 0.22352430555555552 1.0462079927338777 0.6705729166666667 0.627724795640327 C 1.117621527777778 0.20924159854677427 1.7013888888888893 0 2.421875 0 C 3.142361111111111 0 3.719618055555556 0.20924159854677427 4.153645833333333 0.627724795640327 Z M 18.645833333333332 7.345027247956403 C 19.54861111111111 8.32436421435059 20 9.758855585831062 20 11.648501362397822 L 20 19 L 15.716145833333332 19 L 15.716145833333332 12.140326975476839 C 15.716145833333332 11.23433242506812 15.540364583333332 10.524636693914623 15.188802083333332 10.011239782016348 C 14.837239583333332 9.497842870118072 14.288194444444446 9.241144414168938 13.541666666666668 9.241144414168938 C 12.994791666666668 9.241144414168938 12.53689236111111 9.389986376021797 12.16796875 9.68767029972752 C 11.799045138888891 9.985354223433243 11.5234375 10.354223433242508 11.341145833333332 10.794277929155314 C 11.245659722222223 11.053133514986376 11.197916666666668 11.40258855585831 11.197916666666668 11.842643051771118 L 11.197916666666668 19 L 6.9140625 19 C 6.931423611111112 15.557220708446865 6.940104166666666 12.76589464123524 6.940104166666666 10.626021798365123 C 6.940104166666666 8.486148955495004 6.935763888888889 7.209128065395094 6.927083333333334 6.794959128065395 L 6.9140625 6.173705722070846 L 11.197916666666668 6.173705722070846 L 11.197916666666668 8.037465940054496 L 11.171875 8.037465940054496 C 11.34548611111111 7.761353315168028 11.5234375 7.51975476839237 11.705729166666668 7.312670299727522 C 11.888020833333332 7.105585831062671 12.133246527777779 6.881244323342415 12.44140625 6.639645776566757 C 12.749565972222223 6.398047229791097 13.127170138888891 6.210376930063577 13.57421875 6.076634877384197 C 14.021267361111114 5.942892824704814 14.518229166666668 5.876021798365122 15.065104166666668 5.876021798365122 C 16.549479166666668 5.876021798365122 17.743055555555557 6.365690281562215 18.645833333333332 7.345027247956403 Z"></path></svg></a></li><li class="flex mr-[24px] max-xs:mr-[16px] last:mr-0" data-sb-field-path=".1" role="listitem"><a _type="Social" _key="e8bf8d4a-b399-456f-adf0-56a0e9326663" elementId class="group link Social_root__5tl0Y SocialRedesign_root__fgflZ" target="_blank" role="link" aria-label="YouTube logo" rel="noreferrer" href="https://www.youtube.com/takeda-pharmaceuticals"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 310 310" class="Social_icon__8MXQu SocialRedesign_icon__21vHV" role="img" aria-hidden="false" _type="Icon" data-testid="icon-YouTube"><title>YouTube</title><path d="M297.917 64.645c-11.19-13.302-31.85-18.728-71.306-18.728H83.386c-40.359 0-61.369 5.776-72.517 19.938C0 79.663 0 100.008 0 128.166v53.669c0 54.551 12.896 82.248 83.386 82.248h143.226c34.216 0 53.176-4.788 65.442-16.527C304.633 235.518 310 215.863 310 181.835v-53.669c0-29.695-.841-50.16-12.083-63.521zm-98.896 97.765-65.038 33.991a9.997 9.997 0 0 1-14.632-8.863v-67.764a10 10 0 0 1 14.609-8.874l65.038 33.772a10 10 0 0 1 .023 17.738z"></path></svg></a></li></ul></div></div><div class="Footer_footerNavigationWrapperRedesign__AMBpa"><ul data-sb-field-path="undefined:footer.navigationLinks" class="Footer_listRedesign__TfN4y"><li class="Footer_linkItemRedesign__Gxzbj"><a data-sb-field-path="undefined:footer.navigationLinks.links.0" class="Footer_linkRedesign__cw0YU" role="link" aria-label="Locations" href="/worldwide/">Locations</a></li><li class="Footer_linkItemRedesign__Gxzbj"><a data-sb-field-path="undefined:footer.navigationLinks.links.1" class="Footer_linkRedesign__cw0YU" role="link" aria-label="Contact us" href="/contact-us/">Contact us</a></li><li class="Footer_linkItemRedesign__Gxzbj"><a data-sb-field-path="undefined:footer.navigationLinks.links.2" class="Footer_linkRedesign__cw0YU" role="link" aria-label="Careers" href="/careers/">Careers</a></li><li class="Footer_linkItemRedesign__Gxzbj"><a data-sb-field-path="undefined:footer.navigationLinks.links.3" class="Footer_linkRedesign__cw0YU" role="link" aria-label="Financial Highlights" href="/investors/financial-highlights/">Financial Highlights</a></li><li class="Footer_linkItemRedesign__Gxzbj"><a data-sb-field-path="undefined:footer.navigationLinks.links.4" class="Footer_linkRedesign__cw0YU" role="link" aria-label="HCPs" href="/hcps/">HCPs</a></li><li class="Footer_linkItemRedesign__Gxzbj"><a data-sb-field-path="undefined:footer.navigationLinks.links.5" class="Footer_linkRedesign__cw0YU" role="link" aria-label="Patients" href="/patients/">Patients</a></li></ul></div><div class="mt-11"><div class="MarkdownRedesign_root__x_GKG"><div class="Footer_markdownContainer__sz5g9" data-sb-field-path="undefined:footer.disclaimerText"><p>This website provides information about Takeda&#x27;s worldwide business. For specific information about our local markets, please use the <a class="underline" role="link" href="/worldwide/">country selector</a>.</p></div></div></div><div class="flex flex-wrap max-md:flex-col gap-11 justify-between mt-11"><div class="flex flex-wrap max-md:flex-col gap-6"></div><div class="MarkdownRedesign_root__x_GKG"><div class="Footer_copyrightRedesign__YAFml" data-sb-field-path="undefined:footer.copyrightText"><p>Copyright 1995-2023 Takeda Pharmaceutical Company Limited. All rights reserved.</p></div></div></div></div></footer><div class="BackToTopButton_root__LD6u8 BackToTopButton_rootHidden__78Tgv"><button aria-label="Back to top" class="BackToTopButton_button__EyIwR" style="transform:scale(0) translateZ(0)"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 512 512" class="BackToTopButton_icon__CYDFm" role="img" aria-hidden="false" data-testid="icon-BackToTop"><title>Back to top</title><path d="m512 256c0 141.386719-114.613281 256-256 256s-256-114.613281-256-256 114.613281-256 256-256 256 114.613281 256 256zm0 0"></path><g fill="white"><path d="m335.183594 184.558594-79.183594-79.183594-79.183594 79.183594 22.625 22.625 40.558594-40.558594v121.136719h32v-121.136719l40.558594 40.558594zm0 0"></path><path d="m240 319.761719h32v32h-32zm0 0"></path><path d="m240 383.761719h32v32h-32zm0 0"></path></g></svg></button></div></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"page":{"slug":"/","title":"Home","enablePageNavigation":false,"__i18n_lang":"en","metaTitle":"Takeda Pharmaceuticals: Global Homepage","addTitleSuffix":false,"site":{"fallbackSocialImage":{"public_id":"Global/OG Logo","created_at":"2023-05-12T12:02:00Z","format":"jpg","secure_url":"https://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","width":1200,"version":1683892920,"bytes":185717,"created_by":{"type":"user","id":"5c035dcf12017bdefe1298466d0c2f"},"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"height":627,"type":"cloudinary.asset","_version":1,"access_mode":"public","url":"http://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","uploaded_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"resource_type":"image","__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"footer":{"componentLayout":"takeda-com-redesign","footerInternalLabel":"Global Footer - EN","disclaimerText":"This website provides information about Takeda's worldwide business. For specific information about our local markets, please use the [country selector](/worldwide).\n","__i18n_lang":"en","navigationLinks":[{"iconPosition":"right","icon":"arrowRight","altText":"Locations","elementId":"","label":"Locations","url":"/worldwide","showIcon":false,"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","showIcon":false,"url":"/contact-us","elementId":"","icon":"arrowRight","label":"Contact us","altText":"Contact us","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Careers","elementId":"","altText":"Careers","url":"/careers","showIcon":false,"icon":"arrowRight","iconPosition":"right","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","showIcon":false,"url":"/investors/financial-highlights/","altText":"Financial Highlights","icon":"arrowRight","label":"Financial Highlights","elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"iconPosition":"right","label":"HCPs","altText":"HCPs","icon":"arrowRight","url":"/hcps","elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","iconPosition":"right","elementId":"","altText":"Patients","label":"Patients","showIcon":false,"url":"/patients","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"logo":{"priority":true,"url":{"context":{"custom":{"Language":"English","alt":"Takeda logo","caption":"Takeda logo"}},"width":720,"secure_url":"https://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","resource_type":"image","bytes":3692,"created_at":"2022-05-11T09:09:23Z","tags":["Takeda Logo","Takeda","logo"],"version":1652260163,"public_id":"migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257","created_by":{"type":"accesskey","id":"553579438111562"},"type":"cloudinary.asset","uploaded_by":{"id":"553579438111562","type":"accesskey"},"access_mode":"public","format":"svg","height":256,"url":"http://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"elementId":"","altText":"Takeda logo","aspectRatio":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAECAMAAACA5l7/AAAAOVBMVEX4yMn86er4ycv0rrHuf4P3w8X50tNHcEz4zs/ugob73t/0rK763t/wlJfynaD86uv++PjzqKv1t7mDF9BrAAAADXRSTlP+Csdqs60qABrD7/7v1KBqGwAAAC1JREFUCNcdwgESABAIBMBLqJDw/8cydhZCnNpITAK1HrEWTJH3cZ9vRi34Sr0beAEtjhAsjAAAAABJRU5ErkJggg=="},"copyrightText":"Copyright 1995-2023 Takeda Pharmaceutical Company Limited. All rights reserved.\n","socialLinks":[{"elementId":"","altText":"LinkedIn icon","icon":{"variant":"LinkedIn","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"style":"link","label":"LinkedIn","url":"https://www.linkedin.com/company/takeda-pharmaceuticals/","__metadata":{"modelName":"Social","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Social"},{"altText":"YouTube logo","icon":{"variant":"YouTube","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"style":"link","label":"YouTube","url":"https://www.youtube.com/takeda-pharmaceuticals","elementId":"","__metadata":{"modelName":"Social","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Social"}],"__metadata":{"modelName":"DefaultFooter","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"WDc9QDjXlGnV1qjB17rrhg","createdAt":"2023-01-17T14:10:06Z","updatedAt":"2023-08-24T00:18:50Z"},"type":"DefaultFooter"},"configInternalLabel":"Site Configuration - EN","noIndexNoFollow":false,"header":{"headerInternalLabel":"Global Header - EN","enableGlobalNavCollapsing":true,"searchPlaceholder":"Search...","globalNavDefaultState":"collapsed","componentLayout":"takeda-com-redesign","logo":{"elementId":"","altText":"Takeda logo","aspectRatio":"","priority":true,"url":{"uploaded_by":{"type":"accesskey","id":"553579438111562"},"height":256,"access_mode":"public","secure_url":"https://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","context":{"custom":{"Language":"English","alt":"Takeda logo","caption":"Takeda logo"}},"format":"svg","type":"cloudinary.asset","tags":["Takeda Logo","Takeda","logo"],"created_by":{"id":"553579438111562","type":"accesskey"},"resource_type":"image","bytes":3692,"public_id":"migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257","url":"http://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","width":720,"created_at":"2022-05-11T09:09:23Z","version":1652260163,"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAECAMAAACA5l7/AAAAOVBMVEX4yMn86er4ycv0rrHuf4P3w8X50tNHcEz4zs/ugob73t/0rK763t/wlJfynaD86uv++PjzqKv1t7mDF9BrAAAADXRSTlP+Csdqs60qABrD7/7v1KBqGwAAAC1JREFUCNcdwgESABAIBMBLqJDw/8cydhZCnNpITAK1HrEWTJH3cZ9vRi34Sr0beAEtjhAsjAAAAABJRU5ErkJggg=="},"searchPageUrl":"/search","searchLocationPlaceholder":"Search for a country","localNavDefaultState":"collapsed","title":"Takeda - Global","__metadata":{"modelName":"DefaultHeader","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"h5S8Zv8xPUpA8CF4ZOulY2","createdAt":"2023-02-06T13:44:06Z","updatedAt":"2023-05-18T19:26:29Z"},"type":"DefaultHeader"},"exitDisclaimer":{"title":"You are leaving Takeda.com","cancelButtonTitle":"Cancel","okButtonTitle":"Continue","whitelistedUrls":["assets-dam.takeda.com","takeda.com","players.brightcove.net/2299575749001","takedajobs.com","jobs.takeda.com","takedaoncology.com","www.takeda.com","www.takedaoncology.com","clinicaltrials.takeda.com","www.takedajobs.com","www.jp.takedajobs.com"],"isEnabled":true,"description":"Links to sites outside of takeda.com are provided as a resource to the audiences. Please note that Takeda is not responsible or liable for any third-party website and the website may not be appropriate for all audiences. \n\nTo stay on the current website, select “Cancel”\n","__metadata":{"modelName":"ExitDisclaimer","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ExitDisclaimer"},"scripts":[{"title":"EPD-3055 OneTrust Cookie","script":{"code":"\u003c!-- OneTrust Cookies Consent Notice start for takeda.com --\u003e\n\u003c!-- 20230526 --\u003e\n\n\u003cscript\n  type=\"text/javascript\"\n  src=\"https://cdn.cookielaw.org/consent/3625bb82-8e0e-4be8-80d3-257e4f469168/OtAutoBlock.js\"\n\u003e\u003c/script\u003e\n\n\u003cscript\n  src=\"https://cdn.cookielaw.org/scripttemplates/otSDKStub.js\"\n  data-document-language=\"true\"\n  type=\"text/javascript\"\n  charset=\"UTF-8\"\n  data-domain-script=\"3625bb82-8e0e-4be8-80d3-257e4f469168\"\n\u003e\u003c/script\u003e\n\n\u003cscript type=\"text/javascript\"\u003e\n  function OptanonWrapper() {}\n\u003c/script\u003e\n\n\u003c!-- OneTrust Cookies Consent Notice end for takeda.com --\u003e ","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"loadingStrategy":"beforeInteractive","__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"EPD-3519 Schema Script","script":{"code":"\u003cscript type=\"application/ld+json\"\u003e{\"@context\": \"https://schema.org\",\"@type\":\"Organization\",\"name\": \"Takeda Pharmaceutical Company Limited\",\"url\": \"https://www.takeda.com\",\"logo\": \"https://www.takeda.com/4ab4e2/siteassets/system/top/howwework_logo_1600x900.jpg\",\"address\": {\"@type\": \"PostalAddress\",\"streetAddress\": \"2-ch?me-1-1 Nihonbashihonch?\",\"addressLocality\": \"Chuo City\",\"addressRegion\": \"Tokyo\",\"postalCode\": \"103-0023\",\"addressCountry\": \"Japan\"},\"contactPoint\": {\"@type\": \"ContactPoint\",\"contactType\": \"contact\",\"telephone\": \"+81 3-3278-2111\",\"email\": \"Media_Relations@takeda.com\"},\"sameAs\":[\"https://www.linkedin.com/company/takeda-pharmaceuticals/\",\"https://twitter.com/takedapharma\",\"https://www.youtube.com/takeda-pharmaceuticals\"]} \u003c/script\u003e","filename":"","language":"","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"EPD-2855 GTM Script","script":{"code":"\u003c!-- Google Tag Manager --\u003e\n\u003cscript\u003e(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':\nnew Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],\nj=d.createElement(s),dl=l!='dataLayer'?'\u0026l='+l:'';j.async=true;j.src=\n'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);\n})(window,document,'script','dataLayer','GTM-5XBTH5B');\u003c/script\u003e\n\u003c!-- End Google Tag Manager --\u003e","filename":"","language":"","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"script":{"code":"\u003c!-- Matomo Tag Manager --\u003e\r\n\u003cscript\u003e\r\nvar _mtm = window._mtm = window._mtm || [];\r\n_mtm.push({'mtm.startTime': (new Date().getTime()), 'event': 'mtm.Start'});\r\nvar d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];\r\ng.async=true; g.src='https://cdn.matomo.cloud/takeda.matomo.cloud/container_rTZNKGIx.js'; s.parentNode.insertBefore(g,s);\r\n\u003c/script\u003e\r\n\u003c!-- End Matomo Tag Manager --\u003e","language":"js","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"loadingStrategy":"beforeInteractive","title":"EPD-4037 Matomo Tag Manager","__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"EPD-4268 Cookie Script Hack","script":{"code":"\u003cstyle type=\"text/css\"\u003e #onetrust-consent-sdk svg {display: inline;} \u003c/style\u003e","__metadata":{"modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"}],"__i18n_lang":"en","globalLanguages":[{"links":[{"iconPosition":"right","showIcon":false,"elementId":"","url":"","altText":"about","label":"About","icon":"arrowRight","links":[{"url":"/about/our-company/","altText":"Our Company","icon":"arrowRight","elementId":"","iconPosition":"right","showIcon":false,"label":"Our Company","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","altText":"Leadership","icon":"arrowRight","url":"/about/leadership","iconPosition":"right","label":"Leadership","showIcon":false,"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"links":[{"icon":"arrowRight","iconPosition":"right","label":"Corporate Sustainability","showIcon":false,"url":"","elementId":"","altText":"Corporate Sustainability","links":[{"showIcon":false,"url":"/about/corporate-responsibility/corporate-sustainability/sustainability-approach","label":"Sustainability Approach","elementId":"","icon":"arrowRight","altText":"Sustainability Approach","iconPosition":"right","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","altText":"Access to Medicines","iconPosition":"right","showIcon":false,"url":"/about/corporate-responsibility/corporate-sustainability/access-to-medicine","elementId":"","label":"Access to Medicines","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"url":"/about/corporate-responsibility/corporate-sustainability/sustainability-approach/sustainability-disclosures/","icon":"arrowRight","iconPosition":"right","altText":"Sustainability Disclosures","label":"Sustainability Disclosures","elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Ethics","icon":"arrowRight","showIcon":false,"links":[{"showIcon":false,"altText":"Ethics","icon":"arrowRight","url":"/about/corporate-responsibility/ethics-disclosures/ethics","elementId":"","iconPosition":"right","label":"Ethics","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Transparency Disclosures","label":"Transparency Disclosures","showIcon":false,"elementId":"","iconPosition":"right","url":"/about/corporate-responsibility/ethics-disclosures/transparency-disclosures/","icon":"arrowRight","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"url":"","label":"Ethics \u0026 Disclosures","elementId":"","iconPosition":"right","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"altText":"Positions","label":"Positions","elementId":"","icon":"arrowRight","url":"/about/corporate-responsibility/positions/","iconPosition":"right","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"url":"/about/corporate-responsibility/corporate-giving","icon":"arrowRight","showIcon":false,"altText":"Corporate Giving","label":"Corporate Giving","elementId":"","iconPosition":"right","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"icon":"arrowRight","iconPosition":"right","elementId":"","showIcon":false,"altText":"Corporate Responsibility","label":"Corporate Responsibility","url":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"icon":"arrowRight","label":"Corporate Governance","url":"/corporate-governance","links":[{"iconPosition":"right","label":"Governance Strategy","showIcon":false,"elementId":"","icon":"arrowRight","url":"/about/corporate-governance/strategy/","altText":"Governance Strategy","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Governance Structure","iconPosition":"right","url":"/about/corporate-governance/governance-structure","elementId":"","showIcon":false,"icon":"arrowRight","label":"Governance Structure","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Charters and Reports","showIcon":false,"elementId":"","icon":"arrowRight","iconPosition":"right","url":"/about/corporate-governance/charters-and-reports","label":"Charters and Reports","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"elementId":"","altText":"Corporate Governance","iconPosition":"right","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","icon":"arrowRight","links":[{"iconPosition":"right","label":"Areas of Focus","url":"/science/areas-of-focus/","elementId":"","altText":"Areas of Focus","icon":"arrowRight","showIcon":false,"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"url":"/science/research-and-development","iconPosition":"right","icon":"arrowRight","label":"Research and Development","elementId":"","altText":"Research and Development","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Pipeline","url":"/science/pipeline","label":"Pipeline","icon":"arrowRight","iconPosition":"right","showIcon":false,"elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","label":"Products","altText":"Products","icon":"arrowRight","elementId":"","links":[{"label":"Our Products","elementId":"","url":"/science/products","icon":"arrowRight","altText":"Our Products","iconPosition":"right","showIcon":false,"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","url":"/science/products/manufacturing","iconPosition":"right","label":"Manufacturing","showIcon":false,"altText":"Manufacturing","elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"url":"/science/products/suppliers","icon":"arrowRight","iconPosition":"right","altText":"Suppliers","elementId":"","showIcon":false,"label":"Suppliers","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"showIcon":false,"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","showIcon":false,"icon":"arrowRight","altText":"Clinical Trials","url":"/science/clinical-trials","elementId":"","label":"Clinical Trials","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"url":"","showIcon":false,"elementId":"","altText":"science","label":"Science","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","showIcon":false,"url":"","links":[{"label":"Our Stories","url":"/our-impact/our-stories","elementId":"","altText":"Our Stories","iconPosition":"right","icon":"arrowRight","showIcon":false,"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"icon":"arrowRight","iconPosition":"right","label":"Our Impact","altText":"Our Impact","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","label":"Newsroom","url":"","altText":"Newsroom","showIcon":false,"links":[{"showIcon":false,"altText":"Press Releases","icon":"arrowRight","url":"/newsroom/press-releases","elementId":"","iconPosition":"right","label":"Press Releases","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Statements","showIcon":false,"url":"/newsroom/statements","iconPosition":"right","altText":"Statements","icon":"arrowRight","elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Media Resources","showIcon":false,"elementId":"","altText":"Media Resources","url":"/newsroom/media-resources","icon":"arrowRight","iconPosition":"right","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"elementId":"","iconPosition":"right","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Investors","label":"Investors","url":"","showIcon":false,"iconPosition":"right","elementId":"","icon":"arrowRight","links":[{"icon":"arrowRight","label":"Overview ","showIcon":false,"url":"/investors/overview","altText":"Overview","iconPosition":"right","elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","icon":"arrowRight","showIcon":false,"altText":"Financial Results","iconPosition":"right","label":"Financial Results","url":"/investors/financial-results/quarterly-results","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","iconPosition":"right","url":"/investors/events","label":"Investor Events","altText":"Investor Events","icon":"arrowRight","showIcon":false,"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Investor Contact","label":"Investor Contact","url":"/investors/contact","icon":"arrowRight","iconPosition":"right","showIcon":false,"elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"careers","iconPosition":"right","showIcon":false,"elementId":"","url":"/careers","icon":"arrowRight","label":"Careers","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"languageCode":"en","languageUrl":"en","isDefault":true,"additionalLinks":[{"label":"Terms and Conditions","url":"/terms-and-conditions","elementId":"","altText":"Terms and Conditions","showIcon":false,"icon":"arrowRight","iconPosition":"right","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","iconPosition":"right","label":"Privacy Notice","showIcon":false,"altText":"Privacy Notice","elementId":"","url":"/privacy-notice","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"url":"/cookie-policy/","elementId":"","icon":"arrowRight","iconPosition":"right","label":"Cookie Policy","altText":"Cookie Policy","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","altText":"Accessibility Statement","icon":"arrowRight","showIcon":false,"label":"Accessibility Statement","url":"/global-accessibility-statement","elementId":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"displayName":"English","__metadata":{"modelName":"GlobalLanguage","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"GlobalLanguage"},{"isDefault":false,"displayName":"Japanese","links":[{"elementId":"","altText":"企業情報","icon":"arrowRight","label":"企業情報","showIcon":false,"url":"","iconPosition":"right","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"サイエンス","showIcon":false,"elementId":"","altText":"サイエンス","iconPosition":"right","icon":"arrowRight","url":"","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","elementId":"","iconPosition":"right","url":"","label":"私たちのストーリー","showIcon":false,"altText":"私たちのストーリー","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","iconPosition":"right","label":"ニュース","showIcon":false,"url":"","elementId":"","altText":"ニュース","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","icon":"arrowRight","showIcon":false,"url":"","altText":"IR情報","iconPosition":"right","label":"IR情報","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"採用情報","iconPosition":"right","elementId":"","url":"/","label":"採用情報","icon":"arrowRight","showIcon":false,"__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"languageCode":"ja","languageUrl":"jp","__metadata":{"modelName":"GlobalLanguage","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"GlobalLanguage"}],"locations":[{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ar","locationName":"Argentina","languages":[{"isDefault":false,"displayName":"Spanish","languageCode":"es","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Australia","languages":[{"languageCode":"en","isDefault":false,"displayName":"English","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"locationCode":"au","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Austria","languages":[{"languageCode":"de","isDefault":true,"displayName":"German","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"at","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Belgium","languages":[{"languageCode":"en","isDefault":false,"displayName":"English","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"be","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Bosnia Herzegovina","languages":[{"displayName":"Bosnian","languageCode":"bs","isDefault":false,"__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ba","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"br","locationName":"Brazil","languages":[{"displayName":"Portuguese","languageCode":"pt","isDefault":false,"__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"languageCode":"bg","isDefault":false,"displayName":"Bulgarian","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"bg","locationName":"Bulgaria","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ca","locationName":"Canada","languages":[{"isDefault":true,"displayName":"English","languageCode":"en","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"},{"languageCode":"fr","isDefault":false,"displayName":"French","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Chile","languages":[{"languageCode":"es","languageUrl":"/worldwide/chile/","isDefault":false,"displayName":"Spanish","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","altText":"altText of the image","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"cl","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"cn","locationName":"Mainland China","languages":[{"isDefault":false,"displayName":"Chinese","languageCode":"zh","languageUrl":"https://takeda.info/takeda-china","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"co","locationName":"Colombia","languages":[{"languageCode":"es","isDefault":false,"displayName":"Spanish","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Croatia","languages":[{"isDefault":false,"displayName":"Croatian","languageCode":"hr","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"hr","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"cz","locationName":"Czech Republic","languages":[{"languageCode":"cs","isDefault":false,"displayName":"Czech","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"dk","locationName":"Denmark","languages":[{"isDefault":false,"displayName":"Danish","languageCode":"da","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ec","locationName":"Ecuador","languages":[{"isDefault":false,"displayName":"Spanish","languageCode":"es","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Estonia","languages":[{"isDefault":false,"displayName":"Estonian","languageCode":"et","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ee","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"fi","locationName":"Finland","languages":[{"languageCode":"fi","isDefault":false,"displayName":"Finnish","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"fr","locationName":"France","languages":[{"languageCode":"fr","isDefault":false,"displayName":"French","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"de","locationName":"Germany","languages":[{"displayName":"German","languageCode":"de","isDefault":false,"__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"displayName":"Greek","languageCode":"el","isDefault":false,"__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"gr","locationName":"Greece","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Hong Kong SAR","languages":[{"isDefault":true,"displayName":"English","languageCode":"en","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"},{"languageCode":"zh","isDefault":false,"displayName":"Chinese","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"hk","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"hu","locationName":"Hungary","languages":[{"isDefault":false,"displayName":"Hungarian","languageCode":"hu","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"in","locationName":"India","languages":[{"languageCode":"en","isDefault":false,"displayName":"English","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"id","locationName":"Indonesia","languages":[{"languageCode":"id","isDefault":false,"displayName":"Indonesian","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Ireland","languages":[{"languageCode":"en","isDefault":false,"displayName":"English","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ie","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"languageCode":"he","isDefault":false,"displayName":"Hebrew","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"il","locationName":"Israel","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"it","locationName":"Italy","languages":[{"displayName":"Italian","languageCode":"it","isDefault":false,"__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"displayName":"Japanese","languageCode":"ja","isDefault":false,"__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"jp","locationName":"Japan","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Kazakhstan","languages":[{"languageCode":"kk","isDefault":true,"displayName":"Kazakh","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"},{"isDefault":false,"displayName":"Russian","languageCode":"ru","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"kz","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Korea","languages":[{"displayName":"Korean","languageCode":"ko","isDefault":false,"__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"kr","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"isDefault":false,"displayName":"Latvian","languageCode":"lv","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"lv","locationName":"Latvia","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"lt","locationName":"Lithuania","languages":[{"isDefault":false,"displayName":"Lithuanian","languageCode":"lt","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"languageCode":"en","languageUrl":"/worldwide/asia-pacific-pte-ltd/","isDefault":false,"displayName":"English","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"locationCode":"my","locationName":"Malaysia","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"mx","locationName":"Mexico","languages":[{"languageCode":"es","isDefault":false,"displayName":"Spanish","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"nl","locationName":"Netherlands","languages":[{"languageCode":"nl","isDefault":false,"displayName":"Dutch","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"nz","locationName":"New Zealand","languages":[{"languageCode":"en","languageUrl":"/en-au/","isDefault":false,"displayName":"English","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"no","locationName":"Norway","languages":[{"languageCode":"no","languageUrl":"/nn-no","isDefault":false,"displayName":"Norweigan","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"languageCode":"es","isDefault":false,"displayName":"Spanish","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"pe","locationName":"Peru","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Philippines","languages":[{"languageCode":"en","languageUrl":"/worldwide/asia-pacific-pte-ltd/","isDefault":false,"displayName":"English","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"locationCode":"ph","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"isDefault":false,"displayName":"Polish","languageCode":"pl","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"pl","locationName":"Poland","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"pt","locationName":"Portugal","languages":[{"languageCode":"pt","isDefault":false,"displayName":"Portuguese","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"ro","locationName":"Romania","languages":[{"isDefault":false,"displayName":"Romanian","languageCode":"ro","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ru","locationName":"Russia","languages":[{"languageCode":"ru","isDefault":false,"displayName":"Russian","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Saudi Arabia","languages":[{"isDefault":false,"displayName":"Arabic","languageCode":"ar","languageUrl":"/worldwide/saudi-arabia/","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"locationCode":"sa","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"rs","locationName":"Serbia","languages":[{"languageCode":"sr","isDefault":false,"displayName":"Serbian","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"sg","locationName":"Singapore","languages":[{"languageCode":"en","languageUrl":"/worldwide/asia-pacific-pte-ltd/","isDefault":false,"displayName":"English","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"sk","locationName":"Slovakia","languages":[{"languageCode":"sk","isDefault":false,"displayName":"Slovak","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"languageCode":"sl","isDefault":false,"displayName":"Slovenian","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"locationCode":"si","locationName":"Slovenia","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"es","locationName":"Spain","languages":[{"languageCode":"es","isDefault":false,"displayName":"Spanish","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"se","locationName":"Sweden","languages":[{"languageCode":"sv","isDefault":false,"displayName":"Swedish","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Switzerland","languages":[{"languageCode":"de","isDefault":true,"displayName":"German","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"},{"languageCode":"fr","isDefault":false,"displayName":"French","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ch","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"tw","locationName":"Taiwan","languages":[{"isDefault":false,"displayName":"Chinese","languageCode":"zh","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"languageCode":"th","isDefault":false,"displayName":"Thai","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"th","locationName":"Thailand","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Turkey","languages":[{"languageCode":"tr","isDefault":false,"displayName":"Turkish","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"tr","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ua","locationName":"Ukraine","languages":[{"languageCode":"uk","isDefault":false,"displayName":"Ukrainian","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"gb","locationName":"United Kingdom","languages":[{"languageCode":"en","isDefault":false,"displayName":"English","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"United States","languages":[{"languageCode":"en","languageUrl":"","isDefault":false,"displayName":"English","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"altText":"altText of the image","aspectRatio":"","priority":false,"elementId":"","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"us","__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"vn","locationName":"Vietnam","languages":[{"languageCode":"en","languageUrl":"/en-vi","isDefault":false,"displayName":"English","__metadata":{"modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"}],"__metadata":{"modelName":"Config","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"siteSettings","createdAt":"2022-11-11T08:38:36Z","updatedAt":"2023-09-15T07:44:31Z"},"type":"Config"},"visibleInListings":true,"sections":[{"button":{"showIcon":false,"url":"/our-impact/our-stories/hear-from-our-new-global-csr-partners/","altText":"Learn more","style":"primary","iconPosition":"right","label":"Learn More","size":"medium","icon":{"variant":"Globe","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"elementId":"","__metadata":{"modelName":"Action","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Action"},"componentLayout":"takeda-com-redesign","displayName":"","overlayOpacity":30,"hideTitle":false,"media":[{"url":{"resource_type":"image","url":"http://assets-dam.takeda.com/image/upload/v1695947216/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala.jpg","format":"jpg","created_by":{"type":"user","id":"215a9d3c6ca9b1bc6dd955e329194a"},"version":1695947216,"height":2000,"folder_id":"c56f295e34090960a12e5701a9412b6cb4","public_id":"Global/Our-Stories/Voices of New Global CSR Partners in 2023/Takeda_Global_CSR_Program_DNDi_Guatemala","id":"52ab60ef677f402934318145cf44d846","uploaded_by":{"id":"215a9d3c6ca9b1bc6dd955e329194a","type":"user"},"secure_url":"https://assets-dam.takeda.com/image/upload/v1695947216/Global/Our-Stories/Voices%20of%20New%20Global%20CSR%20Partners%20in%202023/Takeda_Global_CSR_Program_DNDi_Guatemala.jpg","type":"cloudinary.asset","access_mode":"public","created_at":"2023-09-29T00:26:56Z","bytes":3888547,"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"width":3000,"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"elementId":"","altText":"Takeda: Hear from our new Global CSR partners ","aspectRatio":"","priority":false,"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAHCAMAAAAGcixRAAAAhFBMVEVPRDRyfnymeV5ZTTtDOzBLT0lgaWV6fnpXVVYIDRJkWk9FKiUeFBEmLTF3hI9alNtvVkOsjGrTSYDaw6dgV0VfXVcwJySVcVYxJRh2g4QCHzxrd5CkhGIVO18MIDWTjphRQS8/Vn8yNzOnb1OmaZ1VaZTEYmGyYo6rj3RXHCryJIO6m3mvkAV3AAAATElEQVQI1w3GRQKAIAAEwFVpUOzujv//T+Y06GcppUEAiiQOh7bUyJnrGo5+TRTHp8i2TKIqOG7oc7edLzxkxKSXjXjhGjxvekSMNj+noASaRqhVIAAAAABJRU5ErkJggg=="}],"excludeFromNavigation":false,"elementId":"","title":"# Hear from our new Global CSR partners\n\n","titleColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"heightVariants":"25%","__metadata":{"modelName":"BannerCTA","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"BannerCTA"},{"componentLayout":"takeda-com-redesign","backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"textColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"titleColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"excludeFromNavigation":false,"text":" \n","elementId":"","title":"","subtitle":"We exist to create better health for people and a brighter future for the world. While the science and technology we advance are constantly evolving, our ambition remains. We move science forward, so we can transform more lives.","displayName":"","hideTitle":false,"__metadata":{"modelName":"TextSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"TextSection"},{"title":"\u003ch2 style=\"text-align: center;\"\u003eRecent News\u003c/h2\u003e\n\n","excludeFromNavigation":false,"displayName":"","count":4,"backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"filterByTaxonomy":[{"displayName":"Press Releases","__metadata":{"modelName":"Taxonomy","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"Wr0KFDIza4E2fCgbz82Z9F","createdAt":"2022-12-08T10:11:40Z","updatedAt":"2023-07-11T11:19:33Z"},"type":"Taxonomy"}],"titleColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"takeda-com-redesign-A","elementId":"","viewAllLink":{"altText":"View All","label":"View All","url":"/newsroom/press-releases","__metadata":{"modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},"hideTitle":false,"__metadata":{"modelName":"NewsroomTextTopicsSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"NewsroomTextTopicsSection","articles":[{"publishDate":"2023-10-03T19:56:00.000Z","__i18n_lang":"en","title":"Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years","content":"*   ***Experts Reviewed Data from QDENGA’s Clinical Program Across 19 Phase 1, 2 and 3 Trials with More Than 28,000 Participants***\n\n*   ***WHO Will Consider the SAGE Recommendation and Provide Final Guidance on the Use of QDENGA in Public Vaccination Programs in the Coming Months***\n\n*   ***Dengue Poses a Significant and Growing Public Health Burden to People Living in and Traveling to Endemic Countries***\n\n**OSAKA, Japan, and CAMBRIDGE, Massachusetts, October 3, 2023** – Takeda ([TSE:4502/NYSE:TAK](https://www.takeda.com/investors/overview/)) today announced that the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on Immunization shared [recommendations ](https://www.who.int/news/item/02-10-2023-who-recommends-r21-matrix-m-vaccine-for-malaria-prevention-in-updated-advice-on-immunization)for use of QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003). In the coming months, the WHO will consider the SAGE recommendation and update its position paper on dengue vaccines to include final guidance on the use of QDENGA in public vaccination programs.\n\nSAGE made the following recommendations:\n\n*   The vaccine to be considered for introduction in settings with high dengue disease burden and high transmission intensity to maximize the public health impact and minimize any potential risk in seronegative persons.\n\n*   The vaccine to be introduced to children aged 6 to 16 years of age. Within this age range, the vaccine should be introduced about 1-2 years prior to the age-specific peak incidence of dengue-related hospitalizations. The vaccine should be administered in a 2-dose schedule with a 3-month interval between doses.\n\n*   The vaccine introduction should be accompanied by a well-designed communication strategy and community engagement.\n\nDengue fever is among the most common mosquito-borne viral diseases worldwide.\u003csup\u003e1 \u003c/sup\u003eIt is endemic in more than 100 countries and causes an estimated 390 million infections each year.\u003csup\u003e2 \u003c/sup\u003eWhile many dengue infections are asymptomatic or produce only mild illness, dengue can occasionally cause more severe disease, and even death.\u003csup\u003e2 \u003c/sup\u003eDengue is also a leading cause of fever among travelers returning from Latin America, the Caribbean and Southeast Asia.\u003csup\u003e3\u003c/sup\u003e\n\n“The global impact of dengue cannot be overlooked as the incidence continues to rise. This week, the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) provided important recommendations for the use of QDENGA in preventing dengue,” said Gary Dubin, M.D., president of the Global Vaccine Business Unit at Takeda. “We’re encouraged by their feedback and look forward to the final position from the WHO in the coming months.”\n\nSAGE reviewed data across 19 Phase 1, 2 and 3 trials with more than 28,000 children and adults, including the pivotal Phase 3 [Tetravalent Immunization against Dengue Efficacy Study ](https://clinicaltrials.gov/study/NCT02747927?tab=table)(TIDES) trial, which was designed according to the WHO’s guidance for a second-generation dengue vaccine. The pivotal TIDES trial met its [primary endpoint ](https://www.nejm.org/doi/full/10.1056/NEJMoa1903869)of overall vaccine efficacy (VE) against virologically-confirmed dengue (VCD) with 80.2% efficacy at 12-months follow-up.\u003csup\u003e4 \u003c/sup\u003eThe trial also met all [secondary endpoints](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20\\)30414-1/fulltext) for which there were a sufficient number of dengue cases at 18-months follow-up.\u003csup\u003e5\u003c/sup\u003e The VE result in preventing hospitalization due to VCD fever was 90.4%.\u003csup\u003e5\u003c/sup\u003e Through four and a half years (54 months after the second dose) in an exploratory analysis, QDENGA demonstrated continued overall protection, with sustained overall VE of 61.2% and 84.1% VE against VCD and hospitalized dengue, respectively.\u003csup\u003e6 \u003c/sup\u003eObservations of VE varies by serotype and remained consistent with previously reported results. QDENGA has been generally well tolerated and no important safety risks have been identified in the TIDES trial, to date.\n\nQDENGA is currently available for children and adults in the private market in countries in Europe, Indonesia and Brazil, and will be available in Argentina and Thailand soon.\n\n## About QDENGA® ▼ (Dengue Tetravalent Vaccine [Live, Attenuated])\n\nQDENGA® (TAK-003) is a dengue vaccine that is based on a live-attenuated dengue serotype 2 virus, which provides the genetic “backbone” for all four dengue virus serotypes and is designed to protect against any of these serotypes.\u003csup\u003e7\u003c/sup\u003e\n\nIn the European Union (EU) Member States, QDENGA is indicated for the prevention of dengue disease in individuals from four years of age and should be administered subcutaneously as a 0.5 mL dose at a two-dose (0 and 3 months) schedule pursuant to approved dosing regimen.\u003csup\u003e8\u003c/sup\u003e\n\nThe use of QDENGA should be in accordance with local recommendations.\n\n## Important Safety Information\n\nPlease consult the Summary of Product Characteristics (SmPC) before prescribing.\n\n**Guidance for use:** QDENGA should be administered by subcutaneous injection preferably in the upper arm in the region of deltoid. QDENGA must not be injected intravascularly, intradermally or intramuscularly. Vaccination should be postponed in subjects suffering from an acute severe febrile illness. The presence of a minor infection, such as a cold, should not result in a deferral of vaccination. Vaccination should be preceded by a review of the individual’s medical history (especially with regards to previous vaccination and possible hypersensitivity reactions which occurred after vaccination). Appropriate medical treatment and supervision must always be readily available in the event of a rare anaphylactic reaction following administration of the vaccine. Anxiety-related reactions, including vasovagal reactions (syncope), hyperventilation or stress-related reactions may occur in association with vaccination as a psychogenic response to the needle injection. It is important that precautions are in place to avoid injury from fainting. A protective immune response with QDENGA may not be elicited in all vaccinees against all serotypes of dengue virus and may decline over time. It is currently unknown whether a lack of protection could result in an increased severity of dengue. It is recommended to continue personal protection measures against mosquito bites after vaccination. Individuals should seek medical care if they develop dengue symptoms or dengue warning signs.\n\n**Contraindications:** Hypersensitivity to the active substances or excipients listed, or to previous QDENGA dose. Individuals with congenital or acquired immune deficiency, including immunosuppressive therapies such as chemotherapy or high doses of systemic corticosteroids (e.g., 20 mg/day or 2 mg/kg body weight/day of prednisone for 2 weeks or more) within 4 weeks prior to vaccination. Individuals with symptomatic HIV infection or asymptomatic HIV infection with impaired immune function. Pregnant and breast-feeding women.\n\n**Adverse Reactions**: Most frequently reported reactions in subjects 4 to 60 years of age were injection site pain (50%), headache (35%), myalgia (31%), injection site erythema (27%), malaise (24%), asthenia (20%), and fever (11%). Very common: (≥1/10 of subjects): upper respiratory tract infection\u003csup\u003ea\u003c/sup\u003e, decreased appetite\u003csup\u003ec\u003c/sup\u003e, irritability\u003csup\u003ec\u003c/sup\u003e, headache, somnolence\u003csup\u003ec\u003c/sup\u003e, myalgia, injection site pain, injection site erythema, malaise, asthenia, fever. Common (≥1/100 to \u003c1/10): nasopharyngitis, pharyngotonsillitis\u003csup\u003eb\u003c/sup\u003e, arthralgia, injection site swelling, injection site bruising\u003csup\u003ee\u003c/sup\u003e, injection site pruritus\u003csup\u003ee\u003c/sup\u003e,\n\n▼ *This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See Section 4.8 of the SmPC for how to report adverse reactions.*\n\ninfluenza like illness. \u003csup\u003ea\u003c/sup\u003eIncludes upper respiratory tract infection and viral upper respiratory tract infection. \u003csup\u003eb\u003c/sup\u003eIncludes pharyngotonsillitis and tonsillitis. \u003csup\u003ec\u003c/sup\u003eCollected in children below 6 years of age in clinical studies. \u003csup\u003ed\u003c/sup\u003eIncludes rash, viral rash, rash maculopapular, and rash pruritic. \u003csup\u003ee\u003c/sup\u003eReported in adults in clinical studies. **Refer to the SmPC for details on full side effect profile and interactions.**\n\nFor full prescribing information, please see the [Summary of Product Characteristics](https://assets-dam.takeda.com/raw/upload/v1674600772/legacy-dotcom/siteassets/system/newsroom/2022/qdenga/ema-combined-h-5155-en.pdf) (SmPC) for QDENGA®▼.\n\nPlease consult with your local regulatory agency for any approved labeling in your country.\n\nThe drug information contained herein is intended to disclose corporate information. Nothing contained in this document should be considered a solicitation, promotion, or indication for any prescription drug, including those currently under development.\n\n## About the Phase 3 TIDES (DEN-301) Trial\n\nThe double-blind, randomized, placebo-controlled Phase 3 TIDES trial is evaluating the safety and efficacy of two doses of TAK-003 in the prevention of laboratory-confirmed symptomatic dengue fever of any severity and due to any of the four dengue virus serotypes in children and adolescents.\u003csup\u003e9\u003c/sup\u003e Study participants were randomized 2:1 to receive two doses of TAK-003 0.5 mL or placebo on months 0 and 3, administered subcutaneously.\u003csup\u003e9\u003c/sup\u003e The study is comprised of five parts. Part 1 and the primary endpoint analysis evaluated VE and safety through 12 months after the second dose.\u003csup\u003e9\u003c/sup\u003e Part 2 continued for an additional six months to complete the assessment of the secondary endpoints of VE by serotype, baseline serostatus and disease severity, including VE against hospitalized dengue.\u003csup\u003e9\u003c/sup\u003e Part 3 evaluated VE and long-term safety by following participants for an additional two and a half to three years, as per World Health Organization recommendations.\u003csup\u003e10\u003c/sup\u003e Part 4 is evaluating efficacy and safety for 13 months following booster vaccination, and Part 5 will evaluate long-term efficacy and safety for one year after completion of Part 4.\u003csup\u003e9\u003c/sup\u003e\n\nThe trial is taking place at sites in dengue-endemic areas in Latin America (Brazil, Colombia, Panama, the Dominican Republic and Nicaragua) and Asia (Philippines, Thailand and Sri Lanka) where there are unmet needs in dengue prevention and where severe dengue is a leading cause of serious illness and death among children.\u003csup\u003e11\u003c/sup\u003e Baseline blood samples were collected from all individuals participating in the trial to allow for evaluation of safety and efficacy based on serostatus. Takeda and an independent Data Monitoring Committee of experts are actively monitoring safety on an ongoing basis.\n\n## About Dengue\n\nDengue is a mosquito-borne viral disease that spreads rapidly around the world and was one of the WHO’s top 10 threats to global health in 2019.\u003csup\u003e2,12\u003c/sup\u003e Dengue is mainly spread by *Aedes aegypti* mosquitoes and, to a lesser extent, *Aedes albopictus* mosquitoes.\u003csup\u003e2\u003c/sup\u003e It is caused by any of four dengue virus serotypes, each of which can cause dengue fever or severe dengue.\u003csup\u003e13\u003c/sup\u003e The prevalence of individual serotypes varies across different geographies, countries, regions, seasons and over time.\u003csup\u003e14\u003c/sup\u003e Recovery from infection by one serotype provides lifelong immunity against only that serotype, and later exposure to any of the remaining serotypes is associated with an increased risk of severe disease.\u003csup\u003e2,15\u003c/sup\u003e\n\n## Takeda’s Commitment to Vaccines\n\nVaccines prevent 3.5 to 5 million deaths each year and have transformed global public health.\u003csup\u003e16\u003c/sup\u003e For more than 70 years, Takeda has supplied vaccines to protect the health of people in Japan. Today, Takeda’s global vaccine business is applying innovation to tackle some of the world’s most challenging infectious diseases, such as dengue, COVID-19, pandemic flu and Zika. Takeda’s team brings an outstanding track record and a wealth of knowledge in vaccine development and manufacturing to advance a pipeline of vaccines to address some of the world’s most pressing public health needs. For more information, visit [www.takeda.com/what-we-do/areas-of-focus/vaccines/](http://www.takeda.com/what-we-do/areas-of-focus/vaccines/).\n\n## About Takeda\n\nTakeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R\u0026D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit [www.takeda.com](http://www.takeda.com).\n\n## Media Contacts:\n\n### Japanese Media\n\nMaiko Miura\n\n[maiko.miura@takeda.com](mailto:maiko.miura@takeda.com)\n\n### U.S. and International Media\n\nCharlotte McCormack\n\n[charlotte.mccormack@takeda.com](mailto:charlotte.mccormack@takeda.com)\n\n## Important Notice\n\nFor the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.\nThe companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.\n\n## Forward-Looking Statements\n\nThis press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could”, “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations, including global health care reforms; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: \u003chttps://www.takeda.com/investors/sec-filings-and-security-reports/\u003e or at [www.sec.gov](http://www.sec.gov). Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.\n\n## Medical Information\n\nThis press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development.\n\n## References\n\n1.  Bhatt, S., Gething, P., Brady, O. et al. The global distribution and burden of dengue. Nature 496, 504–507 (2013). \u003chttps://doi.org/10.1038/nature12060\u003e.\n\n2.  World Health Organization. [Dengue and Severe Dengue](https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue#:~:text=The%20threat%20of%20a%20possible,in%203%20other%20European%20countries.). Published March 17, 2023.\n\n3.  Halstead S, Wilder-Smith A. [Severe dengue in travelers: pathogenesis, risk and clinical management](https://pubmed.ncbi.nlm.nih.gov/31423536/). J Travel Med. 2019;26(7).\n\n4.  Biswal S, et al. Efficacy of a tetravalent dengue vaccine in healthy children and adolescents. N Engl J Med. 2019; 2019;381:2009-2019.\n\n5.  Biswal S, et al. Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomized, placebo controlled, phase 3 trial. Lancet. 2020. 2020;395:1423-1433.\n\n6.  Tricou, V. Efficacy and Safety of Takeda’s Tetravalent Dengue Vaccine Candidate (TAK-003) After 4.5 Years of Follow-Up. Presented at the 8th Northern European Conference of Travel Medicine; June 2022.\n\n7.  Huang CY-H, et al. Genetic and phenotypic characterization of manufacturing seeds for tetravalent dengue vaccine (DENVax). PLoS Negl Trop Dis. 2013;7:e2243.\n\n8.  Takeda. [QDENGA Summary of Product Characteristics](https://assets-dam.takeda.com/raw/upload/v1674600772/legacy-dotcom/siteassets/system/newsroom/2022/qdenga/ema-combined-h-5155-en.pdf). Retrieved October 2023.\n\n9.  ClinicalTrials.Gov. [Efficacy, Safety and Immunogenicity of Takeda’s Tetravalent Dengue Vaccine (TDV) in Healthy Children (TIDES)](https://classic.clinicaltrials.gov/ct2/show/NCT02747927). Retrieved July 2023.\n\n10. World Health Organization (WHO) Technical Report Series No. 979, 2013 Annex 2. Guidelines on the quality, safety and efficacy of dengue tetravalent vaccines (live, attenuated). \u003chttps://cdn.who.int/media/docs/default-source/biologicals/vaccine-standardization/dengue/trs-979-annex-2-dengue.pdf?sfvrsn=bd659777_2\u0026download=true\u003e.\n\n11. Murray, et al. Epidemiology of dengue: past, present and future prospects. Clin Epidemiol. 2013 Aug 20;5:299-309. doi:\n    10.2147/CLEP.S34440.\n\n12. World Health Organization (WHO). T[en threats to global health in 2019](https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019). Retrieved July 2023.\n\n13. CDC. [About Dengue: What You Need to Know](https://www.cdc.gov/dengue/about/index.html). Published April 13, 2023.\n\n14. Guzman MG, et al. Dengue: a continuing global threat. Nature Reviews Microbiology. 2010;8:S7-S16.\n\n15. Reich, et al. Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity. J R Soc Interface 10: 20130414. \u003chttp://dx.doi.org/10.1098/rsif.2013.0414\u003e.\n\n16. World Health Organization. [Vaccines and immunization](https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1). October 2022. Retrieved July 2023.\n\n","taxonomies":[{"displayName":"Press Releases","__metadata":{"modelName":"Taxonomy","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"Wr0KFDIza4E2fCgbz82Z9F","createdAt":"2022-12-08T10:11:40Z","updatedAt":"2023-07-11T11:19:33Z"},"type":"Taxonomy"}],"slug":"/newsroom/newsreleases/2023/Takeda-Dengue-Vaccine-Recommended-by-World-Health-Organization-Advisory-Group-for-Introduction-in-High-Dengue-Burden-and-Transmission-Areas-in-Children-Ages-Six-to-16-Years","description":"QDENGA Recommended by WHO’s Strategic Advisory Group of Experts for Introduction in High Dengue Burden Areas in Children Ages 6 to 16 years","visibleInListings":true,"__metadata":{"modelName":"Article","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"7d226aa9-7378-4456-a673-19bdba45dce4","createdAt":"2023-10-03T19:41:51Z","updatedAt":"2023-10-03T20:21:51Z"},"type":"Article","featuredImg":{"created_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"format":"jpg","url":"http://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","secure_url":"https://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","public_id":"Global/OG Logo","created_at":"2023-05-12T12:02:00Z","_version":1,"bytes":185717,"resource_type":"image","width":1200,"access_mode":"public","type":"cloudinary.asset","version":1683892920,"height":627,"uploaded_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}}},{"visibleInListings":true,"__i18n_lang":"en","title":"Takeda Provides Update on EXKIVITY® (mobocertinib)","publishDate":"2023-10-02T18:00:00.000Z","content":"**OSAKA, Japan and CAMBRIDGE, Massachusetts, October 2, 2023 **– Takeda ([TSE:4502/NYSE:TAK](https://www.takeda.com/investors/overview/)) today announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA towards a voluntary withdrawal of EXKIVITY®\n(mobocertinib) in the U.S. for adult patients with epidermal growth factor receptor (EGFR) Exon20 insertion mutation-positive (insertion+) locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on or after platinum-based chemotherapy. Takeda intends to similarly initiate voluntary withdrawal globally where EXKIVITY is approved and is working with regulators in other countries where it is currently available on next steps.\n\nThis decision was based on the outcome of the Phase 3 EXCLAIM-2 confirmatory trial, which did not meet its primary endpoint and thus did not fulfill the confirmatory data requirements of the [Accelerated Approval ](https://www.takedaoncology.com/news/news-releases/takedas-exkivity-mobocertinib-approved-by-us-fda-as-the-first-oral-therapy-specifically-designed-for-patients-with-egfr-exon20-insertion-nsclc/)granted by the U.S. FDA nor the conditional marketing approvals granted in other countries.\n\nThe EXCLAIM-2 trial was a Phase 3, multicenter, open-label study designed to investigate the safety and efficacy of EXKIVITY as a monotherapy versus platinum-based chemotherapy in first-line EGFR Exon20 insertion+ locally advanced or metastatic NSCLC. No new safety signals were observed in the EXCLAIM-2 trial. Full data from the trial will be presented at an upcoming medical meeting or published in a peer-reviewed journal.\n\n“Our steadfast commitment to pursue solutions for people with high unmet needs led us to develop and launch EXKIVITY as the first oral therapy designed for patients with EGFR Exon20 insertion+ metastatic NSCLC,” said Awny Farajallah, MD, head of Global Medical Affairs Oncology at Takeda. “We have been fortunate to witness the impact EXKIVITY has had on this previously underserved population and are encouraged to see the advancements made since its approval to introduce new therapies for these patients. We hope that findings from the EXCLAIM-2 study will inform future research and development for this disease.”\n\nTakeda is committed to ensuring patients receiving EXKIVITY can maintain access, as appropriate and in consultation with their healthcare provider. We are actively assessing access mechanisms with regulatory authorities. Patients currently being treated with EXKIVITY should consult their healthcare provider. For questions related to ongoing access, please contact us at \u003cglobaloncologymedinfo@takeda.com\u003e.\n\nTakeda will continue to assess the impact of the withdrawal and update our full-year, consolidated forecast for the fiscal year ending March 31, 2024 (Fiscal Year 2023), as appropriate and necessary.\n\n## About EXKIVITY (mobocertinib)\n\nEXKIVITY is a first-in-class, oral tyrosine kinase inhibitor (TKI) specifically designed to selectively target epidermal growth factor receptor (EGFR) Exon20 insertion mutations. EXKIVITY was approved based on the results from the platinum-pretreated population in the Phase 1/2 trial of EXKIVITY in patients with EGFR Exon20 insertion mutation-positive (insertion+) metastatic non-small cell lung cancer (NSCLC). For more information about EXKIVITY in the U.S., healthcare professionals may visit [www.exkivity-update.com](http://www.exkivity-update.com). For the U.S. Prescribing Information, including the Boxed Warning, please visit [www.exkivity-update.com/prescribing-information](http://www.exkivity-update.com/prescribing-information).\n\n## About EGFR Exon20 Insertion+ NSCLC\n\nNon-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for approximately 85% of the estimated 2.2 million new cases of lung cancer diagnosed each year worldwide, according to the World Health Organization.\u003csup\u003e1-2\u003c/sup\u003e Patients with epidermal growth factor receptor (EGFR) Exon20 insertion mutation-positive (insertion+) NSCLC make up approximately 1-2% of patients with NSCLC, and the disease is more common in Asian populations compared to Western populations.\u003csup\u003e3-7\u003c/sup\u003e This mutation carries a worse prognosis than other EGFR mutations, as EGFR tyrosine kinase inhibitors (TKIs) – which do not specifically target EGFR Exon20 insertions – and chemotherapy provide limited benefit for these patients.\n\nTakeda is committed to continuing research and development to meet the needs of the lung cancer community through the discovery and delivery of transformative medicines.\n\n## About Takeda\n\nTakeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare disease, plasma-derived therapies, neuroscience, oncology and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R\u0026D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit [www.takeda.com](http://www.takeda.com).\n\n## Media Contacts:\n\n### Japanese Media\n\nJun Saito\n\n[jun.saito@takeda.com](mailto:jun.saito@takeda.com)\n\n### U.S. and International Media\n\nEmma Nash\n\n[Emma.Nash@takeda.com](mailto:Emma.Nash@takeda.com)\n\n## Important Notice\n\nFor the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws. The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.\n\n## Forward-Looking Statements\n\nThis press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could” “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations, including global health care reforms; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: \u003chttps://www.takeda.com/investors/sec-filings/\u003e or at [www.sec.gov](http://www.sec.gov). Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.\n\n## Medical Information\n\nThis press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development.\n\n## References\n\n1.  Sung H. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. \u003chttps://pubmed.ncbi.nlm.nih.gov/33538338/\u003e. Accessed September 20, 2023\n2.  American Cancer Society. What is Non-Small Cell Lung Cancer? \u003chttps://www.cancer.org/cancer/non-small-cell-lung-cancer/about/what-is-non-small-cell-lung-cancer.html\u003e. Accessed September 20, 2023.\n3.  Riess, Jonathan W. Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC. \u003chttps://www.jto.org/article/S1556-0864(18)30770-6/fulltext\u003e. Accessed September 20, 2023.\n4.  Fang, Wenfeng. BMC Cancer. EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer. \u003chttps://bmccancer.biomedcentral.com/articles/10.1186/s12885-019-5820-0\u003e. Accessed September 20, 2023.\n5.  Kobayashi Y, Mitsudomi T. Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy. Cancer Sci. 2016;107(9):1179-1186. doi:10.1111/cas.12996. Accessed September 20, 2023.\n6.  Yatabe Y, Kerr KM, Utomo A, et al. EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey. J Thorac Oncol. 2015;10(3):438-445. doi:10.1097/JTO.0000000000000422. Accessed September 20, 2023.\n7.  Kris MG, Johnson BE, Berry LD, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014;311(19):1998-2006. doi:10.1001/jama.2014.3741. Accessed September 20, 2023.\n\n","description":"Takeda will be working with the FDA towards a voluntary withdrawal of EXKIVITY (mobocertinib) in the U.S. and globally where it is currently available.","slug":"/newsroom/newsreleases/2023/Takeda-Provides-Update-on-EXKIVITY-mobocertinib","taxonomies":[{"displayName":"Press Releases","__metadata":{"modelName":"Taxonomy","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"Wr0KFDIza4E2fCgbz82Z9F","createdAt":"2022-12-08T10:11:40Z","updatedAt":"2023-07-11T11:19:33Z"},"type":"Taxonomy"}],"__metadata":{"modelName":"Article","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"d2a8c319-4d25-41c7-8a13-8c6d0621b99a","createdAt":"2023-09-29T22:18:27Z","updatedAt":"2023-10-02T20:30:17Z"},"type":"Article","featuredImg":{"created_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"format":"jpg","url":"http://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","secure_url":"https://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","public_id":"Global/OG Logo","created_at":"2023-05-12T12:02:00Z","_version":1,"bytes":185717,"resource_type":"image","width":1200,"access_mode":"public","type":"cloudinary.asset","version":1683892920,"height":627,"uploaded_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}}},{"content":"**OSAKA, Japan and CAMBRIDGE, Massachusetts, October 2, 2023** – Takeda ([TSE:4502/NYSE:TAK)](https://www.takeda.com/investors/overview/) today announced that it has adopted an amended Compensation Recoupment Policy (“clawback policy”), effective October 2, in compliance with Section 303A.14 of the New York Stock Exchange Listed Company Manual and Rule 10d-1 (collectively, “Rule 10d-1”) of the Securities Exchange Act of 1934 (“the Act”). Rule 10d-1 requires, in the event of restatement, Takeda to recover erroneously awarded incentive compensation paid to company’s executive officers (Internal Director and any other member of the Takeda Executive Team).\n\nIn April 2020, Takeda adopted a clawback policy* that provided in the event of a significant restatement of financial statements or significant misconduct, the independent external members of Takeda’s Board of Directors may require Takeda to recoup incentive and other contingent compensation paid to any Internal Director, any other member of the Takeda Executive Team, and any other individual designated by the independent External Directors.\n\nAs Takeda strives to responsibly deliver on its commitments under its robust corporate governance model, the amended clawback policy now also requires that erroneously awarded incentive compensation paid to executive officers during the three prior fiscal years from the date of the determination of a restatement be recovered by Takeda in the event of a restatement, subject to limited exceptions permitted under Rule 10d-1. The independent External Directors also may seek to recoup additional incentive and other contingent compensation of covered executives in the event of restatement at its discretion. Furthermore, the policy for the recoupment of executive compensation in the event of significant misconduct remains unchanged.\n\nFor the amended clawback policy, please visit [Governance Structure](https://www.takeda.com/about/corporate-governance/governance-structure/) page of our company’s website. A direct link to the amended clawback policy is [here](https://assets-dam.takeda.com/image/upload/v1695960760/Global/Corporate%20Governance/governance-structure/takeda-clawback-policy-en.pdf).\n\n*Please refer to “[Takeda Adopts Executive Compensation Recoupment Policy](https://www.takeda.com/newsroom/newsreleases/2020/takeda-adopts-executive-compensation-recoupment-policy/)”, dated April 1, 2020.\n\n## About Takeda\n\nTakeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R\u0026D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit [www.takeda.com](http://www.takeda.com).\n\n### Media Contacts:\n\nJapanese Media\n\nJun Saito\n\n\u003cjun.saito@takeda.com\u003e\n\n+81 (0) 3-3278-2325\n\nU.S. and International Media\n\nMegan Ostrower\n\n\u003cmagan.ostrower@takeda.com\u003e\n\nInvestor Relations\n\nChristopher O’Reilly\n\n\u003cchristopher.oreilly@takeda.com\u003e\n\n+81 (0) 3-3278-2543\n\n## Important Notice\n\nFor the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.\nThe companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.\n\n## Forward-Looking Statements\n\nThis press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could”, “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations, including global health care reforms; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: \u003chttps://www.takeda.com/investors/sec-filings-and-security-reports/\u003e or at [www.sec.gov](http://www.sec.gov). Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.\n","slug":"/newsroom/newsreleases/2023/Amendment-of-Compensation-Recoupment-Policy","title":"Takeda Announces Amendment of Compensation Recoupment Policy","visibleInListings":true,"publishDate":"2023-10-02T06:00:00.000Z","__i18n_lang":"en","taxonomies":[{"displayName":"Press Releases","__metadata":{"modelName":"Taxonomy","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"Wr0KFDIza4E2fCgbz82Z9F","createdAt":"2022-12-08T10:11:40Z","updatedAt":"2023-07-11T11:19:33Z"},"type":"Taxonomy"}],"description":"Takeda Announces Amendment of Compensation Recoupment Policy","__metadata":{"modelName":"Article","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"De5dzzltkKZoWiWEsTkoch","createdAt":"2023-09-27T05:44:38Z","updatedAt":"2023-10-02T06:00:09Z"},"type":"Article","featuredImg":{"created_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"format":"jpg","url":"http://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","secure_url":"https://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","public_id":"Global/OG Logo","created_at":"2023-05-12T12:02:00Z","_version":1,"bytes":185717,"resource_type":"image","width":1200,"access_mode":"public","type":"cloudinary.asset","version":1683892920,"height":627,"uploaded_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}}},{"title":"U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis","description":"Takeda receives FDA approval of subcutaneous ENTYVIO (vedolizumab) for maintenance therapy in adults with moderate to severe ulcerative colitis","visibleInListings":true,"taxonomies":[{"displayName":"Press Releases","__metadata":{"modelName":"Taxonomy","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"Wr0KFDIza4E2fCgbz82Z9F","createdAt":"2022-12-08T10:11:40Z","updatedAt":"2023-07-11T11:19:33Z"},"type":"Taxonomy"}],"slug":"/newsroom/newsreleases/2023/US-FDA-Approves-Subcutaneous-Administration-of-Takeda-ENTYVIO-vedolizumab-for-Maintenance-Therapy-in-Moderately-to-Severely-Active-Ulcerative-Colitis","publishDate":"2023-09-27T19:07:00.000Z","__i18n_lang":"en","content":"*   ***ENTYVIO Is the Only FDA-Approved Ulcerative Colitis Biologic That Offers the Choice of Intravenous or Subcutaneous Maintenance Therapy***\n\n**OSAKA, Japan and CAMBRIDGE, Massachusetts, September 27, 2023** – Takeda [(TSE:4502/NYSE:TAK) ](https://www.takeda.com/investors/overview/)today announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) administration of ENTYVIO® (vedolizumab) for maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) after induction therapy with ENTYVIO intravenous (IV).\u003csup\u003e1 \u003c/sup\u003eENTYVIO SC is expected to be available in the U.S. as a single-dose pre-filled pen (ENTYVIO Pen) by the end of October. Additionally, a Biologics License Application for an investigational SC administration of ENTYVIO for the treatment of adults with moderately to severely active Crohn’s disease is currently under review by the FDA.\n\n“With the FDA approval of subcutaneous ENTYVIO, patients and physicians who want ENTYVIO’s clinical profile along with flexibility of administration now have two choices for maintenance treatment for adults with moderate to severe ulcerative colitis,” said Brandon Monk, senior vice president, head, U.S. Gastroenterology Business Unit, Takeda. “Takeda is committed to meeting the varied medical needs, circumstances and personal preferences of people living with UC as they progress in their lifelong journey with the disease. ENTYVIO is the only FDA-approved biologic for maintenance therapy in ulcerative colitis offering the option of either intravenous or subcutaneous administration.”\n\nThe approval of this new route of administration for ENTYVIO is based on the VISIBLE 1 study (SC UC Trial). VISIBLE 1 was a Phase 3, randomized, double-blind, placebo-controlled trial that assessed the safety and efficacy of an SC formulation of ENTYVIO as maintenance therapy in adult patients with moderately to severely active UC who achieved clinical response* at Week 6 following two doses of open-label vedolizumab intravenous therapy at Weeks 0 and 2.\u003csup\u003e1 \u003c/sup\u003eA total of 162 patients were randomized at Week 6 in a double-blind fashion (2:1) to one of the following regimens: ENTYVIO SC 108 mg or placebo by subcutaneous injection every 2 weeks. Eligible patients included patients who had demonstrated an inadequate response to, loss of response to, or intolerance to at least one 12-week regimen of azathioprine or 6-mercaptopurine, induction with a tumor necrosis factor (TNF) blocker, or corticosteroids. The primary endpoint was clinical remission at Week 52, which was defined as a total Mayo score of ≤2 and no individual subscore \u003e1.\n\n“The VISIBLE 1 trial demonstrated that ENTYVIO SC can provide physicians with an additional administration option for achieving remission in their moderate to severe ulcerative colitis patients. Since its approval in 2014, ENTYVIO has continued to build a robust safety and efficacy profile. I appreciate now having a subcutaneous administration option that provides a clinical profile consistent with ENTYVIO IV while also giving me and my appropriate UC patients a choice of how they receive their maintenance therapy,” said Bruce Sands, M.D., M.S., Chief of the Dr. Henry D. Janowitz Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai. Dr. Sands is a paid consultant of Takeda Pharmaceuticals U.S.A., Inc. He has not been compensated for media work.\n\nA statistically significant proportion of patients receiving ENTYVIO SC 108 mg maintenance therapy administered every 2 weeks achieved clinical remission`**` compared to patients receiving placebo (46% vs. 14%; p\u003c0.001) at Week 52.\u003csup\u003e1 \u003c/sup\u003eIn clinical studies, the ENTYVIO SC safety profile was generally consistent with the known safety profile of ENTYVIO IV, with the addition of injection site reactions (including injection site erythema, rash, swelling, bruising and hematoma) as an adverse reaction for ENTYVIO SC. The most common adverse reactions reported with ENTYVIO IV (incidence ≥3% and ≥1% higher than placebo) were nasopharyngitis, headache, arthralgia, nausea, pyrexia, upper respiratory tract infection, fatigue, cough, bronchitis, influenza, back pain, rash, pruritus, sinusitis, oropharyngeal pain, and pain in extremities.\n\n`*`\u003csub\u003eClinical response is defined as a reduction in complete Mayo score of ≥3 points and ≥30% from baseline with an accompanying decrease in rectal bleeding subscore of ≥1 point or absolute rectal bleeding subscore of ≤1 point.\u003c/sub\u003e\u003csup\u003e1\u003c/sup\u003e\n\n`**`\u003csub\u003eClinical remission is defined as a complete Mayo score of ≤2 points and no individual subscore \u003e1 point at Week 52.\u003c/sub\u003e\u003csup\u003e1\u003c/sup\u003e\n\nTakeda does not expect a material impact on the full year consolidated reported forecast for the year ending March 31, 2024 (Fiscal Year 2023), as a result of this approval.\n\n## About ENTYVIO® (vedolizumab)\n\nVedolizumab is a biologic therapy and is approved for intravenous (IV) and subcutaneous (SC) administration (approvals vary by market).\u003csup\u003e1,2\u003c/sup\u003e Vedolizumab SC has been granted marketing authorization in the United States, European Union and more than 50 countries (vedolizumab SC is not currently approved for Crohn's disease in the U.S.). Vedolizumab IV has been granted marketing authorization in more than 70 countries, including the United States and European Union.  Globally, vedolizumab IV and SC have more than one million patient years of exposure to date.\u003csup\u003e3\u003c/sup\u003e Vedolizumab is a humanized monoclonal antibody designed to specifically antagonize the alpha4beta7 integrin, inhibiting the binding of alpha4beta7 integrin to intestinal mucosal addressin cell adhesion molecule 1 (MAdCAM-1), but not vascular cell adhesion molecule 1 (VCAM-1).\u003csup\u003e4 \u003c/sup\u003eMAdCAM-1 is preferentially expressed on blood vessels and lymph nodes of the gastrointestinal tract.\u003csup\u003e5 \u003c/sup\u003eThe alpha4beta7 integrin is expressed on a subset of circulating white blood cells.\u003csup\u003e4 \u003c/sup\u003eThese cells have been shown to play a role in mediating the inflammatory process in ulcerative colitis and Crohn’s disease.\u003csup\u003e4,6,7\u003c/sup\u003e By inhibiting alpha4beta7 integrin, vedolizumab may limit the ability of certain white blood cells to infiltrate gut tissues.\u003csup\u003e4\u003c/sup\u003e\n\n## INDICATIONS\n\nFor adult patients with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD) when other therapies have not worked well enough or cannot be tolerated.\n\n## IMPORTANT SAFETY INFORMATION\n\n### CONTRAINDICATIONS\n\nENTYVIO is contraindicated in patients who have had a known serious or severe hypersensitivity reaction to ENTYVIO or any of its excipients.\n\n### WARNINGS AND PRECAUTIONS\n\n*   **Infusion-Related and Hypersensitivity Reactions**: Infusion-related reactions and hypersensitivity reactions including anaphylaxis, dyspnea, bronchospasm, urticaria, flushing, rash, and increased blood pressure and heart rate have been reported. These reactions may occur with the first or subsequent infusions and may vary in their time of onset from during infusion or up to several hours post-infusion. If anaphylaxis or other serious infusion-related or hypersensitivity reactions occur, discontinue administration of ENTYVIO immediately and initiate appropriate treatment.\n\n*   **Infections**: Patients treated with ENTYVIO are at increased risk for developing infections. Serious infections have been reported in patients treated with ENTYVIO, including anal abscess, sepsis (some fatal), tuberculosis, salmonella sepsis, Listeria meningitis, giardiasis, and cytomegaloviral colitis. ENTYVIO is not recommended in patients with active, severe infections until the infections are controlled. Consider withholding ENTYVIO in patients who develop a severe infection while on treatment with ENTYVIO. Exercise caution in patients with a history of recurring severe infections. Consider screening for tuberculosis (TB) according to the local practice.\n\n*   **Progressive Multifocal Leukoencephalopathy (PML)**: PML, a rare and often fatal opportunistic infection of the central nervous system (CNS), has been reported with systemic immunosuppressants, including another integrin receptor antagonist. PML  typically only occurs in patients who are immunocompromised. One case of PML in an ENTYVIO-treated patient with multiple contributory factors has been reported. Although unlikely, a risk of PML cannot be ruled out. Monitor patients for any new or worsening neurological signs or symptoms that may include progressive weakness on one side of the body or clumsiness of limbs, disturbance of vision, and changes in thinking, memory, and orientation leading to confusion and personality changes. If PML is suspected, withhold dosing with ENTYVIO and refer to neurologist; if confirmed, discontinue ENTYVIO dosing permanently.\n\n*   **Liver Injury**: There have been reports of elevations of transaminase and/or bilirubin in patients receiving ENTYVIO. ENTYVIO should be discontinued in patients with jaundice or other evidence of significant liver injury.\n\n*   **Live and Oral Vaccines**: Prior to initiating treatment with ENTYVIO, all patients should be brought up to date with all immunizations according to current immunization guidelines. Patients receiving ENTYVIO may receive non-live vaccines and may receive live vaccines if the benefits outweigh the risks.\n\n## ADVERSE REACTIONS\n\nThe most common adverse reactions (incidence ≥3% and ≥1% higher than placebo) were: nasopharyngitis, headache, arthralgia, nausea, pyrexia, upper respiratory tract infection, fatigue, cough, bronchitis, influenza, back pain, rash, pruritus, sinusitis, oropharyngeal pain, pain in extremities, and injection site reactions with subcutaneous administration.\n\n## DRUG INTERACTIONS\n\nBecause of the potential for increased risk of PML and other infections, avoid the concomitant use of ENTYVIO with natalizumab products and with TNF blockers.\n\n## INDICATIONS\n\n### Adult Ulcerative Colitis (UC):\n\nENTYVIO is indicated in adults for the treatment of moderately to severely active UC.\n\n### Adult Crohn’s Disease (CD):\n\nENTYVIO is indicated in adults for the treatment of moderately to severely active CD.\n\n### DOSAGE FORMS \u0026 STRENGTHS:\n\n*   ENTYVIO Intravenous (IV) Infusion: 300 mg vedolizumab\n\n*   ENTYVIO Subcutaneous (SC) Injection: 108 mg vedolizumab\n\n*Please click for* [*Full U.S. Prescribing Information*](https://content.takeda.com/?contenttype=PI\u0026product=ENTY\u0026language=ENG\u0026country=USA\u0026documentnumber=1)*.*\n\n## About Ulcerative Colitis and Crohn’s Disease\n\nUlcerative colitis (UC) and Crohn’s disease (CD) are two of the most common forms of inflammatory bowel disease (IBD).\u003csup\u003e8 \u003c/sup\u003eBoth UC and CD are chronic, relapsing, remitting, inflammatory conditions of the gastrointestinal tract.\u003csup\u003e9,10 \u003c/sup\u003eUC only involves the large intestine as opposed to CD, which can affect any part of the GI tract from mouth to anus.\u003csup\u003e11,12 \u003c/sup\u003eCD can also affect the entire thickness of the bowel wall, while UC only involves the innermost lining of the large intestine.\u003csup\u003e11,12 \u003c/sup\u003eUC can present with symptoms of abdominal discomfort or loose bowel movements, including blood.\u003csup\u003e11,13 \u003c/sup\u003eCD can present with symptoms of abdominal pain, diarrhea, and weight loss.\u003csup\u003e12 \u003c/sup\u003eThe cause of UC or CD is not fully understood; however, research suggests that an interplay between environmental factors, genetics, and intestinal microbiota may contribute to the development of UC or CD.\u003csup\u003e11,14,9\u003c/sup\u003e\n\n## Takeda’s Commitment to Gastroenterology\n\nWith this latest milestone, Takeda continues to demonstrate a commitment to meeting the very real needs of those living with gastrointestinal (GI) diseases. We believe that GI and liver diseases are life-disrupting conditions. Beyond a fundamental need for effective treatment options, we understand that improving patients’ lives also depends on their needs being recognized. With nearly 30 years of experience in gastroenterology, Takeda has made significant strides in addressing patient needs with treatments for inflammatory bowel disease (IBD), acid-related diseases, short bowel syndrome (SBS) and motility disorders. We are making significant strides toward closing the gap on new areas of unmet need. Together with researchers, patient groups and more, we are working to advance scientific research and clinical medicine in GI.\n\n## About Takeda\n\nTakeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R\u0026D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit [www.takeda.com](http://www.takeda.com).\n\n## Media Contacts:\n\n### Japanese Media\n\nJun Saito\n\n\u003cjun.saito@takeda.com\u003e\n\n+81 3-3278-2325\n\n### U.S. and International Media\n\nAmy McCarthy\n\n\u003camy.mccarthy@takeda.com\u003e\n\n+1 781-496-7761\n\n## Important Notice\n\nFor the purposes of this notice, “press release” means this document, any oral presentation, any question-and-answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.\nThe companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.\n\n## Forward-Looking Statements\n\nThis press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could”, “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations, including global health care reforms; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: \u003chttps://www.takeda.com/investors/sec-filings/\u003e or at [www.sec.gov](http://www.sec.gov). Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.\n\n## Medical Information\n\nThis press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development.\n\n## References\n\n1.  ENTYVIO (vedolizumab) Prescribing Information. Takeda Pharmaceuticals U.S.A., Inc.\n\n2.  ENTYVIO Summary of Product Characteristics (SmPC). Available at: \u003chttps://www.ema.europa.eu/en/documents/product-information/entyvio-epar-product-information_en.pdf\u003e. Last updated: April 2023. Last accessed: August 2023.\n\n3.  Data on file. Takeda Pharmaceuticals.\n\n4.  Soler D, Chapman T, Yang LL, et al. J Pharmacol Exp Ther. 2009;330(3):864-875.\n\n5.  Briskin M, Winsor-Hines D, Shyjan A, et al. Am J Pathol. 1997;151:97 110.\n\n6.  Eksteen B, Liaskou E, Adams DH. Inflamm Bowel Dis. 2008;14:1298 1312.\n\n7.  Wyant T, Fedyk E, Abhyankar B. J Crohns Colitis. 2016;10(12):1437-1444. doi:10.1093/ecco-jcc/jjw092.\n\n8.  Baumgart DC, Carding SR. Lancet. 2007;369:1627-1640.\n\n9.  Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Lancet. 2017; 389(10080):1741-1755.\n\n10. Krugliak N, Torres J, Rubin DT. Gastroenterology. 2022;162:1396-1408.\n\n11. Ordas I, Eckmann L, Talamini M, et al. Lancet. 2012;380:1606-1619.\n\n12. Feuerstein JD, Cheifetz AS. Mayo Clin Proc. 2017;92:1088-1103.\n\n13. Sands BE. Gastroenterology. 2004;126:1518-1532.\n\n14. Kobayashi T, Siegmund B, Le Berre C, et al. Nat Rev Dis Primers. 2020;6(74).\n","__metadata":{"modelName":"Article","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"b86b56f8-ed76-4b8e-b88b-7c09c1d9410f","createdAt":"2023-09-27T19:07:08Z","updatedAt":"2023-09-27T20:28:03Z"},"type":"Article","featuredImg":{"created_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"format":"jpg","url":"http://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","secure_url":"https://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","public_id":"Global/OG Logo","created_at":"2023-05-12T12:02:00Z","_version":1,"bytes":185717,"resource_type":"image","width":1200,"access_mode":"public","type":"cloudinary.asset","version":1683892920,"height":627,"uploaded_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}}}]},{"backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"hideTitle":false,"title":"## Better Health, Brighter Future\n\n","componentLayout":"takeda-com-redesign-A","columns":3,"elementId":"","displayName":"","excludeFromNavigation":false,"cards":[{"description":"Work with globally diverse colleagues who are committed to bringing Better Health to people and a Brighter Future to the world.\n","callToActionUrl":"/careers","title":"### Join Us\n\n","image":{"altText":"two women in a laboratory","url":{"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"created_at":"2022-09-09T12:31:57Z","access_mode":"public","type":"cloudinary.asset","resource_type":"image","url":"http://res.cloudinary.com/takeda/image/upload/v1662726717/legacy-dotcom/siteassets/system/careers/careers-banner.jpg","public_id":"legacy-dotcom/siteassets/system/careers/careers-banner","format":"jpg","width":885,"height":395,"secure_url":"https://res.cloudinary.com/takeda/image/upload/v1662726717/legacy-dotcom/siteassets/system/careers/careers-banner.jpg","version":1662726717,"uploaded_by":{"id":"553579438111562","type":"accesskey"},"bytes":151805,"created_by":{"id":"553579438111562","type":"accesskey"},"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAECAMAAACA5l7/AAAARVBMVEXY2NnV1NShp6RsZWKxqqTKxsq0srHFwsHi4eLNzM3t7e2omI+Sm5zg2NiValbOyMJdTUZ8QyLItqyufWi9rqVCnZm4moP9O2iWAAAAL0lEQVQI1wXBhwEAIAgDsCoo4N7/n2oClnHg3swFRJtNVuMI0X49klaPoMEEDhY/IJkBTu1/RuYAAAAASUVORK5CYII="},"callToAction":"**FIND OUT MORE**\n","imageUrl":"/careers","titleUrl":"/careers","__metadata":{"modelName":"ContentCard","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ContentCard"},{"title":"### Investors\n\n","imageUrl":"/investors/overview","titleUrl":"/investors/overview","callToAction":"**FIND OUT MORE**\n","image":{"url":{"version":1684190660,"type":"cloudinary.asset","bytes":10371808,"format":"jpg","created_at":"2023-05-15T22:44:20Z","secure_url":"https://assets-dam.takeda.com/image/upload/v1684190660/Global/Investor/Investors.jpg","width":6000,"resource_type":"image","height":4000,"access_mode":"public","url":"http://assets-dam.takeda.com/image/upload/v1684190660/Global/Investor/Investors.jpg","metadata":{"epzciwdjuelllku8ngpo":["0001"]},"uploaded_by":{"id":"ec6a5b13a6920997f0770195fabdbb","type":"user"},"public_id":"Global/Investor/Investors","created_by":{"id":"ec6a5b13a6920997f0770195fabdbb","type":"user"},"__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"altText":"People shaking hands in office","__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAHCAMAAAAGcixRAAAAdVBMVEW9wsCyopYkQFmNnp+kqK3AyMJiaXDS1tO5t7CKgX/FysWlrq+AjpBRY3FFWGSVnqCKkpVqb3SWh4R+c3KFhomOlpZ1amquuLMXMEfOqpp1jZ03Vm6ZnaGZnZx0eHvQzslBSlaKiounnJTMz9B/YVq5qaS4uLnN2xGSAAAASUlEQVQI1wXBBQKAIAAEsJNGUsDu/P8T3dD2nANSlg+dqurUyPcpGFUFfcqUgcnSuGUtBMfsm2vV4rAAIU7dex2DweACY8wsnv6XMwPm7/VdSgAAAABJRU5ErkJggg=="},"callToActionUrl":"/investors/overview","description":"Discover our balanced, diverse portfolio and strategy for sustainable, patient-centered and resilient growth.\n","__metadata":{"modelName":"ContentCard","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ContentCard"},{"titleUrl":"/science/research-and-development","callToActionUrl":"/science/research-and-development","imageUrl":"/science/research-and-development","callToAction":"**FIND OUT MORE**\n","description":"Fueled by our inherent curiosity, we translate science into highly innovative, life-transforming medicines.\n","title":"### R\\\u0026D\n\n","image":{"altText":"man in labcoat","url":{"access_mode":"public","metadata":{"epzciwdjuelllku8ngpo":["0001"]},"public_id":"Global/Research and Development/R_D_home_cf7hxl","uploaded_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"bytes":193357,"width":2000,"height":862,"secure_url":"https://res.cloudinary.com/takeda/image/upload/v1674480747/Global/Research%20and%20Development/R_D_home_cf7hxl.jpg","format":"jpg","resource_type":"image","created_at":"2023-01-23T13:32:27Z","type":"cloudinary.asset","created_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"version":1674480747,"url":"http://res.cloudinary.com/takeda/image/upload/v1674480747/Global/Research%20and%20Development/R_D_home_cf7hxl.jpg","__metadata":{"modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"__metadata":{"modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAEBAMAAABFFrP+AAAAJ1BMVEXS2uDY3uPP1925v8PAx9Gwra7JycjBwsW6mou/q6SnhHSjgXOvp6A/xFyBAAAAIElEQVQI12NQYBCyCWZgEhTMbmdgEhDIXM6gxCDgagIAKOgDtd/2M8kAAAAASUVORK5CYII="},"__metadata":{"modelName":"ContentCard","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ContentCard"}],"titleColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"modelName":"ContentSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ContentSection"},{"variant":"normal","backgroundColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"elementId":"","hideTitle":false,"titleColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"takeda-com-redesign","displayName":"","excludeFromNavigation":false,"items":[{"media":[{"variant":"dotcom/DigestiveTractCircle","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"}],"showDescription":true,"linkLabel":"### Gastrointestinal and Inflammation","description":"Understanding and addressing life-limiting gastrointestinal and inflammatory diseases","url":"/science/areas-of-focus/gastroenterology","hideIcon":true,"iconColor":{"color":"primary","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"modelName":"QuickLinksItem","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksItem"},{"url":"/science/areas-of-focus/rare-diseases","linkLabel":"### Rare Diseases","iconColor":{"color":"primary","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"showDescription":true,"description":"Working to transform treatments in immunology, hematology, metabolic and lysosomal storage disorders","hideIcon":true,"media":[{"variant":"dotcom/DNA","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"}],"__metadata":{"modelName":"QuickLinksItem","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksItem"},{"hideIcon":true,"description":"Improving the lives of patients with rare and complex chronic diseases through innovation in plasma","iconColor":{"color":"primary","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"url":"/science/areas-of-focus/pdt","linkLabel":"### Plasma-Derived Therapies","showDescription":true,"media":[{"variant":"dotcom/Drop","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"}],"__metadata":{"modelName":"QuickLinksItem","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksItem"},{"hideIcon":true,"showDescription":true,"iconColor":{"color":"primary","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"url":"/science/areas-of-focus/oncology","linkLabel":"### Oncology","description":"Aspiring to cure cancer, with inspiration from patients and innovation from everywhere","media":[{"variant":"dotcom/Molecule","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"}],"__metadata":{"modelName":"QuickLinksItem","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksItem"},{"iconColor":{"color":"primary","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"media":[{"variant":"dotcom/Brain","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"}],"linkLabel":"### Neuroscience","showDescription":true,"hideIcon":true,"url":"/science/areas-of-focus/neuroscience","description":"Driving medical innovation for patients with neurological diseases","__metadata":{"modelName":"QuickLinksItem","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksItem"},{"hideIcon":true,"iconColor":{"color":"primary","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"description":"Addressing unmet global health needs through vaccine development against infectious diseases","media":[{"variant":"dotcom/Syringe","__metadata":{"modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"}],"url":"/science/areas-of-focus/vaccines","linkLabel":"### Vaccines","showDescription":true,"__metadata":{"modelName":"QuickLinksItem","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksItem"}],"title":"## Our Areas of Focus\n","__metadata":{"modelName":"QuickLinksSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksSection"},{"backgroundColor":{"color":"dark-grey","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"takeda-com-redesign-rir","subtitle":"Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planet","title":"## Sign up for investors newsletter\n\n","button":{"elementId":"","altText":"Sign up","size":"large","label":"Sign up","showIcon":false,"url":"/investors/newsletter","iconPosition":"right","style":"primary","__metadata":{"modelName":"Action","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Action"},"elementId":"","displayName":"","heightVariants":"","margin":{"right":"","top":"","left":"","bottom":"20"},"hideTitle":false,"titleColor":{"color":"white","__metadata":{"modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"overlayOpacity":30,"excludeFromNavigation":false,"__metadata":{"modelName":"BannerCTA","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"BannerCTA"}],"keywords":"","disableScrollRestoration":true,"headerPosition":"sticky","isBackToTopBtnEnabled":true,"description":"Home Page","theme":{"cta":{"fontWeightMobile":"700","fontSize":"1rem","fontSizeMobile":"1rem","fontLineHeight":"1.625rem","fontWeight":"700","fontLineHeightMobile":"1.625rem"},"colorDarkGrey":"#333333","subHeading":{"fontWeight":"500","fontLineHeightMobile":"1.5rem","fontWeightMobile":"700","fontSize":"1.125rem","fontSizeMobile":"1rem","fontLineHeight":"1.25rem"},"h3":{"fontWeight":"500","fontLineHeightMobile":"1.75rem","fontWeightMobile":"500","fontSize":"1.5rem","fontSizeMobile":"1.25rem","fontLineHeight":"2rem"},"colorPrimaryContrast":"#ffffff","spacings":{"marginTopMobile":"0rem","marginBottomMobile":"2.5rem","paddingTopMobile":"0rem","marginTopFirstComponent":"3.125rem","marginBottom":"3.125rem","marginTopFirstComponentMobile":"2.5rem","paddingTop":"0rem","paddingBottomMobile":"0rem","marginTop":"0rem","paddingBottom":"0rem"},"colorLightGrey":"#edf2f4","colorPrimary":"#BD120A","colorPrimaryActiveContrast":"#ffffff","colorLightGreyContrast":"#333333","h2":{"fontSizeMobile":"1.5rem","fontLineHeight":"2.6875rem","fontWeight":"300","fontLineHeightMobile":"2rem","fontWeightMobile":"300","fontSize":"2.25rem"},"h4":{"fontWeightMobile":"500","fontSize":"1.25rem","fontSizeMobile":"1.125rem","fontLineHeight":"1.75rem","fontWeight":"500","fontLineHeightMobile":"1.75rem"},"bodyBlock":{"fontWeight":"400","fontLineHeightMobile":"1.625rem","fontWeightMobile":"400","fontSize":"1rem","fontSizeMobile":"1rem","fontLineHeight":"1.625rem"},"colorMediumGrey":"#a1a4ac","textColor":"#333333","buttonPrimary":{"hoverBackgroundColor":"#891515","borderRadiusBottomRight":"","textColor":"#ffffff","backgroundColor":"#BD120A","borderRadiusTopLeft":"","borderRadiusBottomLeft":"1.25rem","borderRadiusTopRight":""},"colorMediumGreyContrast":"#ffffff","buttonSecondary":{"borderRadiusBottomLeft":"","borderRadiusTopRight":"","hoverBackgroundColor":"","borderRadiusBottomRight":"","textColor":"#333333","backgroundColor":"","borderRadiusTopLeft":""},"colorSecondary":"#891515","globalImages":{"borderRadiusTopRight":"","borderRadiusBottomRight":"","borderRadiusTopLeft":"","borderRadiusBottomLeft":"1.875rem"},"quote":{"fontLineHeight":"2.75rem","fontWeight":"400","fontLineHeightMobile":"1.625rem","fontWeightMobile":"400","fontSize":"2rem","fontSizeMobile":"1.25rem"},"__i18n_lang":"en","colorSecondaryContrast":"#ffffff","colorPrimaryActive":"#891515","h1":{"fontSizeMobile":"1.875rem","fontLineHeight":"2.875rem","fontWeight":"300","fontLineHeightMobile":"","fontWeightMobile":"300","fontSize":"2.625rem"},"h5":{"fontSizeMobile":"1rem","fontLineHeight":"1.75rem","fontWeight":"700","fontLineHeightMobile":"1.75rem","fontWeightMobile":"700","fontSize":"1rem"},"colorDarkGreyContrast":"#ffffff","colorHoverGrey":"#DCE6E9","__metadata":{"modelName":"ThemeStyle","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"siteTheme","createdAt":"2022-11-11T08:38:47Z","updatedAt":"2023-05-18T19:29:32Z"},"type":"ThemeStyle"},"noIndexNoFollow":false,"metaDescription":"Takeda is a patient-focused, R\u0026D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.","__metadata":{"modelName":"ContentLayout","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"a6124d37-8099-4bbc-9897-50e7a249e4c5","createdAt":"2022-11-11T08:41:14Z","updatedAt":"2023-10-04T06:00:06Z"},"type":"ContentLayout"},"site":{"noIndexNoFollow":false,"lang":"en","header":{"_createdAt":"2023-02-06T13:44:06Z","enableGlobalNavCollapsing":true,"logo":{"aspectRatio":"","priority":true,"url":{"version":1652260163,"tags":["Takeda Logo","Takeda","logo"],"metadata":[],"access_mode":"public","bytes":3692,"uploaded_by":{"type":"accesskey","id":"553579438111562"},"_type":"cloudinary.asset","height":256,"created_at":"2022-05-11T09:09:23Z","created_by":{"id":"553579438111562","type":"accesskey"},"context":{"custom":{"Language":"English","alt":"Takeda logo","caption":"Takeda logo"}},"duration":null,"width":720,"url":"http://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","public_id":"migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257","access_control":[],"format":"svg","secure_url":"https://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","resource_type":"image","type":"upload"},"elementId":"","altText":"Takeda logo","_type":"ImageBlock"},"searchLocationPlaceholder":"Search for a country","_type":"DefaultHeader","searchPlaceholder":"Search...","headerInternalLabel":"Global Header - EN","type":"DefaultHeader","_updatedAt":"2023-05-18T19:26:29Z","globalNavDefaultState":"collapsed","localNavDefaultState":"collapsed","searchPageUrl":"/search","_id":"h5S8Zv8xPUpA8CF4ZOulY2","title":"Takeda - Global","componentLayout":"takeda-com-redesign","_rev":"5ewRLzywB1Zqp35ZouMWQC"},"footer":{"componentLayout":"takeda-com-redesign","logo":{"aspectRatio":"","priority":true,"url":{"duration":null,"_type":"cloudinary.asset","type":"upload","public_id":"migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257","tags":["Takeda Logo","Takeda","logo"],"access_control":[],"access_mode":"public","created_at":"2022-05-11T09:09:23Z","uploaded_by":{"id":"553579438111562","type":"accesskey"},"secure_url":"https://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","version":1652260163,"created_by":{"id":"553579438111562","type":"accesskey"},"height":256,"metadata":[],"format":"svg","resource_type":"image","bytes":3692,"context":{"custom":{"Language":"English","alt":"Takeda logo","caption":"Takeda logo"}},"width":720,"url":"http://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg"},"elementId":"","altText":"Takeda logo","_type":"ImageBlock"},"copyrightText":"Copyright 1995-2023 Takeda Pharmaceutical Company Limited. All rights reserved.\n","type":"DefaultFooter","_createdAt":"2023-01-17T14:10:06Z","socialLinks":[{"icon":{"variant":"LinkedIn","_type":"Icon"},"style":"link","label":"LinkedIn","_key":"1f14579e-7c12-4849-be12-a7d196bfb058","url":"https://www.linkedin.com/company/takeda-pharmaceuticals/","elementId":"","altText":"LinkedIn icon","_type":"Social"},{"_type":"Social","icon":{"_type":"Icon","variant":"YouTube"},"style":"link","label":"YouTube","_key":"e8bf8d4a-b399-456f-adf0-56a0e9326663","url":"https://www.youtube.com/takeda-pharmaceuticals","elementId":"","altText":"YouTube logo"}],"footerInternalLabel":"Global Footer - EN","__i18n_lang":"en","navigationLinks":[{"iconPosition":"right","label":"Locations","_type":"Link","altText":"Locations","_key":"e65af62b-5cd2-4cb2-9c6c-833457f05f56","showIcon":false,"url":"/worldwide","icon":"arrowRight","links":[],"elementId":""},{"elementId":"","url":"/contact-us","_type":"Link","icon":"arrowRight","_key":"46599b59-9786-42e6-855e-0773ddcb6272","showIcon":false,"altText":"Contact us","iconPosition":"right","label":"Contact us"},{"iconPosition":"right","_type":"Link","showIcon":false,"elementId":"","_key":"fb33e210-d0d5-4ec0-9a1c-a382fa126440","url":"/careers","altText":"Careers","icon":"arrowRight","label":"Careers"},{"_type":"Link","_key":"b1db2e7a-ae4b-480e-b66c-9827bbc21d3b","iconPosition":"right","label":"Financial Highlights","showIcon":false,"url":"/investors/financial-highlights/","elementId":"","altText":"Financial Highlights","icon":"arrowRight"},{"iconPosition":"right","label":"HCPs","showIcon":false,"icon":"arrowRight","url":"/hcps","elementId":"","altText":"HCPs","_type":"Link","_key":"6809bfa4-bb1d-4490-a6c0-6f22d03cb72d"},{"label":"Patients","url":"/patients","elementId":"","_key":"9ef34c8e-eadc-494c-b14b-d19c2f28d0cc","icon":"arrowRight","showIcon":false,"altText":"Patients","_type":"Link","iconPosition":"right"}],"disclaimerText":"This website provides information about Takeda's worldwide business. For specific information about our local markets, please use the [country selector](/worldwide).\n","_updatedAt":"2023-08-24T00:18:50Z","_rev":"k9rLvnt3lIyfAKaj0Sw9bm","_id":"WDc9QDjXlGnV1qjB17rrhg","_type":"DefaultFooter"},"fallbackSocialImage":{"_key":"jdDRKJnyuW8qunA0HPL3m","metadata":{"epzciwdjuelllku8ngpo":["0001"]},"_type":"cloudinary.asset","created_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"type":"upload","tags":[],"resource_type":"image","access_mode":"public","url":"http://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","_version":1,"secure_url":"https://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","version":1683892920,"width":1200,"format":"jpg","access_control":[],"bytes":185717,"created_at":"2023-05-12T12:02:00Z","public_id":"Global/OG Logo","duration":null,"uploaded_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"height":627},"locations":[{"locationCode":"ar","locationName":"Argentina","languages":[{"languageCode":"es","isDefault":false,"displayName":"Spanish","_type":"LanguageWithNavigation","_key":"0c99cbf700cd"}],"_type":"Location","flagImg":{"priority":false,"elementId":"","_type":"ImageBlock","aspectRatio":""},"_key":"948b1b570929"},{"_type":"Location","_key":"f8ea65a9-6c08-4957-a804-e8ce3e95755e","locationCode":"au","locationName":"Australia","languages":[{"displayName":"English","_type":"LanguageWithNavigation","_key":"8fb62d64-2efc-4b96-8944-e0d77ba05f6a","languageCode":"en","isDefault":false}]},{"languages":[{"isDefault":true,"displayName":"German","_type":"LanguageWithNavigation","_key":"991a32326b68","languageCode":"de"}],"_type":"Location","flagImg":{"priority":false,"elementId":"","_type":"ImageBlock","aspectRatio":""},"_key":"5052b2f2019d","locationCode":"at","locationName":"Austria"},{"_key":"2414b53417b0","locationCode":"be","locationName":"Belgium","languages":[{"_key":"f84639b4c2768353407ab42ee083fe45","languageCode":"en","isDefault":false,"displayName":"English","_type":"LanguageWithNavigation"}],"_type":"Location","flagImg":{"priority":false,"elementId":"","_type":"ImageBlock","aspectRatio":""}},{"flagImg":{"_type":"ImageBlock","aspectRatio":"","priority":false,"elementId":""},"_key":"759f24745e31","locationCode":"ba","locationName":"Bosnia Herzegovina","languages":[{"_type":"LanguageWithNavigation","_key":"d17d14235909bd9bf60cf35d6ef95422","languageCode":"bs","isDefault":false,"displayName":"Bosnian"}],"_type":"Location"},{"locationName":"Brazil","languages":[{"isDefault":false,"displayName":"Portuguese","_type":"LanguageWithNavigation","_key":"b1702899e9a2bc28bcec6ec7cef8804e","languageCode":"pt"}],"_type":"Location","flagImg":{"priority":false,"elementId":"","_type":"ImageBlock","aspectRatio":""},"_key":"4a83cf470cac","locationCode":"br"},{"_key":"e8dd0bdf26df","locationCode":"bg","locationName":"Bulgaria","languages":[{"_type":"LanguageWithNavigation","_key":"99d0e81fb856857587cff2d487ad7b3e","languageCode":"bg","isDefault":false,"displayName":"Bulgarian"}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false}},{"_key":"d239fcdd1b08","locationCode":"ca","locationName":"Canada","languages":[{"displayName":"English","_type":"LanguageWithNavigation","_key":"2ea4e00aa7b4e9a16f35b1fcc37d73fa","languageCode":"en","isDefault":true},{"languageCode":"fr","isDefault":false,"displayName":"French","_type":"LanguageWithNavigation","_key":"b26a418ef0ad"}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false}},{"_type":"Location","flagImg":{"elementId":"","altText":"altText of the image","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"d80ea3282c82","locationCode":"cl","locationName":"Chile","languages":[{"isDefault":false,"displayName":"Spanish","_type":"LanguageWithNavigation","_key":"26c4b9e18772a15915595aedaab4fc93","languageCode":"es","languageUrl":"/worldwide/chile/"}]},{"locationCode":"cn","locationName":"Mainland China","languages":[{"displayName":"Chinese","_type":"LanguageWithNavigation","_key":"c5309e01-d446-49f4-856c-b145e3b87a8a","languageCode":"zh","languageUrl":"https://takeda.info/takeda-china","isDefault":false}],"_type":"Location","_key":"f3d7aac7-df0b-471a-8ecb-1cb02559a4e2"},{"locationName":"Colombia","languages":[{"isDefault":false,"displayName":"Spanish","_type":"LanguageWithNavigation","_key":"db94b5d878cb","languageCode":"es"}],"_type":"Location","flagImg":{"priority":false,"elementId":"","_type":"ImageBlock","aspectRatio":""},"_key":"6ede577a45a4","locationCode":"co"},{"flagImg":{"aspectRatio":"","priority":false,"elementId":"","_type":"ImageBlock"},"_key":"4bc918143d7c","locationCode":"hr","locationName":"Croatia","languages":[{"_key":"5782ad4a8f53d55447d6105f77e9bb36","languageCode":"hr","isDefault":false,"displayName":"Croatian","_type":"LanguageWithNavigation"}],"_type":"Location"},{"_type":"Location","flagImg":{"_type":"ImageBlock","aspectRatio":"","priority":false,"elementId":""},"_key":"195a35d3eae4","locationCode":"cz","locationName":"Czech Republic","languages":[{"_key":"674d5f466dbd9327eda8551c62615a02","languageCode":"cs","isDefault":false,"displayName":"Czech","_type":"LanguageWithNavigation"}]},{"flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"cfbc5255b3a2","locationCode":"dk","locationName":"Denmark","languages":[{"displayName":"Danish","_type":"LanguageWithNavigation","_key":"56b09306acc498a419fb78b3b07d34f3","languageCode":"da","isDefault":false}],"_type":"Location"},{"locationName":"Ecuador","languages":[{"isDefault":false,"displayName":"Spanish","_type":"LanguageWithNavigation","_key":"b7b7bdf3b242fa5fb28a6a42e0a805d6","languageCode":"es"}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"c2499fe60b4e","locationCode":"ec"},{"locationName":"Estonia","languages":[{"languageCode":"et","isDefault":false,"displayName":"Estonian","_type":"LanguageWithNavigation","_key":"7a578ed067171f8b98e5f25aaec6546d"}],"_type":"Location","flagImg":{"aspectRatio":"","priority":false,"elementId":"","_type":"ImageBlock"},"_key":"9b107a62ff80","locationCode":"ee"},{"_key":"fc60d263723e","locationCode":"fi","locationName":"Finland","languages":[{"displayName":"Finnish","_type":"LanguageWithNavigation","_key":"0de5a3e8a936006b6506edd0b2e734ae","languageCode":"fi","isDefault":false}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false}},{"locationName":"France","languages":[{"isDefault":false,"displayName":"French","_type":"LanguageWithNavigation","_key":"9a51b9c941cb093935bc06b25da48457","languageCode":"fr"}],"_type":"Location","flagImg":{"_type":"ImageBlock","aspectRatio":"","priority":false,"elementId":""},"_key":"2ed662381229","locationCode":"fr"},{"_key":"3bd9a83ecc91","locationCode":"de","locationName":"Germany","languages":[{"displayName":"German","_type":"LanguageWithNavigation","_key":"36755bd4b50755060fb44ca01b384544","languageCode":"de","isDefault":false}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false}},{"languages":[{"displayName":"Greek","_type":"LanguageWithNavigation","_key":"f84727f84581d50f73eeff99fab909b0","languageCode":"el","isDefault":false}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"8ec2f153c4dd","locationCode":"gr","locationName":"Greece"},{"locationCode":"hk","locationName":"Hong Kong SAR","languages":[{"isDefault":true,"displayName":"English","_type":"LanguageWithNavigation","_key":"40954b6e76d8","languageCode":"en"},{"_type":"LanguageWithNavigation","_key":"454493affcd40cea7155f0b9fb293a98","languageCode":"zh","isDefault":false,"displayName":"Chinese"}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"50dce634d384"},{"locationCode":"hu","locationName":"Hungary","languages":[{"_type":"LanguageWithNavigation","_key":"35c25211b310510226999ca16fbe5732","languageCode":"hu","isDefault":false,"displayName":"Hungarian"}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"3d8fe415cb2d"},{"locationName":"India","languages":[{"_type":"LanguageWithNavigation","_key":"3d2bd74dbaf61d64a38f23ec6c09954d","languageCode":"en","isDefault":false,"displayName":"English"}],"_type":"Location","flagImg":{"priority":false,"elementId":"","_type":"ImageBlock","aspectRatio":""},"_key":"d53941beaa80","locationCode":"in"},{"locationCode":"id","locationName":"Indonesia","languages":[{"_key":"e9e0f4508432bf5457e17c2085305334","languageCode":"id","isDefault":false,"displayName":"Indonesian","_type":"LanguageWithNavigation"}],"_type":"Location","flagImg":{"priority":false,"elementId":"","_type":"ImageBlock","aspectRatio":""},"_key":"b22ed6ad123c"},{"locationName":"Ireland","languages":[{"_type":"LanguageWithNavigation","_key":"52d738370cf0f52b0fa048d8a4f4d33f","languageCode":"en","isDefault":false,"displayName":"English"}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"3e311e501ef4","locationCode":"ie"},{"locationName":"Israel","languages":[{"_key":"b87a2f6abcb9f74b945c5557c89b765d","languageCode":"he","isDefault":false,"displayName":"Hebrew","_type":"LanguageWithNavigation"}],"_type":"Location","flagImg":{"_type":"ImageBlock","aspectRatio":"","priority":false,"elementId":""},"_key":"09ca8169990d","locationCode":"il"},{"locationName":"Italy","languages":[{"isDefault":false,"displayName":"Italian","_type":"LanguageWithNavigation","_key":"2ae0e155bddc09f8321c778d38f825d5","languageCode":"it"}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"c9a733b4a1b4","locationCode":"it"},{"_key":"5c227b8eb366","locationCode":"jp","locationName":"Japan","languages":[{"displayName":"Japanese","_type":"LanguageWithNavigation","_key":"6f8af788ef5228f92ecabe2f8191bf29","languageCode":"ja","isDefault":false}],"_type":"Location","flagImg":{"priority":false,"elementId":"","_type":"ImageBlock","aspectRatio":""}},{"languages":[{"isDefault":true,"displayName":"Kazakh","_type":"LanguageWithNavigation","_key":"b1aaa674f94b9f9f5b82dab56f194b18","languageCode":"kk"},{"_type":"LanguageWithNavigation","_key":"34fc4c88e09a","languageCode":"ru","isDefault":false,"displayName":"Russian"}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"fcab0b6bf271","locationCode":"kz","locationName":"Kazakhstan"},{"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"882820b3cb78","locationCode":"kr","locationName":"Korea","languages":[{"isDefault":false,"displayName":"Korean","_type":"LanguageWithNavigation","_key":"d30f1f213fbab4f6962cd191e694e53c","languageCode":"ko"}]},{"locationName":"Latvia","languages":[{"isDefault":false,"displayName":"Latvian","_type":"LanguageWithNavigation","_key":"571aac0ebd3d55c39de0ab783eb6fa54","languageCode":"lv"}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"19ab19b52d66","locationCode":"lv"},{"locationCode":"lt","locationName":"Lithuania","languages":[{"displayName":"Lithuanian","_type":"LanguageWithNavigation","_key":"c68510ec271b74880bc96d204c6fa01b","languageCode":"lt","isDefault":false}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"aee9c2c47de6"},{"_type":"Location","_key":"44b6d54a-2753-4148-a51d-96bd15c9bfe4","locationCode":"my","locationName":"Malaysia","languages":[{"languageCode":"en","languageUrl":"/worldwide/asia-pacific-pte-ltd/","isDefault":false,"displayName":"English","_type":"LanguageWithNavigation","_key":"27143d3b-12d6-4515-b07f-371c1520d0ee"}]},{"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"580505e6a0f1","locationCode":"mx","locationName":"Mexico","languages":[{"languageCode":"es","isDefault":false,"displayName":"Spanish","_type":"LanguageWithNavigation","_key":"807d211bc4bbd2b9451d8d5f7731b1af"}]},{"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"739def278fea","locationCode":"nl","locationName":"Netherlands","languages":[{"_type":"LanguageWithNavigation","_key":"b74e118226d2cbea0f5db4c7e5063239","languageCode":"nl","isDefault":false,"displayName":"Dutch"}]},{"flagImg":{"priority":false,"elementId":"","_type":"ImageBlock","aspectRatio":""},"_key":"7fe0fbd18aa5","locationCode":"nz","locationName":"New Zealand","languages":[{"isDefault":false,"displayName":"English","_type":"LanguageWithNavigation","_key":"0d4a84429a32e368e1e5326bdec7f3d9","languageCode":"en","languageUrl":"/en-au/"}],"_type":"Location"},{"languages":[{"isDefault":false,"displayName":"Norweigan","_type":"LanguageWithNavigation","_key":"971d1d8399a93d871a71e0619bbd09a5","languageCode":"no","languageUrl":"/nn-no"}],"_type":"Location","flagImg":{"aspectRatio":"","priority":false,"elementId":"","_type":"ImageBlock"},"_key":"becc12e4c8bf","locationCode":"no","locationName":"Norway"},{"_type":"Location","flagImg":{"priority":false,"elementId":"","_type":"ImageBlock","aspectRatio":""},"_key":"27a61f558e93","locationCode":"pe","locationName":"Peru","languages":[{"displayName":"Spanish","_type":"LanguageWithNavigation","_key":"dbfbfbf65b8af8a537b67b6bedd0370f","languageCode":"es","isDefault":false}]},{"locationName":"Philippines","languages":[{"languageUrl":"/worldwide/asia-pacific-pte-ltd/","isDefault":false,"displayName":"English","_type":"LanguageWithNavigation","_key":"7895ba24-1391-4890-a519-c8ab2d186a04","languageCode":"en"}],"_type":"Location","_key":"a91fe2c4-6f44-4fbb-893b-ad46db5c8e85","locationCode":"ph"},{"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"0b1a9b99e3d0","locationCode":"pl","locationName":"Poland","languages":[{"_type":"LanguageWithNavigation","_key":"212f42416fd9917670d147909f2b4081","languageCode":"pl","isDefault":false,"displayName":"Polish"}]},{"locationCode":"pt","locationName":"Portugal","languages":[{"displayName":"Portuguese","_type":"LanguageWithNavigation","_key":"e49fa3704dd5858f0ac29b46f1588699","languageCode":"pt","isDefault":false}],"_type":"Location","flagImg":{"aspectRatio":"","priority":false,"elementId":"","_type":"ImageBlock"},"_key":"32e45d965e32"},{"_key":"a68b3c484969","locationCode":"ro","locationName":"Romania","languages":[{"displayName":"Romanian","_type":"LanguageWithNavigation","_key":"5217a6a39613bd461f2fdca44a416c72","languageCode":"ro","isDefault":false}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false}},{"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"7fe262ffaafa","locationCode":"ru","locationName":"Russia","languages":[{"_type":"LanguageWithNavigation","_key":"9d002a8ee9316705443dd9f39119b05e","languageCode":"ru","isDefault":false,"displayName":"Russian"}]},{"locationCode":"sa","locationName":"Saudi Arabia","languages":[{"languageUrl":"/worldwide/saudi-arabia/","isDefault":false,"displayName":"Arabic","_type":"LanguageWithNavigation","_key":"0e26f8be-54bb-47f9-8504-c7bcd27e162f","languageCode":"ar"}],"_type":"Location","_key":"78673589-c8fa-401d-b3ef-3c55e63bcbe4"},{"locationName":"Serbia","languages":[{"isDefault":false,"displayName":"Serbian","_type":"LanguageWithNavigation","_key":"cfd6dffdd254daef6af52e78f19ecd34","languageCode":"sr"}],"_type":"Location","flagImg":{"aspectRatio":"","priority":false,"elementId":"","_type":"ImageBlock"},"_key":"0ed3666494de","locationCode":"rs"},{"locationName":"Singapore","languages":[{"isDefault":false,"displayName":"English","_type":"LanguageWithNavigation","_key":"cb4397bb-4ea5-4386-aed8-54c36a3c0321","languageCode":"en","languageUrl":"/worldwide/asia-pacific-pte-ltd/"}],"_type":"Location","_key":"3d950a4f-17c6-4274-9744-9df9d986af9d","locationCode":"sg"},{"_type":"Location","flagImg":{"priority":false,"elementId":"","_type":"ImageBlock","aspectRatio":""},"_key":"87ad980c0f9b","locationCode":"sk","locationName":"Slovakia","languages":[{"displayName":"Slovak","_type":"LanguageWithNavigation","_key":"4b0ae0b44fa5","languageCode":"sk","isDefault":false}]},{"languages":[{"displayName":"Slovenian","_type":"LanguageWithNavigation","_key":"02f19af7d437","languageCode":"sl","isDefault":false}],"_type":"Location","_key":"c5754f0a-2e41-4cf8-aeb0-94496ed2294b","locationCode":"si","locationName":"Slovenia"},{"locationName":"Spain","languages":[{"displayName":"Spanish","_type":"LanguageWithNavigation","_key":"ea32876928965792936b149eed6cc575","languageCode":"es","isDefault":false}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"eb6976cee9e3","locationCode":"es"},{"flagImg":{"priority":false,"elementId":"","_type":"ImageBlock","aspectRatio":""},"_key":"6e587e4fe367","locationCode":"se","locationName":"Sweden","languages":[{"languageCode":"sv","isDefault":false,"displayName":"Swedish","_type":"LanguageWithNavigation","_key":"660e556b3bb9207b498512ad682394fc"}],"_type":"Location"},{"_key":"43e55f0ec03a","locationCode":"ch","locationName":"Switzerland","languages":[{"isDefault":true,"displayName":"German","_type":"LanguageWithNavigation","_key":"98849442a7dd81888ab4cbdea85921ed","languageCode":"de"},{"languageCode":"fr","isDefault":false,"displayName":"French","_type":"LanguageWithNavigation","_key":"5731873303ed"}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false}},{"_type":"Location","flagImg":{"_type":"ImageBlock","aspectRatio":"","priority":false,"elementId":""},"_key":"ea71f4301625","locationCode":"tw","locationName":"Taiwan","languages":[{"isDefault":false,"displayName":"Chinese","_type":"LanguageWithNavigation","_key":"9298cddb36e9ec40cc9d7b2e9dd90597","languageCode":"zh"}]},{"locationCode":"th","locationName":"Thailand","languages":[{"_key":"62e07053049af28cbecfec5cb4821c2b","languageCode":"th","isDefault":false,"displayName":"Thai","_type":"LanguageWithNavigation"}],"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"98a4732e1754"},{"_type":"Location","flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"6f8f610c6a6c","locationCode":"tr","locationName":"Turkey","languages":[{"isDefault":false,"displayName":"Turkish","_type":"LanguageWithNavigation","_key":"523fc5e9cb25c71f896bf9a549b40fe6","languageCode":"tr"}]},{"flagImg":{"elementId":"","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"91462a371166","locationCode":"ua","locationName":"Ukraine","languages":[{"isDefault":false,"displayName":"Ukrainian","_type":"LanguageWithNavigation","_key":"a5e316cbf4b294a050c987aaa7e86684","languageCode":"uk"}],"_type":"Location"},{"_key":"16b567975428","locationCode":"gb","locationName":"United Kingdom","languages":[{"languageCode":"en","isDefault":false,"displayName":"English","_type":"LanguageWithNavigation","_key":"0a1ad6f1ee49050ea291dad6f8d356fa"}],"_type":"Location","flagImg":{"_type":"ImageBlock","aspectRatio":"","priority":false,"elementId":""}},{"languages":[{"isDefault":false,"displayName":"English","_type":"LanguageWithNavigation","_key":"0d009d2afbbcb36e4ac071882ed60b3b","languageCode":"en","languageUrl":""}],"_type":"Location","flagImg":{"elementId":"","altText":"altText of the image","_type":"ImageBlock","aspectRatio":"","priority":false},"_key":"5009df8d65c3","locationCode":"us","locationName":"United States"},{"locationCode":"vn","locationName":"Vietnam","languages":[{"_type":"LanguageWithNavigation","_key":"ae2031182d746c2e88215a0dea862024","languageCode":"en","languageUrl":"/en-vi","isDefault":false,"displayName":"English"}],"_type":"Location","flagImg":{"_type":"ImageBlock","aspectRatio":"","priority":false,"elementId":""},"_key":"ceb335a75a7a"}],"exitDisclaimer":{"title":"You are leaving Takeda.com","cancelButtonTitle":"Cancel","okButtonTitle":"Continue","whitelistedUrls":["assets-dam.takeda.com","takeda.com","players.brightcove.net/2299575749001","takedajobs.com","jobs.takeda.com","takedaoncology.com","www.takeda.com","www.takedaoncology.com","clinicaltrials.takeda.com","www.takedajobs.com","www.jp.takedajobs.com"],"isEnabled":true,"_type":"ExitDisclaimer","description":"Links to sites outside of takeda.com are provided as a resource to the audiences. Please note that Takeda is not responsible or liable for any third-party website and the website may not be appropriate for all audiences. \n\nTo stay on the current website, select “Cancel”\n"},"type":"Config","globalLanguages":[{"_key":"0ccf9ae0719a","languageCode":"en","languageUrl":"en","isDefault":true,"additionalLinks":[{"elementId":"","url":"/terms-and-conditions","altText":"Terms and Conditions","_type":"Link","label":"Terms and Conditions","_key":"4006b6f4-1255-44f6-be1e-0cb8024a2a3d","icon":"arrowRight","iconPosition":"right","showIcon":false},{"_key":"7383d8fe-456a-4fcd-9333-c3ae2dc817ab","showIcon":false,"icon":"arrowRight","_type":"Link","iconPosition":"right","label":"Privacy Notice","altText":"Privacy Notice","url":"/privacy-notice","elementId":""},{"url":"/cookie-policy/","elementId":"","iconPosition":"right","label":"Cookie Policy","_key":"26488e27-becd-41fe-a610-29b37bdcc88f","icon":"arrowRight","showIcon":false,"_type":"Link","altText":"Cookie Policy"},{"elementId":"","iconPosition":"right","_key":"b517a103-c0d3-440f-97c8-beb8e332c240","url":"/global-accessibility-statement","_type":"Link","label":"Accessibility Statement","icon":"arrowRight","altText":"Accessibility Statement","showIcon":false}],"displayName":"English","_type":"GlobalLanguage","links":[{"_type":"Link","label":"About","showIcon":false,"url":"","iconPosition":"right","icon":"arrowRight","links":[{"icon":"arrowRight","label":"Our Company","url":"/about/our-company/","elementId":"","altText":"Our Company","links":[],"showIcon":false,"_type":"Link","_key":"aa4a7088-05f4-408e-8f1d-51675afce470","iconPosition":"right"},{"url":"/about/leadership","altText":"Leadership","_type":"Link","_key":"f0220992-3cbc-4042-9351-9d2a351372c5","elementId":"","iconPosition":"right","icon":"arrowRight","links":[],"label":"Leadership","showIcon":false},{"showIcon":false,"_type":"Link","links":[{"altText":"Corporate Sustainability","iconPosition":"right","label":"Corporate Sustainability","showIcon":false,"_type":"Link","elementId":"","url":"","icon":"arrowRight","links":[{"showIcon":false,"url":"/about/corporate-responsibility/corporate-sustainability/sustainability-approach","elementId":"","altText":"Sustainability Approach","_type":"Link","label":"Sustainability Approach","iconPosition":"right","icon":"arrowRight","links":[],"_key":"45cdd84b-b636-456e-9843-effa55122913"},{"_type":"Link","iconPosition":"right","_key":"a205f933-9801-48fe-a9ec-4f314c9149b7","showIcon":false,"url":"/about/corporate-responsibility/corporate-sustainability/access-to-medicine","altText":"Access to Medicines","icon":"arrowRight","elementId":"","label":"Access to Medicines"},{"url":"/about/corporate-responsibility/corporate-sustainability/sustainability-approach/sustainability-disclosures/","elementId":"","altText":"Sustainability Disclosures","iconPosition":"right","icon":"arrowRight","_key":"bf08ae00c264","showIcon":false,"_type":"Link","label":"Sustainability Disclosures"}],"_key":"d290bb68-a155-4b1a-8811-c7816a189e65"},{"elementId":"","icon":"arrowRight","showIcon":false,"altText":"Ethics","url":"","_type":"Link","label":"Ethics \u0026 Disclosures","iconPosition":"right","links":[{"label":"Ethics","showIcon":false,"url":"/about/corporate-responsibility/ethics-disclosures/ethics","icon":"arrowRight","_type":"Link","iconPosition":"right","_key":"328b2aaa-ecf3-4542-8c56-eec4f3e32b60","elementId":"","altText":"Ethics"},{"icon":"arrowRight","label":"Transparency Disclosures","altText":"Transparency Disclosures","_key":"9f3e0a04-e90d-4302-adbc-8969a4eff1ad","_type":"Link","elementId":"","iconPosition":"right","showIcon":false,"url":"/about/corporate-responsibility/ethics-disclosures/transparency-disclosures/"}],"_key":"3ddecbfe-aeff-446d-8475-9245e263f09a"},{"label":"Positions","showIcon":false,"elementId":"","_key":"57cbef5e-2866-4725-93d5-75ca4dd18efb","_type":"Link","url":"/about/corporate-responsibility/positions/","altText":"Positions","icon":"arrowRight","iconPosition":"right"},{"altText":"Corporate Giving","iconPosition":"right","elementId":"","_type":"Link","label":"Corporate Giving","_key":"83c3a813-724b-47b0-ad14-c46d6eb6e340","showIcon":false,"icon":"arrowRight","url":"/about/corporate-responsibility/corporate-giving"}],"altText":"Corporate Responsibility","_key":"17d2ad41-f5df-426b-b48b-74a4cefff292","url":"","icon":"arrowRight","iconPosition":"right","label":"Corporate Responsibility","elementId":""},{"elementId":"","_type":"Link","_key":"fb54ce14-b3f6-4854-bff0-d07f154baf50","showIcon":false,"icon":"arrowRight","iconPosition":"right","links":[{"altText":"Governance Strategy","elementId":"","icon":"arrowRight","links":[],"_key":"72af665b-569a-4670-9679-40081634978b","iconPosition":"right","label":"Governance Strategy","url":"/about/corporate-governance/strategy/","_type":"Link","showIcon":false},{"_type":"Link","icon":"arrowRight","label":"Governance Structure","elementId":"","_key":"7bb80e0c-c5ef-47aa-b05f-ac93b19e59c8","url":"/about/corporate-governance/governance-structure","altText":"Governance Structure","showIcon":false,"iconPosition":"right","links":[]},{"label":"Charters and Reports","elementId":"","altText":"Charters and Reports","_key":"2a711927-050b-464a-8a85-2a38477ca165","url":"/about/corporate-governance/charters-and-reports","iconPosition":"right","links":[],"showIcon":false,"_type":"Link","icon":"arrowRight"}],"label":"Corporate Governance","url":"/corporate-governance","altText":"Corporate Governance"}],"_key":"095c4670-ee60-4202-b896-a2b91d5bc4e4","altText":"about","elementId":""},{"altText":"science","links":[{"label":"Areas of Focus","links":[],"altText":"Areas of Focus","iconPosition":"right","url":"/science/areas-of-focus/","elementId":"","_key":"8ab70fde-08f0-403d-9796-19d66e0302d5","_type":"Link","icon":"arrowRight","showIcon":false},{"altText":"Research and Development","links":[],"_key":"49d309a9-6eaa-4d3a-8f52-eabca51ac616","url":"/science/research-and-development","elementId":"","_type":"Link","icon":"arrowRight","showIcon":false,"iconPosition":"right","label":"Research and Development"},{"links":[],"label":"Pipeline","_key":"50d03863-1230-4e99-9b27-5a8291a1d44a","showIcon":false,"url":"/science/pipeline","elementId":"","altText":"Pipeline","icon":"arrowRight","_type":"Link","iconPosition":"right"},{"label":"Products","altText":"Products","icon":"arrowRight","_key":"55983ed9-a027-4ff0-849b-39b7a4546f7e","showIcon":false,"elementId":"","links":[{"elementId":"","altText":"Our Products","iconPosition":"right","label":"Our Products","showIcon":false,"_type":"Link","_key":"1ca9b57c-41ce-41a4-b28d-e25029a1df32","icon":"arrowRight","url":"/science/products"},{"icon":"arrowRight","url":"/science/products/manufacturing","elementId":"","showIcon":false,"iconPosition":"right","label":"Manufacturing","altText":"Manufacturing","_type":"Link","_key":"bdceea3e-44ae-452f-bb5a-455c4bc5cbb1"},{"_key":"205e2d6c-ac95-4070-a8e6-5595f440ce63","label":"Suppliers","url":"/science/products/suppliers","icon":"arrowRight","iconPosition":"right","showIcon":false,"elementId":"","altText":"Suppliers","_type":"Link"}],"_type":"Link","iconPosition":"right"},{"url":"/science/clinical-trials","elementId":"","_type":"Link","_key":"c11272fc-6017-47fd-89ae-3dec05cc66d6","showIcon":false,"iconPosition":"right","links":[],"label":"Clinical Trials","altText":"Clinical Trials","icon":"arrowRight"}],"_type":"Link","_key":"435c8304-6ec5-4763-bd5d-59e13f4829d9","label":"Science","iconPosition":"right","showIcon":false,"url":"","elementId":"","icon":"arrowRight"},{"icon":"arrowRight","iconPosition":"right","label":"Our Impact","altText":"Our Impact","_type":"Link","links":[{"showIcon":false,"elementId":"","altText":"Our Stories","label":"Our Stories","_key":"cbd8ffca-bc84-490c-b31c-8e8df96e434d","url":"/our-impact/our-stories","iconPosition":"right","_type":"Link","links":[],"icon":"arrowRight"}],"_key":"ff3dbd5e-2b1e-49b5-b3d0-2de4cfe278d6","elementId":"","showIcon":false,"url":""},{"_type":"Link","icon":"arrowRight","label":"Newsroom","links":[{"iconPosition":"right","label":"Press Releases","_key":"bb732da3-054b-4673-88ed-74539b14853f","showIcon":false,"url":"/newsroom/press-releases","altText":"Press Releases","links":[],"elementId":"","_type":"Link","icon":"arrowRight"},{"url":"/newsroom/statements","_type":"Link","iconPosition":"right","links":[],"label":"Statements","elementId":"","altText":"Statements","icon":"arrowRight","_key":"c152ae03-5e13-41a0-b30b-64d8c8a2fbfa","showIcon":false},{"elementId":"","label":"Media Resources","_key":"1786f7a6-a242-4462-a1b9-3e9733edf891","links":[],"showIcon":false,"icon":"arrowRight","iconPosition":"right","url":"/newsroom/media-resources","altText":"Media Resources","_type":"Link"}],"_key":"fe8f3911-b301-4985-9f61-843018373faf","showIcon":false,"elementId":"","altText":"Newsroom","url":"","iconPosition":"right"},{"_key":"19cbc22a-1abe-414b-b986-979008fdf9ac","showIcon":false,"iconPosition":"right","links":[{"showIcon":false,"label":"Overview ","url":"/investors/overview","icon":"arrowRight","iconPosition":"right","_key":"4c3a2f13-601e-4bd4-aefe-536205605ec9","altText":"Overview","elementId":"","_type":"Link"},{"icon":"arrowRight","iconPosition":"right","url":"/investors/financial-results/quarterly-results","elementId":"","links":[],"showIcon":false,"altText":"Financial Results","label":"Financial Results","_type":"Link","_key":"79017a31-869a-40ab-bdc2-7c9bb5431abd"},{"icon":"arrowRight","url":"/investors/events","elementId":"","_type":"Link","links":[],"label":"Investor Events","_key":"c8965460-f53f-4605-ad9f-b3301cd419d5","showIcon":false,"altText":"Investor Events","iconPosition":"right"},{"altText":"Investor Contact","_type":"Link","label":"Investor Contact","iconPosition":"right","url":"/investors/contact","_key":"e2bc33e9-99cc-4af3-bd08-f99d9158c7d9","showIcon":false,"links":[],"elementId":"","icon":"arrowRight"}],"url":"","altText":"Investors","icon":"arrowRight","_type":"Link","label":"Investors","elementId":""},{"iconPosition":"right","_key":"44c09c12-0667-4c5f-8c4d-4a6e1b3f5043","_type":"Link","label":"Careers","url":"/careers","altText":"careers","showIcon":false,"elementId":"","icon":"arrowRight","links":[]}]},{"displayName":"Japanese","_type":"GlobalLanguage","links":[{"label":"企業情報","showIcon":false,"icon":"arrowRight","url":"","_type":"Link","iconPosition":"right","_key":"02656de7-c49b-4283-9ae4-72bfa356e09c","elementId":"","altText":"企業情報"},{"icon":"arrowRight","iconPosition":"right","label":"サイエンス","_key":"a6d6c397-c6f6-4586-9913-b3063de22c5b","altText":"サイエンス","_type":"Link","url":"","elementId":"","showIcon":false},{"icon":"arrowRight","iconPosition":"right","_key":"d7133969-6899-47e1-8cdf-105128f40936","showIcon":false,"url":"","label":"私たちのストーリー","elementId":"","altText":"私たちのストーリー","_type":"Link"},{"showIcon":false,"label":"ニュース","elementId":"","altText":"ニュース","iconPosition":"right","_type":"Link","icon":"arrowRight","_key":"b5aa79b7-beb6-40de-ac46-4ee147e03c44","url":""},{"url":"","icon":"arrowRight","elementId":"","label":"IR情報","_key":"f37f33ba-24d3-408c-b1f2-3c3c163c3d81","showIcon":false,"altText":"IR情報","_type":"Link","iconPosition":"right"},{"label":"採用情報","icon":"arrowRight","url":"/","_type":"Link","iconPosition":"right","altText":"採用情報","showIcon":false,"elementId":"","_key":"b5f85248-d909-4e37-a225-4cec02249d01"}],"_key":"0e90a000-69a8-403d-b6fd-1e0bd9bc42b5","languageCode":"ja","languageUrl":"jp","isDefault":false,"additionalLinks":[]}],"scripts":[{"_type":"Script","_key":"96fac00f-4962-4d0d-8c5f-5839536ed0ac","loadingStrategy":"beforeInteractive","title":"EPD-3055 OneTrust Cookie","script":{"_type":"code","code":"\u003c!-- OneTrust Cookies Consent Notice start for takeda.com --\u003e\n\u003c!-- 20230526 --\u003e\n\n\u003cscript\n  type=\"text/javascript\"\n  src=\"https://cdn.cookielaw.org/consent/3625bb82-8e0e-4be8-80d3-257e4f469168/OtAutoBlock.js\"\n\u003e\u003c/script\u003e\n\n\u003cscript\n  src=\"https://cdn.cookielaw.org/scripttemplates/otSDKStub.js\"\n  data-document-language=\"true\"\n  type=\"text/javascript\"\n  charset=\"UTF-8\"\n  data-domain-script=\"3625bb82-8e0e-4be8-80d3-257e4f469168\"\n\u003e\u003c/script\u003e\n\n\u003cscript type=\"text/javascript\"\u003e\n  function OptanonWrapper() {}\n\u003c/script\u003e\n\n\u003c!-- OneTrust Cookies Consent Notice end for takeda.com --\u003e "}},{"_key":"63262da4-9c32-435b-80a5-67f5449f1352","loadingStrategy":"beforeInteractive","title":"EPD-3519 Schema Script","script":{"language":"","highlightedLines":[],"code":"\u003cscript type=\"application/ld+json\"\u003e{\"@context\": \"https://schema.org\",\"@type\":\"Organization\",\"name\": \"Takeda Pharmaceutical Company Limited\",\"url\": \"https://www.takeda.com\",\"logo\": \"https://www.takeda.com/4ab4e2/siteassets/system/top/howwework_logo_1600x900.jpg\",\"address\": {\"@type\": \"PostalAddress\",\"streetAddress\": \"2-ch?me-1-1 Nihonbashihonch?\",\"addressLocality\": \"Chuo City\",\"addressRegion\": \"Tokyo\",\"postalCode\": \"103-0023\",\"addressCountry\": \"Japan\"},\"contactPoint\": {\"@type\": \"ContactPoint\",\"contactType\": \"contact\",\"telephone\": \"+81 3-3278-2111\",\"email\": \"Media_Relations@takeda.com\"},\"sameAs\":[\"https://www.linkedin.com/company/takeda-pharmaceuticals/\",\"https://twitter.com/takedapharma\",\"https://www.youtube.com/takeda-pharmaceuticals\"]} \u003c/script\u003e","filename":"","_type":"code"},"_type":"Script"},{"_type":"Script","_key":"f11e0f99-ac48-43de-8fd1-3ff7332effea","loadingStrategy":"beforeInteractive","title":"EPD-2855 GTM Script","script":{"highlightedLines":[],"code":"\u003c!-- Google Tag Manager --\u003e\n\u003cscript\u003e(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':\nnew Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],\nj=d.createElement(s),dl=l!='dataLayer'?'\u0026l='+l:'';j.async=true;j.src=\n'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);\n})(window,document,'script','dataLayer','GTM-5XBTH5B');\u003c/script\u003e\n\u003c!-- End Google Tag Manager --\u003e","filename":"","_type":"code","language":""}},{"script":{"code":"\u003c!-- Matomo Tag Manager --\u003e\r\n\u003cscript\u003e\r\nvar _mtm = window._mtm = window._mtm || [];\r\n_mtm.push({'mtm.startTime': (new Date().getTime()), 'event': 'mtm.Start'});\r\nvar d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];\r\ng.async=true; g.src='https://cdn.matomo.cloud/takeda.matomo.cloud/container_rTZNKGIx.js'; s.parentNode.insertBefore(g,s);\r\n\u003c/script\u003e\r\n\u003c!-- End Matomo Tag Manager --\u003e","_type":"code","language":"js"},"_type":"Script","_key":"81654c8cf9a8","loadingStrategy":"beforeInteractive","title":"EPD-4037 Matomo Tag Manager"},{"loadingStrategy":"beforeInteractive","title":"EPD-4268 Cookie Script Hack","script":{"_type":"code","code":"\u003cstyle type=\"text/css\"\u003e #onetrust-consent-sdk svg {display: inline;} \u003c/style\u003e"},"_type":"Script","_key":"b8b6fa15-4703-4000-9231-9d6f3cd26a9f"}]},"defaultTheme":{"h1":{"fontLineHeight":"2.875rem","fontWeight":"300","fontLineHeightMobile":"","fontWeightMobile":"300","fontSize":"2.625rem","fontSizeMobile":"1.875rem"},"h2":{"fontLineHeight":"2.6875rem","fontWeight":"300","fontLineHeightMobile":"2rem","fontWeightMobile":"300","fontSize":"2.25rem","fontSizeMobile":"1.5rem"},"h5":{"fontWeight":"700","fontLineHeightMobile":"1.75rem","fontWeightMobile":"700","fontSize":"1rem","fontSizeMobile":"1rem","fontLineHeight":"1.75rem"},"colorDarkGreyContrast":"#ffffff","colorLightGrey":"#edf2f4","colorDarkGrey":"#333333","colorLightGreyContrast":"#333333","h3":{"fontLineHeightMobile":"1.75rem","fontWeightMobile":"500","fontSize":"1.5rem","fontSizeMobile":"1.25rem","fontLineHeight":"2rem","fontWeight":"500"},"h4":{"fontSizeMobile":"1.125rem","fontLineHeight":"1.75rem","fontWeight":"500","fontLineHeightMobile":"1.75rem","fontWeightMobile":"500","fontSize":"1.25rem"},"buttonPrimary":{"borderRadiusBottomLeft":"1.25rem","borderRadiusTopRight":"","hoverBackgroundColor":"#891515","borderRadiusBottomRight":"","textColor":"#ffffff","backgroundColor":"#BD120A","borderRadiusTopLeft":""},"colorSecondary":"#891515","bodyBlock":{"fontWeight":"400","fontLineHeightMobile":"1.625rem","fontWeightMobile":"400","fontSize":"1rem","fontSizeMobile":"1rem","fontLineHeight":"1.625rem"},"textColor":"#333333","colorPrimaryActive":"#891515","colorHoverGrey":"#DCE6E9","cta":{"fontWeightMobile":"700","fontSize":"1rem","fontSizeMobile":"1rem","fontLineHeight":"1.625rem","fontWeight":"700","fontLineHeightMobile":"1.625rem"},"colorMediumGrey":"#a1a4ac","colorPrimary":"#BD120A","colorSecondaryContrast":"#ffffff","subHeading":{"fontLineHeightMobile":"1.5rem","fontWeightMobile":"700","fontSize":"1.125rem","fontSizeMobile":"1rem","fontLineHeight":"1.25rem","fontWeight":"500"},"__i18n_lang":"en","buttonSecondary":{"backgroundColor":"","borderRadiusTopLeft":"","borderRadiusBottomLeft":"","borderRadiusTopRight":"","hoverBackgroundColor":"","borderRadiusBottomRight":"","textColor":"#333333"},"quote":{"fontWeight":"400","fontLineHeightMobile":"1.625rem","fontWeightMobile":"400","fontSize":"2rem","fontSizeMobile":"1.25rem","fontLineHeight":"2.75rem"},"colorMediumGreyContrast":"#ffffff","colorPrimaryActiveContrast":"#ffffff","globalImages":{"borderRadiusBottomRight":"","borderRadiusTopLeft":"","borderRadiusBottomLeft":"1.875rem","borderRadiusTopRight":""},"colorPrimaryContrast":"#ffffff","spacings":{"marginTopMobile":"0rem","marginTopFirstComponentMobile":"2.5rem","marginTop":"0rem","marginTopFirstComponent":"3.125rem","paddingTop":"0rem","marginBottomMobile":"2.5rem","paddingTopMobile":"0rem","marginBottom":"3.125rem","paddingBottomMobile":"0rem","paddingBottom":"0rem"},"__metadata":{"modelName":"ThemeStyle","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"siteTheme","createdAt":"2022-11-11T08:38:47Z","updatedAt":"2023-05-18T19:29:32Z"},"type":"ThemeStyle"},"alternatePageLangData":{"baseSlug":"/","currentSlug":"/","alternateLanguages":[{"slug":"/jp/","lang":"ja"}],"currentLanguage":"en"},"currentLanguage":"en"},"__N_SSG":true},"page":"/[[...slug]]","query":{},"buildId":"nFkK7YISqlZ_ykhgcoPzV","isFallback":false,"dynamicIds":[39099,11735,40982,75033,11467,69838,44676,76896,42066,25997,85530,20675,16237,47588,25003,14656,43829,83477,60320,39413,53442,33644,69144,46787,98242,46978,72049,79634,53085,93566,13329,75259,28532,32255,37726,46914,45191,87560,41075,52737,76647,11009,62616,60297,35918,77427,95609,61078,85160,24124,47133,18102,46362,19457],"gsp":true,"locale":"en","locales":["en","jp"],"defaultLocale":"en","scriptLoader":[]}</script><script defer src="https://static.cloudflareinsights.com/beacon.min.js/v8b253dfea2ab4077af8c6f58422dfbfd1689876627854" integrity="sha512-bjgnUKX4azu3dLTVtie9u6TKqgx29RBwfj3QXYt5EKfWM/9hPSAI/4qcV5NACjwAo8UtTeWefx6Zq5PHcMm7Tg==" data-cf-beacon='{"rayId":"811619ade95c85ab","version":"2023.8.0","b":1,"token":"07a32066cb3b44f9931014efa4603dd9","si":100}' crossorigin="anonymous"></script>
</body></html>